NO152133B - ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE 2,3-ALKYLENE-BIS-OXYBENZAMIDES - Google Patents
ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE 2,3-ALKYLENE-BIS-OXYBENZAMIDES Download PDFInfo
- Publication number
- NO152133B NO152133B NO772739A NO772739A NO152133B NO 152133 B NO152133 B NO 152133B NO 772739 A NO772739 A NO 772739A NO 772739 A NO772739 A NO 772739A NO 152133 B NO152133 B NO 152133B
- Authority
- NO
- Norway
- Prior art keywords
- benzodioxane
- carboxamide
- pyrrolidylmethyl
- ethyl
- methyl
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims description 19
- 238000002360 preparation method Methods 0.000 title claims description 5
- 230000001225 therapeutic effect Effects 0.000 title claims description 4
- 150000001875 compounds Chemical class 0.000 claims description 34
- -1 C 1 -C 4 alkoxy Chemical group 0.000 claims description 23
- 239000002253 acid Substances 0.000 claims description 22
- UNRBEYYLYRXYCG-UHFFFAOYSA-N (1-ethylpyrrolidin-2-yl)methanamine Chemical compound CCN1CCCC1CN UNRBEYYLYRXYCG-UHFFFAOYSA-N 0.000 claims description 18
- 238000004519 manufacturing process Methods 0.000 claims description 14
- 229910052739 hydrogen Inorganic materials 0.000 claims description 12
- 239000001257 hydrogen Substances 0.000 claims description 12
- RKSFKFSIQAQPHQ-UHFFFAOYSA-N 7-(methylsulfamoyl)-2,3-dihydro-1,4-benzodioxine-5-carbonyl chloride Chemical compound O1CCOC2=C1C=C(S(=O)(=O)NC)C=C2C(Cl)=O RKSFKFSIQAQPHQ-UHFFFAOYSA-N 0.000 claims description 11
- AJEDNQSLTXJFJG-UHFFFAOYSA-N 7-ethylsulfonyl-2,3-dihydro-1,4-benzodioxine-5-carbonyl chloride Chemical compound O1CCOC2=C1C=C(S(=O)(=O)CC)C=C2C(Cl)=O AJEDNQSLTXJFJG-UHFFFAOYSA-N 0.000 claims description 10
- 150000002431 hydrogen Chemical group 0.000 claims description 10
- 229910052736 halogen Inorganic materials 0.000 claims description 9
- 150000002367 halogens Chemical group 0.000 claims description 9
- YRXDDQLZROFCKK-UHFFFAOYSA-N n-[(1-ethylpyrrolidin-2-yl)methyl]-7-ethylsulfonyl-2,3-dihydro-1,4-benzodioxine-5-carboxamide Chemical compound CCN1CCCC1CNC(=O)C1=CC(S(=O)(=O)CC)=CC2=C1OCCO2 YRXDDQLZROFCKK-UHFFFAOYSA-N 0.000 claims description 9
- POVZSJGKGZYZPS-UHFFFAOYSA-N n-[(1-methylpyrrolidin-2-yl)methyl]-7-(methylsulfamoyl)-2,3-dihydro-1,4-benzodioxine-5-carboxamide Chemical compound C=1C(S(=O)(=O)NC)=CC=2OCCOC=2C=1C(=O)NCC1CCCN1C POVZSJGKGZYZPS-UHFFFAOYSA-N 0.000 claims description 9
- JUFKJRCMBLLXNH-UHFFFAOYSA-N (1-methylpyrrolidin-2-yl)methanamine Chemical compound CN1CCCC1CN JUFKJRCMBLLXNH-UHFFFAOYSA-N 0.000 claims description 8
- HTGKTSVPJJNEMQ-QMMMGPOBSA-N [(2s)-1-prop-2-enylpyrrolidin-2-yl]methanamine Chemical compound NC[C@@H]1CCCN1CC=C HTGKTSVPJJNEMQ-QMMMGPOBSA-N 0.000 claims description 8
- 150000001412 amines Chemical class 0.000 claims description 8
- SXAKAOFKGIOPHK-UHFFFAOYSA-N methyl 7-sulfamoyl-2,3-dihydro-1,4-benzodioxine-5-carboxylate Chemical compound O1CCOC2=C1C=C(S(N)(=O)=O)C=C2C(=O)OC SXAKAOFKGIOPHK-UHFFFAOYSA-N 0.000 claims description 8
- 125000004397 aminosulfonyl group Chemical group NS(=O)(=O)* 0.000 claims description 7
- XOPARDXSIMENIK-UHFFFAOYSA-N 7-(dimethylsulfamoyl)-2,3-dihydro-1,4-benzodioxine-5-carbonyl chloride Chemical compound O1CCOC2=C1C=C(S(=O)(=O)N(C)C)C=C2C(Cl)=O XOPARDXSIMENIK-UHFFFAOYSA-N 0.000 claims description 6
- JTKAQKREMDVCLQ-UHFFFAOYSA-N 7-(dimethylsulfamoyl)-n-[(1-methylpyrrolidin-2-yl)methyl]-2,3-dihydro-1,4-benzodioxine-5-carboxamide Chemical compound C=1C(S(=O)(=O)N(C)C)=CC=2OCCOC=2C=1C(=O)NCC1CCCN1C JTKAQKREMDVCLQ-UHFFFAOYSA-N 0.000 claims description 6
- 238000006243 chemical reaction Methods 0.000 claims description 6
- UAMRSLPXDICKQF-UHFFFAOYSA-N methyl 7-(methylsulfamoyl)-2,3-dihydro-1,4-benzodioxine-5-carboxylate Chemical compound O1CCOC2=C1C=C(S(=O)(=O)NC)C=C2C(=O)OC UAMRSLPXDICKQF-UHFFFAOYSA-N 0.000 claims description 6
- YHFLGEVINDZKFY-UHFFFAOYSA-N 7-ethylsulfonyl-n-[(1-methylpyrrolidin-2-yl)methyl]-2,3-dihydro-1,4-benzodioxine-5-carboxamide Chemical compound C=1C(S(=O)(=O)CC)=CC=2OCCOC=2C=1C(=O)NCC1CCCN1C YHFLGEVINDZKFY-UHFFFAOYSA-N 0.000 claims description 4
- LLANSHIYQPLIKH-UHFFFAOYSA-N n-[(1-ethylpyrrolidin-2-yl)methyl]-7-sulfamoyl-2,3-dihydro-1,4-benzodioxine-5-carboxamide Chemical compound CCN1CCCC1CNC(=O)C1=CC(S(N)(=O)=O)=CC2=C1OCCO2 LLANSHIYQPLIKH-UHFFFAOYSA-N 0.000 claims description 4
- 150000003242 quaternary ammonium salts Chemical class 0.000 claims description 4
- 150000003839 salts Chemical class 0.000 claims description 4
- AUIYGHHLPMMOGF-UHFFFAOYSA-N 7-(dimethylsulfamoyl)-n-[(1-ethylpyrrolidin-2-yl)methyl]-2,3-dihydro-1,4-benzodioxine-5-carboxamide Chemical compound CCN1CCCC1CNC(=O)C1=CC(S(=O)(=O)N(C)C)=CC2=C1OCCO2 AUIYGHHLPMMOGF-UHFFFAOYSA-N 0.000 claims description 3
- 150000001204 N-oxides Chemical class 0.000 claims description 3
- 125000005843 halogen group Chemical group 0.000 claims description 3
- DPEPZAJVZHRORQ-UHFFFAOYSA-N 1-cyclohexylpyrrolidin-3-amine Chemical compound C1C(N)CCN1C1CCCCC1 DPEPZAJVZHRORQ-UHFFFAOYSA-N 0.000 claims description 2
- 125000004399 C1-C4 alkenyl group Chemical group 0.000 claims description 2
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 2
- LVYXPIJZDUZGKR-UHFFFAOYSA-N n-[(1-methylpyrrolidin-2-yl)methyl]-7-sulfamoyl-2,3-dihydro-1,4-benzodioxine-5-carboxamide Chemical compound CN1CCCC1CNC(=O)C1=CC(S(N)(=O)=O)=CC2=C1OCCO2 LVYXPIJZDUZGKR-UHFFFAOYSA-N 0.000 claims description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 97
- 239000000243 solution Substances 0.000 description 81
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 72
- 238000002844 melting Methods 0.000 description 72
- 230000008018 melting Effects 0.000 description 72
- 239000000203 mixture Substances 0.000 description 68
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 58
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 55
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 41
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 40
- 239000002244 precipitate Substances 0.000 description 38
- 239000013078 crystal Substances 0.000 description 31
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 30
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 26
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 24
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 24
- 235000011054 acetic acid Nutrition 0.000 description 24
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 description 24
- 239000002585 base Substances 0.000 description 23
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 21
- 229910021529 ammonia Inorganic materials 0.000 description 20
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 18
- 238000003756 stirring Methods 0.000 description 16
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 15
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 15
- 239000006229 carbon black Substances 0.000 description 15
- 238000010992 reflux Methods 0.000 description 15
- 239000002904 solvent Substances 0.000 description 13
- 238000001953 recrystallisation Methods 0.000 description 12
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 11
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 10
- 238000001816 cooling Methods 0.000 description 10
- 235000017550 sodium carbonate Nutrition 0.000 description 10
- 229910000029 sodium carbonate Inorganic materials 0.000 description 10
- 238000005481 NMR spectroscopy Methods 0.000 description 9
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 8
- KHDSNFILCIVZDT-UHFFFAOYSA-N n-[(1-ethylpyrrolidin-2-yl)methyl]-7-(methylsulfamoyl)-2,3-dihydro-1,4-benzodioxine-5-carboxamide Chemical compound CCN1CCCC1CNC(=O)C1=CC(S(=O)(=O)NC)=CC2=C1OCCO2 KHDSNFILCIVZDT-UHFFFAOYSA-N 0.000 description 8
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 8
- 239000000047 product Substances 0.000 description 8
- NCSFGFOXYGSSSH-UHFFFAOYSA-N 7-chlorosulfonyl-2,3-dihydro-1,4-benzodioxine-5-carboxylic acid Chemical compound O1CCOC2=C1C=C(S(Cl)(=O)=O)C=C2C(=O)O NCSFGFOXYGSSSH-UHFFFAOYSA-N 0.000 description 6
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 6
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 6
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 6
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 6
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 6
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 6
- 238000009835 boiling Methods 0.000 description 6
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 6
- 229910052794 bromium Inorganic materials 0.000 description 6
- 150000003857 carboxamides Chemical class 0.000 description 6
- 150000007513 acids Chemical class 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 150000002148 esters Chemical class 0.000 description 5
- 238000010438 heat treatment Methods 0.000 description 5
- 235000011121 sodium hydroxide Nutrition 0.000 description 5
- LYCFLVALOZTFDX-UHFFFAOYSA-N 5-acetamido-2,3-dihydro-1,4-benzodioxine-8-carboxylic acid Chemical compound O1CCOC2=C1C(C(O)=O)=CC=C2NC(=O)C LYCFLVALOZTFDX-UHFFFAOYSA-N 0.000 description 4
- LKYLYFSTNNVQNS-UHFFFAOYSA-N 5-amino-2,3-dihydro-1,4-benzodioxine-8-carboxylic acid Chemical compound O1CCOC2=C1C(C(O)=O)=CC=C2N LKYLYFSTNNVQNS-UHFFFAOYSA-N 0.000 description 4
- MVYGNUFUGOZHQE-UHFFFAOYSA-N 66411-18-5 Chemical compound O1CCOC2=C1C([N+]([O-])=O)=C(Br)C(Br)=C2C(=O)O MVYGNUFUGOZHQE-UHFFFAOYSA-N 0.000 description 4
- ZRISRDUHJZSFSK-UHFFFAOYSA-N 7-(dimethylsulfamoyl)-2,3-dihydro-1,4-benzodioxine-5-carboxylic acid Chemical compound O1CCOC2=C1C=C(S(=O)(=O)N(C)C)C=C2C(O)=O ZRISRDUHJZSFSK-UHFFFAOYSA-N 0.000 description 4
- NQEQVGJQJCYZNI-UHFFFAOYSA-N 7-(methylsulfamoyl)-2,3-dihydro-1,4-benzodioxine-5-carboxylic acid Chemical compound O1CCOC2=C1C=C(S(=O)(=O)NC)C=C2C(O)=O NQEQVGJQJCYZNI-UHFFFAOYSA-N 0.000 description 4
- ZHWMIKHMSOYRBC-UHFFFAOYSA-N 7-ethylsulfonyl-2,3-dihydro-1,4-benzodioxine-5-carboxylic acid Chemical compound O1CCOC2=C1C=C(S(=O)(=O)CC)C=C2C(O)=O ZHWMIKHMSOYRBC-UHFFFAOYSA-N 0.000 description 4
- KXDAEFPNCMNJSK-UHFFFAOYSA-N Benzamide Chemical compound NC(=O)C1=CC=CC=C1 KXDAEFPNCMNJSK-UHFFFAOYSA-N 0.000 description 4
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 4
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 4
- 125000005153 alkyl sulfamoyl group Chemical group 0.000 description 4
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 4
- 230000002903 catalepsic effect Effects 0.000 description 4
- 239000000460 chlorine Substances 0.000 description 4
- 229910052801 chlorine Inorganic materials 0.000 description 4
- 239000000706 filtrate Substances 0.000 description 4
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 description 4
- 238000000655 nuclear magnetic resonance spectrum Methods 0.000 description 4
- 229910000027 potassium carbonate Inorganic materials 0.000 description 4
- 238000000746 purification Methods 0.000 description 4
- LPXPTNMVRIOKMN-UHFFFAOYSA-M sodium nitrite Chemical compound [Na+].[O-]N=O LPXPTNMVRIOKMN-UHFFFAOYSA-M 0.000 description 4
- KEQGZUUPPQEDPF-UHFFFAOYSA-N 1,3-dichloro-5,5-dimethylimidazolidine-2,4-dione Chemical compound CC1(C)N(Cl)C(=O)N(Cl)C1=O KEQGZUUPPQEDPF-UHFFFAOYSA-N 0.000 description 3
- VCLSWKVAHAJSFL-UHFFFAOYSA-N 2,3-dihydro-1,4-benzodioxine-5-carboxylic acid Chemical compound O1CCOC2=C1C=CC=C2C(=O)O VCLSWKVAHAJSFL-UHFFFAOYSA-N 0.000 description 3
- YIHVNRIFOBREPB-UHFFFAOYSA-N 5-acetamido-n-[(1-ethylpyrrolidin-2-yl)methyl]-2,3-dihydro-1,4-benzodioxine-8-carboxamide Chemical compound CCN1CCCC1CNC(=O)C1=CC=C(NC(C)=O)C2=C1OCCO2 YIHVNRIFOBREPB-UHFFFAOYSA-N 0.000 description 3
- YVMFPRFSXLLATH-UHFFFAOYSA-N 5-amino-n-[(1-ethylpyrrolidin-2-yl)methyl]-2,3-dihydro-1,4-benzodioxine-8-carboxamide;dihydrochloride Chemical compound Cl.Cl.CCN1CCCC1CNC(=O)C1=CC=C(N)C2=C1OCCO2 YVMFPRFSXLLATH-UHFFFAOYSA-N 0.000 description 3
- PWJRPWPPVFPUQD-UHFFFAOYSA-N 5-methoxy-2,3-dihydro-1,4-benzodioxine-8-carboxylic acid Chemical compound O1CCOC2=C1C(C(O)=O)=CC=C2OC PWJRPWPPVFPUQD-UHFFFAOYSA-N 0.000 description 3
- DAZVOZDOZMSYIL-UHFFFAOYSA-N 5-methoxy-6-sulfamoyl-2,3-dihydro-1,4-benzodioxine-8-carboxylic acid Chemical compound O1CCOC2=C(C(O)=O)C=C(S(N)(=O)=O)C(OC)=C21 DAZVOZDOZMSYIL-UHFFFAOYSA-N 0.000 description 3
- YAQJEXMCCBHATG-UHFFFAOYSA-N 6,7-dibromo-2,3-dihydro-1,4-benzodioxine-5-carboxylic acid Chemical compound O1CCOC2=C1C=C(Br)C(Br)=C2C(=O)O YAQJEXMCCBHATG-UHFFFAOYSA-N 0.000 description 3
- SJKOZUVHRPRMRJ-UHFFFAOYSA-N 6,7-dibromo-5-nitro-2,3-dihydro-1,4-benzodioxine-8-carbonyl chloride Chemical compound O1CCOC2=C1C(C(Cl)=O)=C(Br)C(Br)=C2[N+](=O)[O-] SJKOZUVHRPRMRJ-UHFFFAOYSA-N 0.000 description 3
- CJPGSUPNJOCTCY-UHFFFAOYSA-N 7-(diethylsulfamoyl)-2,3-dihydro-1,4-benzodioxine-5-carboxylic acid Chemical compound O1CCOC2=C1C=C(S(=O)(=O)N(CC)CC)C=C2C(O)=O CJPGSUPNJOCTCY-UHFFFAOYSA-N 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 3
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 3
- QOSSAOTZNIDXMA-UHFFFAOYSA-N Dicylcohexylcarbodiimide Chemical compound C1CCCCC1N=C=NC1CCCCC1 QOSSAOTZNIDXMA-UHFFFAOYSA-N 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- 125000003545 alkoxy group Chemical group 0.000 description 3
- 125000004390 alkyl sulfonyl group Chemical group 0.000 description 3
- 238000007112 amidation reaction Methods 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 150000008064 anhydrides Chemical class 0.000 description 3
- 230000003474 anti-emetic effect Effects 0.000 description 3
- 229940054066 benzamide antipsychotics Drugs 0.000 description 3
- 150000003936 benzamides Chemical class 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- XTHPWXDJESJLNJ-UHFFFAOYSA-N chlorosulfonic acid Substances OS(Cl)(=O)=O XTHPWXDJESJLNJ-UHFFFAOYSA-N 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 3
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 3
- CWMGJIZXWZOWJU-UHFFFAOYSA-N n-[(1-benzylpyrrolidin-2-yl)methyl]-7-(diethylsulfamoyl)-2,3-dihydro-1,4-benzodioxine-5-carboxamide;phosphoric acid Chemical compound OP(O)(O)=O.C=1C(S(=O)(=O)N(CC)CC)=CC=2OCCOC=2C=1C(=O)NCC1CCCN1CC1=CC=CC=C1 CWMGJIZXWZOWJU-UHFFFAOYSA-N 0.000 description 3
- 229910017604 nitric acid Inorganic materials 0.000 description 3
- 231100000957 no side effect Toxicity 0.000 description 3
- FVAUCKIRQBBSSJ-UHFFFAOYSA-M sodium iodide Chemical compound [Na+].[I-] FVAUCKIRQBBSSJ-UHFFFAOYSA-M 0.000 description 3
- 125000001424 substituent group Chemical group 0.000 description 3
- IEWVBBWTJOHHCY-UHFFFAOYSA-N 2,3-dihydro-1,4-benzodioxine-5-carbonyl chloride Chemical compound O1CCOC2=C1C=CC=C2C(=O)Cl IEWVBBWTJOHHCY-UHFFFAOYSA-N 0.000 description 2
- CFMZSMGAMPBRBE-UHFFFAOYSA-N 2-hydroxyisoindole-1,3-dione Chemical compound C1=CC=C2C(=O)N(O)C(=O)C2=C1 CFMZSMGAMPBRBE-UHFFFAOYSA-N 0.000 description 2
- YOETUEMZNOLGDB-UHFFFAOYSA-N 2-methylpropyl carbonochloridate Chemical compound CC(C)COC(Cl)=O YOETUEMZNOLGDB-UHFFFAOYSA-N 0.000 description 2
- OZGDSSXESIMADL-UHFFFAOYSA-N 5-acetamido-6-nitro-2,3-dihydro-1,4-benzodioxine-8-carboxylic acid Chemical compound O1CCOC2=C(C(O)=O)C=C([N+]([O-])=O)C(NC(=O)C)=C21 OZGDSSXESIMADL-UHFFFAOYSA-N 0.000 description 2
- QYLUBOYUQYTVSP-UHFFFAOYSA-N 5-methoxy-2,3-dihydro-1,4-benzodioxine-8-carbonyl chloride Chemical compound O1CCOC2=C1C(C(Cl)=O)=CC=C2OC QYLUBOYUQYTVSP-UHFFFAOYSA-N 0.000 description 2
- QFTQYWNNATXJGG-UHFFFAOYSA-N 6-chlorosulfonyl-5-methoxy-2,3-dihydro-1,4-benzodioxine-8-carboxylic acid Chemical compound O1CCOC2=C(C(O)=O)C=C(S(Cl)(=O)=O)C(OC)=C21 QFTQYWNNATXJGG-UHFFFAOYSA-N 0.000 description 2
- RNNLXFYGDGETIY-UHFFFAOYSA-N 7-ethylsulfanyl-2,3-dihydro-1,4-benzodioxine-5-carboxylic acid Chemical compound O1CCOC2=C1C=C(SCC)C=C2C(O)=O RNNLXFYGDGETIY-UHFFFAOYSA-N 0.000 description 2
- GPKDBCCYRICYKP-UHFFFAOYSA-N 7-sulfamoyl-2,3-dihydro-1,4-benzodioxine-5-carboxylic acid Chemical compound O1CCOC2=C1C=C(S(=O)(=O)N)C=C2C(O)=O GPKDBCCYRICYKP-UHFFFAOYSA-N 0.000 description 2
- ICGQFSSFYCENOY-UHFFFAOYSA-N 7-sulfanyl-2,3-dihydro-1,4-benzodioxine-5-carboxylic acid Chemical compound O1CCOC2=C1C=C(S)C=C2C(=O)O ICGQFSSFYCENOY-UHFFFAOYSA-N 0.000 description 2
- HCXGTVQTCVPNPQ-UHFFFAOYSA-N 8-acetamido-6-nitro-2,3-dihydro-1,4-benzodioxine-5-carboxylic acid Chemical compound O1CCOC2=C1C(C(O)=O)=C([N+]([O-])=O)C=C2NC(=O)C HCXGTVQTCVPNPQ-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- LCGLNKUTAGEVQW-UHFFFAOYSA-N Dimethyl ether Chemical compound COC LCGLNKUTAGEVQW-UHFFFAOYSA-N 0.000 description 2
- ROSDSFDQCJNGOL-UHFFFAOYSA-N Dimethylamine Chemical compound CNC ROSDSFDQCJNGOL-UHFFFAOYSA-N 0.000 description 2
- 206010060800 Hot flush Diseases 0.000 description 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 2
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 2
- BAVYZALUXZFZLV-UHFFFAOYSA-N Methylamine Chemical compound NC BAVYZALUXZFZLV-UHFFFAOYSA-N 0.000 description 2
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 2
- 239000007868 Raney catalyst Substances 0.000 description 2
- 229910000564 Raney nickel Inorganic materials 0.000 description 2
- 241000700159 Rattus Species 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
- ATJFFYVFTNAWJD-UHFFFAOYSA-N Tin Chemical compound [Sn] ATJFFYVFTNAWJD-UHFFFAOYSA-N 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- 206010047700 Vomiting Diseases 0.000 description 2
- 125000005907 alkyl ester group Chemical group 0.000 description 2
- 125000000217 alkyl group Chemical group 0.000 description 2
- VMWNQDUVQKEIOC-CYBMUJFWSA-N apomorphine Chemical compound C([C@H]1N(C)CC2)C3=CC=C(O)C(O)=C3C3=C1C2=CC=C3 VMWNQDUVQKEIOC-CYBMUJFWSA-N 0.000 description 2
- 229960004046 apomorphine Drugs 0.000 description 2
- 125000003118 aryl group Chemical group 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 238000002425 crystallisation Methods 0.000 description 2
- 230000008025 crystallization Effects 0.000 description 2
- 201000003146 cystitis Diseases 0.000 description 2
- 238000004090 dissolution Methods 0.000 description 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 2
- KIWBPDUYBMNFTB-UHFFFAOYSA-M ethyl sulfate Chemical compound CCOS([O-])(=O)=O KIWBPDUYBMNFTB-UHFFFAOYSA-M 0.000 description 2
- 238000011065 in-situ storage Methods 0.000 description 2
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 2
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 2
- 150000002540 isothiocyanates Chemical class 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- NUJOXMJBOLGQSY-UHFFFAOYSA-N manganese dioxide Chemical compound O=[Mn]=O NUJOXMJBOLGQSY-UHFFFAOYSA-N 0.000 description 2
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 2
- NVNRWKTVXWAHHF-UHFFFAOYSA-N methyl 5-methoxy-6-sulfamoyl-2,3-dihydro-1,4-benzodioxine-8-carboxylate Chemical compound O1CCOC2=C1C(OC)=C(S(N)(=O)=O)C=C2C(=O)OC NVNRWKTVXWAHHF-UHFFFAOYSA-N 0.000 description 2
- ZYEKQMNBMUWLOB-UHFFFAOYSA-N n-[(1-benzylpyrrolidin-2-yl)methyl]-2,3-dihydro-1,4-benzodioxine-5-carboxamide;phosphoric acid Chemical compound OP(O)(O)=O.C=1C=CC=2OCCOC=2C=1C(=O)NCC1CCCN1CC1=CC=CC=C1 ZYEKQMNBMUWLOB-UHFFFAOYSA-N 0.000 description 2
- OSHBWNDEMSQXLY-UHFFFAOYSA-N n-[(1-ethylpyrrolidin-2-yl)methyl]-1,3-benzodioxole-4-carboxamide Chemical compound CCN1CCCC1CNC(=O)C1=CC=CC2=C1OCO2 OSHBWNDEMSQXLY-UHFFFAOYSA-N 0.000 description 2
- NHROVAANFJEPPV-UHFFFAOYSA-N n-[(1-ethylpyrrolidin-2-yl)methyl]-2,3-dihydro-1,4-benzodioxine-5-carboxamide;hydrochloride Chemical compound Cl.CCN1CCCC1CNC(=O)C1=CC=CC2=C1OCCO2 NHROVAANFJEPPV-UHFFFAOYSA-N 0.000 description 2
- PNQWQELYAPSYBA-UHFFFAOYSA-N n-[(1-ethylpyrrolidin-2-yl)methyl]-5-methoxy-6-sulfamoyl-2,3-dihydro-1,4-benzodioxine-8-carboxamide Chemical compound CCN1CCCC1CNC(=O)C1=CC(S(N)(=O)=O)=C(OC)C2=C1OCCO2 PNQWQELYAPSYBA-UHFFFAOYSA-N 0.000 description 2
- 229910052759 nickel Inorganic materials 0.000 description 2
- 235000006408 oxalic acid Nutrition 0.000 description 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 2
- FAIAAWCVCHQXDN-UHFFFAOYSA-N phosphorus trichloride Chemical class ClP(Cl)Cl FAIAAWCVCHQXDN-UHFFFAOYSA-N 0.000 description 2
- XHXFXVLFKHQFAL-UHFFFAOYSA-N phosphoryl trichloride Chemical compound ClP(Cl)(Cl)=O XHXFXVLFKHQFAL-UHFFFAOYSA-N 0.000 description 2
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 2
- 239000011541 reaction mixture Substances 0.000 description 2
- 230000009291 secondary effect Effects 0.000 description 2
- 235000010288 sodium nitrite Nutrition 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 239000007858 starting material Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 2
- DLYUQMMRRRQYAE-UHFFFAOYSA-N tetraphosphorus decaoxide Chemical compound O1P(O2)(=O)OP3(=O)OP1(=O)OP2(=O)O3 DLYUQMMRRRQYAE-UHFFFAOYSA-N 0.000 description 2
- 229910052727 yttrium Inorganic materials 0.000 description 2
- OEYAFMGVIFWPQI-UHFFFAOYSA-N (1-benzylpyrrolidin-2-yl)methanamine Chemical compound NCC1CCCN1CC1=CC=CC=C1 OEYAFMGVIFWPQI-UHFFFAOYSA-N 0.000 description 1
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 description 1
- 125000006656 (C2-C4) alkenyl group Chemical group 0.000 description 1
- CFGDUGSIBUXRMR-UHFFFAOYSA-N 1,2-dihydropyrrol-2-ide Chemical class C=1C=[C-]NC=1 CFGDUGSIBUXRMR-UHFFFAOYSA-N 0.000 description 1
- LVBLTFSJUMJXBI-UHFFFAOYSA-N 1,3-benzodioxole-4-carbonyl chloride Chemical compound ClC(=O)C1=CC=CC2=C1OCO2 LVBLTFSJUMJXBI-UHFFFAOYSA-N 0.000 description 1
- UHJCPTUYASMZRC-UHFFFAOYSA-N 1,3-benzodioxole-4-carboxamide Chemical class NC(=O)C1=CC=CC2=C1OCO2 UHJCPTUYASMZRC-UHFFFAOYSA-N 0.000 description 1
- VEFLKXRACNJHOV-UHFFFAOYSA-N 1,3-dibromopropane Chemical compound BrCCCBr VEFLKXRACNJHOV-UHFFFAOYSA-N 0.000 description 1
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 1
- YGDRPEIHNMXLJM-UHFFFAOYSA-N 2,3-dihydroxy-4-methoxybenzoic acid Chemical compound COC1=CC=C(C(O)=O)C(O)=C1O YGDRPEIHNMXLJM-UHFFFAOYSA-N 0.000 description 1
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 description 1
- BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 1
- VXEGSRKPIUDPQT-UHFFFAOYSA-N 4-[4-(4-methoxyphenyl)piperazin-1-yl]aniline Chemical compound C1=CC(OC)=CC=C1N1CCN(C=2C=CC(N)=CC=2)CC1 VXEGSRKPIUDPQT-UHFFFAOYSA-N 0.000 description 1
- HAQXDCQBSQSHSQ-UHFFFAOYSA-N 6,7-dibromo-n-[(1-ethylpyrrolidin-2-yl)methyl]-5-nitro-2,3-dihydro-1,4-benzodioxine-8-carboxamide Chemical compound CCN1CCCC1CNC(=O)C1=C(Br)C(Br)=C([N+]([O-])=O)C2=C1OCCO2 HAQXDCQBSQSHSQ-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- 241000282472 Canis lupus familiaris Species 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- ZAFNJMIOTHYJRJ-UHFFFAOYSA-N Diisopropyl ether Chemical compound CC(C)OC(C)C ZAFNJMIOTHYJRJ-UHFFFAOYSA-N 0.000 description 1
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 1
- 208000017604 Hodgkin disease Diseases 0.000 description 1
- 208000010747 Hodgkins lymphoma Diseases 0.000 description 1
- 208000033830 Hot Flashes Diseases 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- 206010029333 Neurosis Diseases 0.000 description 1
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 208000004403 Prostatic Hyperplasia Diseases 0.000 description 1
- 206010036940 Prostatic adenoma Diseases 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- 206010042464 Suicide attempt Diseases 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000007059 acute toxicity Effects 0.000 description 1
- 231100000403 acute toxicity Toxicity 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 150000003797 alkaloid derivatives Chemical class 0.000 description 1
- 150000001350 alkyl halides Chemical class 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 230000003276 anti-hypertensive effect Effects 0.000 description 1
- 239000002111 antiemetic agent Substances 0.000 description 1
- 229940125683 antiemetic agent Drugs 0.000 description 1
- 239000002249 anxiolytic agent Substances 0.000 description 1
- 230000000949 anxiolytic effect Effects 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 150000001540 azides Chemical class 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- GJQBHOAJJGIPRH-UHFFFAOYSA-N benzoyl cyanide Chemical class N#CC(=O)C1=CC=CC=C1 GJQBHOAJJGIPRH-UHFFFAOYSA-N 0.000 description 1
- RDHPKYGYEGBMSE-UHFFFAOYSA-N bromoethane Chemical compound CCBr RDHPKYGYEGBMSE-UHFFFAOYSA-N 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 150000001718 carbodiimides Chemical class 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- JYYOBHFYCIDXHH-UHFFFAOYSA-N carbonic acid;hydrate Chemical compound O.OC(O)=O JYYOBHFYCIDXHH-UHFFFAOYSA-N 0.000 description 1
- PFKFTWBEEFSNDU-UHFFFAOYSA-N carbonyldiimidazole Chemical compound C1=CN=CN1C(=O)N1C=CN=C1 PFKFTWBEEFSNDU-UHFFFAOYSA-N 0.000 description 1
- 150000001733 carboxylic acid esters Chemical class 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 235000010980 cellulose Nutrition 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000002512 chemotherapy Methods 0.000 description 1
- DQTRYXANLKJLPK-UHFFFAOYSA-N chlorophosphonous acid Chemical class OP(O)Cl DQTRYXANLKJLPK-UHFFFAOYSA-N 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- HPNMFZURTQLUMO-UHFFFAOYSA-N diethylamine Chemical compound CCNCC HPNMFZURTQLUMO-UHFFFAOYSA-N 0.000 description 1
- 125000000118 dimethyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 239000002895 emetic Substances 0.000 description 1
- 150000002081 enamines Chemical class 0.000 description 1
- TYQKHCZKVCIXAJ-UHFFFAOYSA-N ethyl 1,3-benzodioxole-4-carboxylate Chemical compound CCOC(=O)C1=CC=CC2=C1OCO2 TYQKHCZKVCIXAJ-UHFFFAOYSA-N 0.000 description 1
- 125000006125 ethylsulfonyl group Chemical group 0.000 description 1
- WMYNMYVRWWCRPS-UHFFFAOYSA-N ethynoxyethane Chemical group CCOC#C WMYNMYVRWWCRPS-UHFFFAOYSA-N 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 206010016629 fibroma Diseases 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 230000005484 gravity Effects 0.000 description 1
- 150000004820 halides Chemical class 0.000 description 1
- 229940042795 hydrazides for tuberculosis treatment Drugs 0.000 description 1
- 150000007928 imidazolide derivatives Chemical class 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 238000007912 intraperitoneal administration Methods 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 125000001972 isopentyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])C([H])([H])* 0.000 description 1
- 238000009533 lab test Methods 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- 230000009245 menopause Effects 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 230000006996 mental state Effects 0.000 description 1
- 229910052753 mercury Inorganic materials 0.000 description 1
- 229940098779 methanesulfonic acid Drugs 0.000 description 1
- QRNDDJXJUHBGSG-UHFFFAOYSA-N methoxyethyne Chemical compound COC#C QRNDDJXJUHBGSG-UHFFFAOYSA-N 0.000 description 1
- DOAJWTSNTNAEIY-UHFFFAOYSA-N methyl 2,3-dihydroxybenzoate Chemical compound COC(=O)C1=CC=CC(O)=C1O DOAJWTSNTNAEIY-UHFFFAOYSA-N 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- GNQRWGKVRSPWSM-UHFFFAOYSA-N n-(1-cyclohexylpyrrolidin-3-yl)-7-(methylsulfamoyl)-2,3-dihydro-1,4-benzodioxine-5-carboxamide Chemical compound C=1C(S(=O)(=O)NC)=CC=2OCCOC=2C=1C(=O)NC(C1)CCN1C1CCCCC1 GNQRWGKVRSPWSM-UHFFFAOYSA-N 0.000 description 1
- QAXBBRZVNDSSPG-UHFFFAOYSA-N n-[(1-ethylpyrrolidin-2-yl)methyl]-1,3-benzodioxole-4-carboxamide;hydrochloride Chemical compound Cl.CCN1CCCC1CNC(=O)C1=CC=CC2=C1OCO2 QAXBBRZVNDSSPG-UHFFFAOYSA-N 0.000 description 1
- JYHVHIHNOSYGLA-UHFFFAOYSA-N n-[(1-ethylpyrrolidin-2-yl)methyl]-5-methoxy-2,3-dihydro-1,4-benzodioxine-8-carboxamide Chemical compound CCN1CCCC1CNC(=O)C1=CC=C(OC)C2=C1OCCO2 JYHVHIHNOSYGLA-UHFFFAOYSA-N 0.000 description 1
- NFQKESSYOQXCKS-UHFFFAOYSA-N n-[(1-ethylpyrrolidin-2-yl)methyl]-7-ethylsulfonyl-2,3-dihydro-1,4-benzodioxine-5-carboxamide;hydrochloride Chemical compound Cl.CCN1CCCC1CNC(=O)C1=CC(S(=O)(=O)CC)=CC2=C1OCCO2 NFQKESSYOQXCKS-UHFFFAOYSA-N 0.000 description 1
- 230000008693 nausea Effects 0.000 description 1
- 208000015238 neurotic disease Diseases 0.000 description 1
- YCWSUKQGVSGXJO-NTUHNPAUSA-N nifuroxazide Chemical group C1=CC(O)=CC=C1C(=O)N\N=C\C1=CC=C([N+]([O-])=O)O1 YCWSUKQGVSGXJO-NTUHNPAUSA-N 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 239000012074 organic phase Substances 0.000 description 1
- 125000001147 pentyl group Chemical group C(CCCC)* 0.000 description 1
- 230000010412 perfusion Effects 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 235000011007 phosphoric acid Nutrition 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 229920005862 polyol Polymers 0.000 description 1
- 150000003077 polyols Chemical class 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 239000003368 psychostimulant agent Substances 0.000 description 1
- 230000001624 sedative effect Effects 0.000 description 1
- 239000005049 silicon tetrachloride Substances 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- HRZFUMHJMZEROT-UHFFFAOYSA-L sodium disulfite Chemical compound [Na+].[Na+].[O-]S(=O)S([O-])(=O)=O HRZFUMHJMZEROT-UHFFFAOYSA-L 0.000 description 1
- 235000009518 sodium iodide Nutrition 0.000 description 1
- 239000004296 sodium metabisulphite Substances 0.000 description 1
- 235000010262 sodium metabisulphite Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- NVBFHJWHLNUMCV-UHFFFAOYSA-N sulfamide Chemical class NS(N)(=O)=O NVBFHJWHLNUMCV-UHFFFAOYSA-N 0.000 description 1
- 150000003467 sulfuric acid derivatives Chemical class 0.000 description 1
- 229910021653 sulphate ion Inorganic materials 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 235000012222 talc Nutrition 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 210000001364 upper extremity Anatomy 0.000 description 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 239000008096 xylene Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D319/10—1,4-Dioxanes; Hydrogenated 1,4-dioxanes
- C07D319/14—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems
- C07D319/16—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D319/18—Ethylenedioxybenzenes, not substituted on the hetero ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D321/00—Heterocyclic compounds containing rings having two oxygen atoms as the only ring hetero atoms, not provided for by groups C07D317/00 - C07D319/00
- C07D321/02—Seven-membered rings
- C07D321/10—Seven-membered rings condensed with carbocyclic rings or ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Heart & Thoracic Surgery (AREA)
- Psychiatry (AREA)
- Anesthesiology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Cardiology (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Description
Foreliggende oppfinnelse angår fremstilling av nye substituerte 2,3-alkylen-bis-oksybenzamider med den generelle formel I, farmasøytisk akseptable syreaddisjonssalter derav, deres kvaternære ammoniumsalter, oksyder, dekstro- og levoroterende isomerer. The present invention relates to the preparation of new substituted 2,3-alkylene-bis-oxybenzamides of the general formula I, pharmaceutically acceptable acid addition salts thereof, their quaternary ammonium salts, oxides, dextro- and levorotatory isomers.
US-PS 2.688.026 og NO-PS 112.728 beskriver metylen-dioksybenzamider med terapeutisk aktivitet. US-PS 2,688,026 and NO-PS 112,728 describe methylenedioxybenzamides with therapeutic activity.
Således beskriver US-PS 2.688.026 benzamider med antihypertensiv og diuretisk virkning, dvs. virkninger på områder som er forskjellige fra virkningen til de forbindelser som beskrives nedenfor. Thus, US-PS 2,688,026 describes benzamides with antihypertensive and diuretic action, i.e. effects on areas that are different from the action of the compounds described below.
NO-PS 112.728 beskriver benzamider som spesielt er virksomme som antiemetiske midler. Den antiemetiske virkning er. imidlertid ikke så god som den antiemetiske virkning til de forbindelser som beskrives nedenfor. NO-PS 112,728 describes benzamides which are particularly effective as antiemetic agents. The antiemetic effect is however, not as good as the antiemetic action of the compounds described below.
Strukturen for forbindelsene fremstilt1ifølge oppfinnelsen kan generelt vises; ved følgende formel: The structure of the compounds prepared according to the invention can generally be shown; by the following formula:
der: there:
A er C-j^-C^-alkylen; A is C 1 -C 4 -alkylene;
R er C1~C4-alkyl; C^-C^-alkenyl, -Cg-cykloalkyl eller R is C1-C4 alkyl; C 1 -C 4 -alkenyl, -C 8 -cycloalkyl or
benzyl; benzyl;
X er hydrogen, C^-C^-alkoksy, nitro, amino eller acetamino; X is hydrogen, C₁-C₁ alkoxy, nitro, amino or acetamino;
Y er hydrogen, halogen, sulfamoyl, C^-C^-alkylsulfamoyl, Y is hydrogen, halogen, sulfamoyl, C₁-C₄ alkylsulfamoyl,
C1~C3-dialkylsulfamoyl, C-^- C^ -alkylsulf onyl eller X og Y er forbundet seg imellom og danner en azimidogruppe; C1-C3-dialkylsulfamoyl, C-1-C3-alkylsulfonyl or X and Y are linked together to form an azimido group;
Z er hydrogen, halogen eller Y og Z er forbundet seg imellom Z is hydrogen, halogen or Y and Z are interconnected
og danner en azimidogruppe; og and forms an azimido group; and
n er 0 eller 1. n is 0 or 1.
Innenfor de definisjoner som er angitt i beskrivelsen omfatter: C1-C4-alkyl metyl,, etyl , propyl, isopropyl, butvl, isobutvl, Within the definitions set out in the description include: C1-C4-alkyl methyl,, ethyl, propyl, isopropyl, butyl, isobutyl,
tert.-butyl; tert-butyl;
C^-C^-alkylen metylen, etylen, <p>ropylen; C 1 -C 4 -alkylene methylene, ethylene, <p>ropylene;
C2-C4-alkenyl hovedsakelig vinyl, allyl; C2-C4-alkenyl mainly vinyl, allyl;
C-^-C4-alkoksy metoksy, etoksy, propoksy, isoprop- C-^-C4-Alkoxy methoxy, ethoxy, propoxy, isoprop-
oksy, butoksy, isobutoksy, t-butoksy; oxy, butoxy, isobutoxy, t-butoxy;
halogen klor, brom, jod, fluor. halogen chlorine, bromine, iodine, fluorine.
De fortrinnsvise betydninger av substituentene er: for X: hydrogen, alkoksy og hovedsakelig metoksy, nitro, The preferred meanings of the substituents are: for X: hydrogen, alkoxy and mainly methoxy, nitro,
amino, acetamino; amino, acetamino;
for Y: hydrogen, halogen og hovedsakelig brom og klor, alkyl-sulfonyl og hovedsakelig etylsulfonyl, sulfamoyl, alkylsulfamoyl og spesielt metylsulfaitioyl, dialkylsulfamoyl for Y: hydrogen, halogen and mainly bromine and chlorine, alkyl-sulfonyl and mainly ethylsulfonyl, sulfamoyl, alkylsulfamoyl and especially methylsulfathioyl, dialkylsulfamoyl
og spesielt dimetyl- og dietylsulfamoyl, and especially dimethyl and diethylsulfamoyl,
for Z: hydrogen, halogen og hovedsakelig brom og klor, for Z: hydrogen, halogen and mainly bromine and chlorine,
og der de fortrinnsvise betydninger av substituentene i de disubstituerte forbindelser er: and where the preferred meanings of the substituents in the disubstituted compounds are:
' X = alkoksy og særlig metoksy ' X = alkoxy and especially methoxy
Y = sulfamoyl Y = sulfamoyl
X og Y er forbundet seg imellom for å danne en azimidogruppe. X and Y are joined together to form an azimido group.
Y = Z = halogen og særlig brom Y = Z = halogen and especially bromine
Y og Z kan være bundet sammen for å danne en azimidogruppe, og de fortrinnsvise betydninger for substituentene i de tri-substituerte forbindelser er: Y and Z may be linked together to form an azimido group, and the preferred meanings of the substituents in the tri-substituted compounds are:
f X = nitro f X = nitro
\_Y = Z = halogen og særlig klor oq brom. \_Y = Z = halogen and especially chlorine and bromine.
Forbindelsene kan ifølge oppfinnelsen fremstilles According to the invention, the compounds can be produced
ved omsetning av én forbindelse med den generelle formel: by reacting one compound with the general formula:
der: there:
A, X, Y og Z er som angitt ovenfor, D angir en hydroksygruppe, et halogenatom eller en organisk rest, med et amin med den generelle formel: A, X, Y and Z are as indicated above, D denotes a hydroxy group, a halogen atom or an organic residue, with an amine of the general formula:
der: there:
R og n er som angitt ovenfor, eller ved reaksjon mellom reaktive derivater. R and n are as stated above, or by reaction between reactive derivatives.
I utgangsforbindelsene omfatter den organiske rest grupper som er i stand til å danne reaktive syrederivater. Disse kan være lavere alkylestere, slik som metyl, etyl, propyl, isopropyl, butyl, isobutyl, t-butyl, pentyl eller isopentyl; reaktive syreestere, slik som metoksymetylester, cyanometylester, substituerte eller usubstituerte aromatiske estere eller N-hydroksyimidestere; syreazider; syrehydrazider; symmetriske anhydrider; blandede anhydrider, slik som de som dannes fra karboksylsyreestere og halogenmaursyreestere; azolider, slik som triazolider, tetrazolider og spesielt imida-zolider; substituerte a)-trihalogenacetofenoner; syreisotio-cyanater; substituerte a-oksobenzenacetonitriler; benzamider, som er substituert på ringen, eller andre ekvivalenter, eller forbindelsen med den generelle formel: In the starting compounds, the organic residue comprises groups capable of forming reactive acid derivatives. These may be lower alkyl esters, such as methyl, ethyl, propyl, isopropyl, butyl, isobutyl, t-butyl, pentyl or isopentyl; reactive acid esters, such as methoxymethyl ester, cyanomethyl ester, substituted or unsubstituted aromatic esters or N-hydroxyimide esters; acid azides; acid hydrazides; symmetrical anhydrides; mixed anhydrides, such as those formed from carboxylic acid esters and haloformic acid esters; azolides, such as triazolides, tetrazolides and especially imidazolides; substituted a)-trihaloacetophenones; acid isothiocyanates; substituted α-oxobenzeneacetonitrile; benzamides, which are substituted on the ring, or other equivalents, or the compound of the general formula:
(dannet fra syren og et isoksazoliumsalt). I den ovenfor angitte formel er A, X, Y og Z som angitt ovenfor. Imidlertid er oppfinnelsen ikke begrenset til anvendelsen av de ovenfor angitte derivater. (formed from the acid and an isoxazolium salt). In the above formula, A, X, Y and Z are as above. However, the invention is not limited to the use of the above-mentioned derivatives.
Ifølge oppfinnelsen kan aminet reagere i form av et av sine reaktive derivater. For eksempel kan nevnes reaksjonspro-duktene av aminet med fosforklorider, fosforoksyklorid, dialkyl-, diaryl- og ortofenylenklorfosfitter, alkyl- eller aryldiklorfos-fitter eller isotiocyanat av aminet eller aminets symmetriske eller asymmetriske sulfamider, det tilsvarende symmetriske urea, de tilsvarende enaminer eller enhver annen ekvivalent. According to the invention, the amine can react in the form of one of its reactive derivatives. For example, mention may be made of the reaction products of the amine with phosphorus chlorides, phosphorus oxychloride, dialkyl, diaryl and orthophenylene chlorophosphites, alkyl or aryldichlorophosphites or isothiocyanate of the amine or the amine's symmetrical or asymmetrical sulfamides, the corresponding symmetrical urea, the corresponding enamines or any other equivalent.
De ovenfor angitte reaktive derivater kan reagere med syren in situ eller etter foregående isolering. Imidlertid er oppfinnelsen ikke begrenset til anvendelse av de ovenfor beskrevne reaktive derivater. The above-mentioned reactive derivatives can react with the acid in situ or after previous isolation. However, the invention is not limited to the use of the reactive derivatives described above.
I tillegg er det også mulig å gjennomføre reaksjonen In addition, it is also possible to carry out the reaction
på den frie syre og det frie amin i nærvær av et kondensasjons-middel, f.eks. silisiumtetraklorid, fosforsyreanhydrid eller et karbodiimid, slik som dicykloheksylkarbodiimid eller alkoksy-acetylener, slik som metoksy- eller etoksyacetylen. on the free acid and the free amine in the presence of a condensing agent, e.g. silicon tetrachloride, phosphoric anhydride, or a carbodiimide, such as dicyclohexylcarbodiimide, or alkoxyacetylenes, such as methoxy- or ethoxyacetylene.
Blant de synteseprosesser, som er beskrevet for fremstilling ifølge oppfinnelsen av forbindelsene med formel I, er: Among the synthesis processes, which are described for the production according to the invention of the compounds of formula I, are:
- bruken av et syrehalogenid spesielt egnet for - the use of an acid halide particularly suitable for
- forbindelser som er usubstituerte i benzenringen - forbindelser som er monosubstituerte med et halogenatom, en nitrogruppe, en alkylsulfonylgruppe, en sulfamoylgruppe, alkyl- eller dialkylsulfamoylgruppe; - bruken av alkylestere, aktiverte sure estere eller - compounds that are unsubstituted in the benzene ring - compounds that are monosubstituted with a halogen atom, a nitro group, an alkylsulfonyl group, a sulfamoyl group, alkyl or dialkylsulfamoyl group; - the use of alkyl esters, activated acid esters or
aromatiske estere spesielt egnet for aromatic esters particularly suitable for
- forbindelser der benzenringen er substituert med en aminogruppe, en acetaminogruppe, en alkylsulfonylgruppe, en sulfamoylgruppe, en alkylsulfamoyl- eller dialkylsulfamoylgruppe - forbindelser der to av X og Y eller Y og Z-restene er bundet sammen for å danne en azimidogruppe; - bruken av blandede anhydrider (dannet in situ ved omsetning av utgangsbenzosyren på halogenmaursyreestere, fortrinnsvis klormaursyreestere) er spesielt egnet for forbindelser som er substituert med en nitrogruppe, en acetaminogruppe, en sulfamoylgruppe, alkylsulfamoyl-eller dialkylsulfamoylgruppe. - compounds in which the benzene ring is substituted with an amino group, an acetamino group, an alkylsulfonyl group, a sulfamoyl group, an alkylsulfamoyl or dialkylsulfamoyl group - compounds in which two of the X and Y or Y and Z residues are linked together to form an azimido group; - the use of mixed anhydrides (formed in situ by reaction of the starting benzoic acid on haloformic acid esters, preferably chloroformic acid esters) is particularly suitable for compounds substituted with a nitro group, an acetamino group, a sulfamoyl group, alkylsulfamoyl or dialkylsulfamoyl group.
Amideringsreaksjonen ifølge oppfinnelsen kan gjennomføres i nærvær eller i fravær av et oppløsningsmiddel . De systemer, som benyttes som oppløsningsmiddel, som er inerte med henblikk på amideringsreaksjonen, er f.eks. alkoholer, polyoler, benzen, toluen, dioksan, kloroform eller dietylenglykol, dimetyleter, xylen. Det er også mulig å benytte et overskudd av aminet, som benyttes som utgangsstof f. Det kan være foretrukket å vatrme opp reaksjonsblandingen under amideringsreaksjonen, f.eks. til de ovenfor angitte oppløsningsmidlers kokepunkt. The amidation reaction according to the invention can be carried out in the presence or in the absence of a solvent. The systems used as solvents, which are inert with regard to the amidation reaction, are e.g. alcohols, polyols, benzene, toluene, dioxane, chloroform or diethylene glycol, dimethyl ether, xylene. It is also possible to use an excess of the amine, which is used as starting material f. It may be preferred to warm up the reaction mixture during the amidation reaction, e.g. to the boiling point of the above-mentioned solvents.
Forbindelsene, som fremstilles ved fremgangsmåten ifølge oppfinnelsen, kan, hvis ønskelig, omsettes med farmasøytisk akseptable organiske eller uorganiske syrer, slik som saltsyre, hydrobromsyre, svovelsyre, fosforsyre, oksalsyre, eddiksyre, vinsyre, sitronsyre, metansulfonsyre, for å oppnå syreaddisjons-saltene. The compounds, which are produced by the method according to the invention, can, if desired, be reacted with pharmaceutically acceptable organic or inorganic acids, such as hydrochloric acid, hydrobromic acid, sulfuric acid, phosphoric acid, oxalic acid, acetic acid, tartaric acid, citric acid, methanesulfonic acid, to obtain the acid addition salts.
Man kan også omsette med alkylhalogenider eller -"sulfater for å oppnå kvaternære ammoniumsalter. One can also react with alkyl halides or sulfates to obtain quaternary ammonium salts.
Forbindelsene kan også oksyderes på i og for seg kjent måte, f.eks. ved hjelp av hydrogenperoksyd og mangandioksyd, The compounds can also be oxidized in a manner known per se, e.g. using hydrogen peroxide and manganese dioxide,
for å oppnå det tilsvarende N-oksyd. to obtain the corresponding N-oxide.
Oppfinnelsen skal illustreres nærmere ved de nedenfor følgende eksempler. The invention shall be illustrated in more detail by the following examples.
Eksempel 1 Example 1
N-( l- allyl- 2- pyrrolidylmetyl)- 7- metylsulfamoyl- 1, 4-benzodioksan- 5- karboksamid N-(1-allyl-2-pyrrolidylmethyl)-7-methylsulfamoyl-1,4-benzodioxane-5-carboxamide
7- klorsulfonyl- 1, 4- benzodloksan- 5- karboksylsyre 7- chlorosulfonyl- 1, 4- benzodloxane- 5- carboxylic acid
670 g klorsulfonsyre ble tilført til en rundkolbe utstyrt med en kondensator og et termometer, 173 g 1,4-benzodioksan-5-karboksylsyre ble tilsatt i porsjoner mens temperaturen ble holdt ved 5-10°C. Blandingen ble oppvarmet til 55°C og deretter avkjølt og helt på is. Bunnfallet ble separert, 670 g of chlorosulfonic acid was added to a round bottom flask equipped with a condenser and a thermometer, 173 g of 1,4-benzodioxane-5-carboxylic acid was added in portions while the temperature was maintained at 5-10°C. The mixture was heated to 55°C and then cooled and poured onto ice. The precipitate was separated,
vasket og tørket og det ble oppnådd 250 g 7-klorsulfonyl-1,4-benzodioksan-5-karboksylsyre med et smeltepunkt på 210-215°C washed and dried and 250 g of 7-chlorosulfonyl-1,4-benzodioxane-5-carboxylic acid with a melting point of 210-215°C were obtained
i et utbytte på 93,5%. in a yield of 93.5%.
7- metylsulfamoyl- 1, 4- bénzodioksan- 5- karboksylsyre 7- methylsulfamoyl- 1, 4- benzodioxane- 5- carboxylic acid
139,5 g av en 40%-ig vandig metylaminoppløsning og 139,5 cm 3 vann ble tilført til en rundkolbe utstyrt med røreverk og et termometer hvoretter i porsjoner 250 g 7-klorsulfonyl-1,4-benzodioksan-5-karboksylsyre og en oppløsning av 180 cm 3 3 0%-ig sodaoppløsning i 180 cm 3 vann ble tilsatt. Blandingen ble omrørt og deretter helt i 2200 cm 3 vann. Oppløsningen ble filtrert, deretter behandlet med 13 9 cm 3 konsentrert saltsyre. Bunnfallet ble separert, vasket og tørket, og det ble oppnådd 190,5 g 7-metylsulfamoyl-1,4-benzodioksan-5-karboksylsyre med et smeltepunkt på 208-209°C i et utbytte på 80%. 139.5 g of a 40% aqueous methylamine solution and 139.5 cm 3 of water were added to a round flask equipped with a stirrer and a thermometer, after which, in portions, 250 g of 7-chlorosulfonyl-1,4-benzodioxane-5-carboxylic acid and a solution of 180 cm 3 of 30% soda ash solution in 180 cm 3 of water was added. The mixture was stirred and then poured into 2200 cm 3 of water. The solution was filtered, then treated with 13 9 cm 3 of concentrated hydrochloric acid. The precipitate was separated, washed and dried, and 190.5 g of 7-methylsulfamoyl-1,4-benzodioxane-5-carboxylic acid with a melting point of 208-209°C was obtained in a yield of 80%.
7- metylsulfamoyl- 1, 4- benzodioksan- 5- karbonylklorid 7- methylsulfamoyl- 1, 4- benzodioxane- 5- carbonyl chloride
176,5 g tionylklorid ble tilført til en rundkolbe utstyrt med en kondensator hvoretter i porsjoner 135 g 7-metylsulfamoyl-1,4-benzodioksan-5-karboksylsyre ble tilsatt under oppvarming til 40-45°C. Blandingen ble oppvarmet under tilbakeløp og deretter behandlet med 250 cm^ kloroform. Bunnfallet ble separert og vasket med kloroform. 176.5 g of thionyl chloride was added to a round bottom flask equipped with a condenser after which 135 g of 7-methylsulfamoyl-1,4-benzodioxane-5-carboxylic acid was added in portions while heating to 40-45°C. The mixture was heated under reflux and then treated with 250 cc of chloroform. The precipitate was separated and washed with chloroform.
N-( l- allyl- 2- pyrrolidylmetyl)- 7- metylsulfamoyl- 1, 4- benzodioksan-5- karboksamid N-(1-allyl-2-pyrrolidylmethyl)-7-methylsulfamoyl-1,4-benzodioxane-5-carboxamide
69 g l-allyl-2-aminometylpyrrolidin og 432 ml kloroform ble tilført til en 1 liters rundkolbe utstyrt med termometer og røreverk. 144 g 7-metylsulfamoyl-1,4-benzodioksan-5-karbonylklorid ble tilsatt i Dorsinnpi- mens t-pmnprflt-nrpti hie holdt vprl 5-10°C. Omrøring av blandingen ble fortsatt i 1 time og deretter ble blandingen behandlet med 1750 ml vann. Etter avdestillering av kloroformen ble blandingen surgjort til en pH-verdi på 4 ved hjelp av 4 ml 20%-ig svovelsyre og deretter filtrert over kjønrøk, oppløsningen av det dannede sulfat ble gjort alkalisk ved hjelp av 60 ml 20%-ig ammoniakk. Etter krystallisering ble basen separert, vasket med vann og tørket ved 40°C. Etter omkrystallisering fra acetonitril ble det oppnådd 134 g N-(l-allyl-2-pyrrolidylmetyl)-7-metylsulfamoyl-1,4-benzodioksan-5-karboksamid med et smeltepunkt på 142-143°C i et utbytte på 68,7%. 69 g of 1-allyl-2-aminomethylpyrrolidine and 432 ml of chloroform were added to a 1 liter round bottom flask equipped with a thermometer and stirrer. 144 g of 7-methylsulfamoyl-1,4-benzodioxane-5-carbonyl chloride were added in Dorsinnpimens t-pmnprflt-nrpti hie vprl 5-10°C. Stirring of the mixture was continued for 1 hour and then the mixture was treated with 1750 ml of water. After distilling off the chloroform, the mixture was acidified to a pH value of 4 using 4 ml of 20% sulfuric acid and then filtered over carbon black, the solution of the sulphate formed was made alkaline using 60 ml of 20% ammonia. After crystallization, the base was separated, washed with water and dried at 40°C. After recrystallization from acetonitrile, 134 g of N-(1-allyl-2-pyrrolidylmethyl)-7-methylsulfamoyl-1,4-benzodioxane-5-carboxamide with a melting point of 142-143°C were obtained in a yield of 68.7 %.
Det oppnådde NMR-spektrum tilsvarte den antatte struktur. The obtained NMR spectrum corresponded to the assumed structure.
Eksempel 2 Example 2
N-( l- etyl- 2- pyrrolidylmetyl)- 7- sulfamoyl- 1, 4- benzodioksan- 5- karboksamid N-(l- ethyl- 2- pyrrolidylmethyl)- 7- sulfamoyl- 1, 4- benzodioxane- 5- carboxamide
7- sul. f amoyl- 1, 4- benzodioksan- 5- karboksylsyre 7- sul. f amoyl- 1, 4- benzodioxane- 5- carboxylic acid
209 g 34%-ig ammoniakk og 97 g 7-klorsulfonyl-1,4-benzodioksan-5-karboksylsyre ble tilført til en rundkolbe utstyrt med røreverk og termometer ved en temperatur på 5-10°C. Blandingen ble omrørt ved omgivelsestemperatur og deretter ble bunnfallet oppløst i 415 cm 3 vann. Oppløsningen ble filtrert og behandlet med 14 0 cm <3>konsentrert saltsyre. Krystallene ble separert, vasket med vann og tørket, og det ble oppnådd 78 g 7-sulfamoyl-1,4-benzodioksan-5-karboksylsyre med et smeltepunkt på 272-274°C i et utbytte på 87%. 209 g of 34% ammonia and 97 g of 7-chlorosulfonyl-1,4-benzodioxane-5-carboxylic acid were added to a round flask equipped with a stirrer and thermometer at a temperature of 5-10°C. The mixture was stirred at ambient temperature and then the precipitate was dissolved in 415 cm 3 of water. The solution was filtered and treated with 140 cm <3>concentrated hydrochloric acid. The crystals were separated, washed with water and dried, and 78 g of 7-sulfamoyl-1,4-benzodioxane-5-carboxylic acid with a melting point of 272-274°C were obtained in a yield of 87%.
Metyl- 7- sulfamoyl- 1, 4- benzodioksan- 5- karboksylat Methyl- 7- sulfamoyl- 1, 4- benzodioxane- 5- carboxylate
429 g metanol ble tilført til en rundkolbe utstyrt med en kondensator og deretter ble, under avkjøling, 54 g 93%-ig svovelsyre og 111 g 7-sulfamoyl-1,4-benzodioksan-5-karboksylsyre tilsatt. Blandingen ble oppvarmet under tilbakeløp og deretter avkjølt. Krystallene ble separert, vasket med metanol og deretter behandlet med 500 cm 3 vann og 5 g natriumkarbonat. Bunnfallet ble separert, vasket med vann og tørket, og det ble oppnådd 95 g metyl-7-sulfamoyl-1,4-benzodioksan-5-karboksylat med et smeltepunkt på 225-226°C i et utbytte på 81%. 429 g of methanol was added to a round bottom flask equipped with a condenser and then, with cooling, 54 g of 93% sulfuric acid and 111 g of 7-sulfamoyl-1,4-benzodioxane-5-carboxylic acid were added. The mixture was heated under reflux and then cooled. The crystals were separated, washed with methanol and then treated with 500 cm 3 of water and 5 g of sodium carbonate. The precipitate was separated, washed with water and dried, and 95 g of methyl-7-sulfamoyl-1,4-benzodioxane-5-carboxylate with a melting point of 225-226°C were obtained in a yield of 81%.
N-( l- etyl- 2- pyrrolidylmetyl)- 7- sulfamoyl- 1, 4- benzodioksan- 5-karboksamid N-(l- ethyl- 2- pyrrolidylmethyl)- 7- sulfamoyl- 1, 4- benzodioxane- 5-carboxamide
145 g metyl-7-sulfamoyl-1,4-benzodioksan-5-karboksylat, 48 g vann og 81,5 g l-etyl-2-aminometylpyrrolidin ble tilført til en rundkolbe utstyrt med en tilbakeløpskondensator og et røreverk. Den resulterende suspensjon ble oppvarmet på en vannbad inntil en prøve var oppløselig i fortynnede syrer. Reaksjonsblandingen ble deretter behandlet med 1 liter vann og gjort sur ved hjelp av 70 ml eddiksyre. Acetatoppløsningen, 145 g of methyl 7-sulfamoyl-1,4-benzodioxane-5-carboxylate, 48 g of water and 81.5 g of 1-ethyl-2-aminomethylpyrrolidine were added to a round bottom flask equipped with a reflux condenser and a stirrer. The resulting suspension was heated on a water bath until a sample was soluble in dilute acids. The reaction mixture was then treated with 1 liter of water and acidified with 70 ml of acetic acid. The acetate solution,
som ble dannet, ble filtrert på kjønrøk, og basen ble felt ut med 20%-ig ammoniakk. Krystallene ble separert, vasket med vann og tørket. Benzamidet ble renset ved overføring til hydroklorid (smp. 238-240°C). Basen ble gjenutfelt ved tilsetning av 20%-ig ammoniakk. Det ble oppnådd 120 g N-(l-etyl-2-pyrrolidylmetyl)-7-sulfamoyl-1,4-benzodioksan-5-karboksamid med et smeltepunkt på 160-161°C i et utbytte på 61,5%. which was formed, was filtered on carbon black, and the base was precipitated with 20% ammonia. The crystals were separated, washed with water and dried. The benzamide was purified by transfer to the hydrochloride (m.p. 238-240°C). The base was reprecipitated by adding 20% ammonia. 120 g of N-(1-ethyl-2-pyrrolidylmethyl)-7-sulfamoyl-1,4-benzodioxane-5-carboxamide with a melting point of 160-161°C were obtained in a yield of 61.5%.
Det oppnådde NMR-spektrum tilsvarte den antatte struktur. The obtained NMR spectrum corresponded to the assumed structure.
Eksempel 3 Example 3
N-( l- metyl- 2- pyrrolidylmetyl)- 7- etylsulfonyl- 1, 4- benzodioksan- 5- karboksamid N-(1- methyl- 2- pyrrolidylmethyl)- 7- ethylsulfonyl- 1, 4- benzodioxane- 5- carboxamide
7- merkapto- l, 4- benzodioksan- 5- karboksylsyre 7- mercapto-l, 4- benzodioxane- 5- carboxylic acid
243 g 7-klorsulfonyl-1,4-benzodioksan-5-karboksylsyre og 654 cm<3> eddiksyre ble tilført til en rundkolbe utstyrt med røre-verk og en kondensator. Blandingen ble oppvarmet til 90°C og deretter avkjølt til 45°C. 398 g tinn og 1744 cm<3> saltsyre ble deretter tilsatt. Blandingen ble oppvarmet til 55-60°C, avkjølt og helt i vann. Bunnfallet ble separert, basket og tørket, og det ble oppnådd 166 g 7-merkapto-l,4-benzodioksan-5-karboksylsyre med et smeltepunkt på 191-192°C i et utbytte på 90%. 7- etyltio- l, 4- benzodioksan- 5- karboksylsyre 243 g of 7-chlorosulfonyl-1,4-benzodioxane-5-carboxylic acid and 654 cm<3> of acetic acid were added to a round bottom flask equipped with a stirrer and a condenser. The mixture was heated to 90°C and then cooled to 45°C. 398 g of tin and 1744 cm<3> of hydrochloric acid were then added. The mixture was heated to 55-60°C, cooled and poured into water. The precipitate was separated, basted and dried, and 166 g of 7-mercapto-1,4-benzodioxane-5-carboxylic acid with a melting point of 191-192°C was obtained in a yield of 90%. 7- ethylthiol, 4- benzodioxane- 5- carboxylic acid
166 g 7-merkapto-l,4-benzodioksan-5-karboksylsyre, 242 166 g 7-mercapto-1,4-benzodioxane-5-carboxylic acid, 242
3 3 3 3
cm vann, 216 cm sodaoppløsning og 181 g etylsulfat ble til-ført til en rundkolbe utstyrt med kondensator. Blandingen ble oppvarmet under tilbakeløp og deretter avkjølt. Blandingen ble helt 1,3 1 vann, filtrert og behandlet med 110 cm 3 saltsyre. Bunnfallet ble separert, vasket med vann og tørket, og det ble cm of water, 216 cm of soda solution and 181 g of ethyl sulphate were added to a round bottom flask equipped with a condenser. The mixture was heated under reflux and then cooled. The mixture was poured into 1.3 l of water, filtered and treated with 110 cm 3 of hydrochloric acid. The precipitate was separated, washed with water and dried, and it remained
oppnådd 152 g 7-etyltio-l,4-benzodioksan-5-karboksylsyre med et smeltepunkt på 154-154°C i et utbytte på 81%. obtained 152 g of 7-ethylthio-1,4-benzodioxane-5-carboxylic acid with a melting point of 154-154°C in a yield of 81%.
7- etylsulfonyl- 1, 4- benzodioksan- 5- karboksylsyre 7- ethylsulfonyl- 1, 4- benzodioxane- 5- carboxylic acid
152 g 7-etyltio-l,4-benzodioksan-5-karboksylsyre og 152 g of 7-ethylthio-1,4-benzodioxane-5-carboxylic acid and
958 cm 3 eddiksyre ble tilført til en rundkolbe utstyrt med kondensator. 398 cm<3> hydrogenperoksyd ble deretter tilsatt, og blandingen ble oppvarmet. Krystallene, som dannet seg ved av-kjøling, ble separert, vasket og tørket, og det ble oppnådd 139 g 7-etylsulfonyl-1,4-benzodioksan-5-karboksylsyre med et smeltepunkt på 217-218°C i et utbytte på 81%. 958 cm 3 of acetic acid was added to a round bottom flask equipped with a condenser. 398 cm<3> of hydrogen peroxide was then added and the mixture was heated. The crystals formed on cooling were separated, washed and dried, and 139 g of 7-ethylsulfonyl-1,4-benzodioxane-5-carboxylic acid with a melting point of 217-218°C were obtained in a yield of 81 %.
7- etylsulfonyl- 1, 4- benzodioksan- 5- karbonylklorid 7- ethylsulfonyl- 1, 4- benzodioxane- 5- carbonyl chloride
243 g tionylklorid, noen dråper dimetylformamid og 139 g 7-etylsulfonyl-1,4-benzodioksan-5-karboksylsyre ble tilført til en rundkolbe utstyrt med kondensator. Blandingen ble oppvarmet og deretter ble overskytende tionylklorid destillert av under 243 g of thionyl chloride, a few drops of dimethylformamide and 139 g of 7-ethylsulfonyl-1,4-benzodioxane-5-carboxylic acid were added to a round bottom flask equipped with a condenser. The mixture was heated and then excess thionyl chloride was distilled off
vakuum. Det ble oppnådd 148 g 7-etylsulfonyl-1,4-benzodioksan-5-karbonylklorid med et smeltepunkt på 146-147°C i et utbytte på 100% . vacuum. 148 g of 7-ethylsulfonyl-1,4-benzodioxane-5-carbonyl chloride with a melting point of 146-147°C were obtained in a yield of 100%.
N-( l- metyl- 2- pyrrolidylmetyl)- 7- etylsulfonyl- l, 4- benzodioksan- 5-karboksamid 59 g l-metyl-2-aminometylpyrrolidin, 450 ml kloroform og deretter i porsjoner 150 g 7-etylsulfonyl-1,4-benzodioksan-5-karbonylklorid ble tilført ved en temperatur fra 5-10°C til en rundkolbe utstyrt med røreverk og termometer. Blandingen ble deretter omrørt i 1 time ved omgivelsestemperatur hvoretter det ble tilsatt 1850 ml vann. Etter avdestillering av kloroformen ble oppløsningen filtrert over kjønrøk og benzamidet ble felt ut ved tilsetning av 65 ml sodaoppløsning. Det faste stoff ble separert, vasket med vann og tørket ved 4 0°C. Etter omkrystallisering fra absolutt alkohol ble det oppnådd 151 g N-(l-metyl-2-pyrrolidylmetyl)-7-etylsulfonyl-l,4-benzodioksan-5-karboksamid med et smeltepunkt på 140-141°C i et utbytte på 80,5%. N-(1-methyl-2-pyrrolidylmethyl)-7-ethylsulfonyl-1,4-benzodioxane-5-carboxamide 59 g of l-methyl-2-aminomethylpyrrolidine, 450 ml of chloroform and then in portions 150 g of 7-ethylsulfonyl-1, 4-benzodioxane-5-carbonyl chloride was added at a temperature of 5-10°C to a round flask equipped with a stirrer and thermometer. The mixture was then stirred for 1 hour at ambient temperature after which 1850 ml of water was added. After distilling off the chloroform, the solution was filtered over carbon black and the benzamide was precipitated by adding 65 ml of soda solution. The solid was separated, washed with water and dried at 40°C. After recrystallization from absolute alcohol, 151 g of N-(1-methyl-2-pyrrolidylmethyl)-7-ethylsulfonyl-1,4-benzodioxane-5-carboxamide with a melting point of 140-141°C were obtained in a yield of 80, 5%.
Den antatte struktur ble bekreftet ved NMR-spektroskopi. The presumed structure was confirmed by NMR spectroscopy.
Eksempel 4 Example 4
N-( l- metyl- 2- pyrrolidylmetyl)- 7- dimetylsulfamoyl- 1, 4 - benzodioksan- 5- karboksamid N-(l- methyl- 2- pyrrolidylmethyl)- 7- dimethylsulfamoyl- 1, 4- benzodioxane- 5- carboxamide
7- dimetylsulfamoyl- 1, 4- benzodioksan- 5- karboksylsyre 7- dimethylsulfamoyl- 1, 4- benzodioxane- 5- carboxylic acid
500 cm<3> aceton og en oppløsning av 99 g dimetylamin i 500 cm<3> of acetone and a solution of 99 g of dimethylamine in
250 cm 3 aceton ble tilført til en rundkolbe utstyrt med røreverk og termometer. Blandingen ble avkjølt til 0°C, og deretter ble 139 g 7-klorsulfonyl-1,4-benzodioksan-5-karboksylsyre tilsatt. Blandingen ble omrørt ved omgivelsestemperatur, aceton destillert av og. resten oppløst i 1 liter vann. Oppløsningen ble gjort alkalisk, filtrert og behandlet med 70 cm 3 saltsyre. Bunnfallet ble separert, vasket og tørket, og det ble oppnådd 128 g 7-dimetylsulf amoyl-1 , 4-benzodioksan-5-karboksylsyre med et smeltepunkt på 220-221°C i et utbytte på 89%. 250 cm 3 of acetone was added to a round bottom flask equipped with a stirrer and thermometer. The mixture was cooled to 0°C, and then 139 g of 7-chlorosulfonyl-1,4-benzodioxane-5-carboxylic acid was added. The mixture was stirred at ambient temperature, acetone distilled off and. the remainder dissolved in 1 liter of water. The solution was made alkaline, filtered and treated with 70 cm 3 of hydrochloric acid. The precipitate was separated, washed and dried, and 128 g of 7-dimethylsulfamoyl-1,4-benzodioxane-5-carboxylic acid with a melting point of 220-221°C was obtained in a yield of 89%.
7- dimetylsulfamoyl- 1, 4- benzodioksan- 5- karbonylklorid 7- dimethylsulfamoyl- 1, 4- benzodioxane- 5- carbonyl chloride
190 g tionylklorid og 153 g 7-dimetylsulfamoyl-1,4-benzodioksan-5-karboksylsyre ble tilført til en rundkolbe utstyrt med kondensator. Blandingen ble oppvarmet og deretter ble overskytende tionylklorid destillert av. Det ble oppnådd 163 g 7-dimetylsulfamoyl-1,4-benzodioksan-5-karbonylklorid med et smeltepunkt på 160-162°C i et utbytte på 100%. 190 g of thionyl chloride and 153 g of 7-dimethylsulfamoyl-1,4-benzodioxane-5-carboxylic acid were added to a round bottom flask equipped with a condenser. The mixture was heated and then excess thionyl chloride was distilled off. 163 g of 7-dimethylsulfamoyl-1,4-benzodioxane-5-carbonyl chloride with a melting point of 160-162°C were obtained in a yield of 100%.
N-( l- metyl- 2- pyrrolidylmetyl)- 7- dimetylsulfamoyl- 1, 4- benzodioksan- 5- karboksamid 61 g l-metyl-2-aminometylpyrrolidin og 560 ml kloroform ble tilført til en rundkolbe utstyrt med røreverk og termometer og deretter ble, mens temperaturen ble holdt ved 0-5°C, 163 g 7-dimetylsulfamoyl-1,4-benzodioksan-5-karbonylklorid tilført. Blandingen ble omrørt i 1 time mens man tillot temperaturen å stige, og deretter ble 1 liter vann tilsatt. Etter avdestillering av kloroformen, ble oppløsningen filtrert og karboksamidet ble felt ut ved tilsetning av 30%-ig sodaoppløsning. N-(1-methyl-2-pyrrolidylmethyl)-7-dimethylsulfamoyl-1,4-benzodioxane-5-carboxamide 61 g of 1-methyl-2-aminomethylpyrrolidine and 560 ml of chloroform were added to a round-bottomed flask equipped with a stirrer and thermometer and then while maintaining the temperature at 0-5°C, 163 g of 7-dimethylsulfamoyl-1,4-benzodioxane-5-carbonyl chloride was added. The mixture was stirred for 1 hour while allowing the temperature to rise, and then 1 liter of water was added. After distilling off the chloroform, the solution was filtered and the carboxamide was precipitated by adding a 30% soda solution.
De fremstilte krystaller ble filtrert, vasket med vann og The crystals produced were filtered, washed with water and
tørket. dried.
Etter omkrystallisering fra absolutt alkohol ble det oppnådd 157 g N-(l-metyl-2-pyrrolidylmetyl)-7-dimetylsulfamoyl-1,4-benzodioksan-5-karboksamid med et smeltepunkt på 165-166°C After recrystallization from absolute alcohol, 157 g of N-(1-methyl-2-pyrrolidylmethyl)-7-dimethylsulfamoyl-1,4-benzodioxane-5-carboxamide with a melting point of 165-166°C were obtained
i et utbytte på 76,9%. in a yield of 76.9%.
Strukturen ble bekreftet ved NMR-spektra. The structure was confirmed by NMR spectra.
Eksempel 5 Example 5
N-( l- benzyl- 2- pyrrolidylmetyl)- 1, 4- benzodioksan- 5- kar-boksamidfosfat N-(l- benzyl- 2- pyrrolidylmethyl)- 1, 4- benzodioxane- 5- carboxamide phosphate
440 ml kloroform og 110 ml l-benzyl-2-aminpmetylpyrroli-din ble tilført til en rundkolbe utstyrt med røreverk og termometer, og deretter ble, ved en temperatur fra 5-10°C, 110 g 1,4-benzodioksan-5-karbonylklorid tilsatt. Etter omrøring av blandingen og tilsetning av 3 1 vann ble kloroformen fjernet. 440 ml of chloroform and 110 ml of 1-benzyl-2-aminopmethylpyrrolidine were added to a round-bottomed flask equipped with a stirrer and thermometer, and then, at a temperature of 5-10°C, 110 g of 1,4-benzodioxane-5- carbonyl chloride added. After stirring the mixture and adding 3 1 of water, the chloroform was removed.
Oppløsningen ble behandlet med ammoniakk og deretter The solution was treated with ammonia and then
ble bunnfallet ekstrahert ved hjelp av metylenklorid. Den organiske oppløsning ble tørket, og deretter ble oppløsningsmidlet fjernet. Den resulterende forbindelse, oppløst i absolutt etanol, ble behandlet med 30 ml 85%-ig fosforsyre. Det dannede bunnfall ble separert, vasket med etanol og tørket. Det ble oppnådd 153 g N-(1-benzy1-2-pyrrolidylmetyl)-1,4-benzodioksan-5-karboksamidfosfat med et smeltepunkt på 165°C i et utbytte på 61%. the precipitate was extracted with methylene chloride. The organic solution was dried, and then the solvent was removed. The resulting compound, dissolved in absolute ethanol, was treated with 30 ml of 85% phosphoric acid. The precipitate formed was separated, washed with ethanol and dried. 153 g of N-(1-benzyl-2-pyrrolidylmethyl)-1,4-benzodioxane-5-carboxamide phosphate with a melting point of 165°C were obtained in a yield of 61%.
Eksempel 6 Example 6
N- ( l- allyl- 2- pyrrolidylmetyl)- 7- sulfamoyl- 1, 4- benzodioksan- 5- karboksamid N-(1-allyl-2-pyrrolidylmethyl)-7-sulfamoyl-1,4-benzodioxane-5-carboxamide
145 g metyl-7-sulfamoyl-1,4-benzodioksan-5-karboksylat, 48 g vann og 89 g l-allyl-2-aminometylpyrrolidin ble tilført til en rundkolbe utstyrt med en kondensator. Blandingen ble oppvarmet på et vannbad inntil en prøve var oppløselig i fortynnede syrer, og deretter ble 1 liter vann tilsatt. Det utfelte karboksamid ble oppløst igjen ved acetatdannelse. Den oppnådde oppløs-ning ble filtrert over kjønrøk, og deretter ble basen felt ut ved tilsetning av 20%-ig ammoniakk. De resulterende krystaller ble separert, vasket med vann, tørket og renset ved overføring til hydroklorid (smeltepunkt 228-230°C), fulgt av omdanning til base ved behandling med 20%-ig ammoniakk. Det ble oppnådd 131 g N-(l-allyl-2-pyrrolidylmetyl)-7-sulfamoyl-1,4-benzodioksan-5-karboksamid med et smeltepunkt på 143-144°C i et utbytte på 64,8%. 145 g of methyl 7-sulfamoyl-1,4-benzodioxane-5-carboxylate, 48 g of water and 89 g of 1-allyl-2-aminomethylpyrrolidine were added to a round bottom flask equipped with a condenser. The mixture was heated on a water bath until a sample was soluble in dilute acids, and then 1 liter of water was added. The precipitated carboxamide was redissolved by acetate formation. The solution obtained was filtered over carbon black, and then the base was precipitated by adding 20% ammonia. The resulting crystals were separated, washed with water, dried and purified by transfer to the hydrochloride (m.p. 228-230°C), followed by conversion to base by treatment with 20% ammonia. 131 g of N-(1-allyl-2-pyrrolidylmethyl)-7-sulfamoyl-1,4-benzodioxane-5-carboxamide with a melting point of 143-144°C were obtained in a yield of 64.8%.
Strukturen ble bekreftet ved NMR-analyse. The structure was confirmed by NMR analysis.
Eksempel 7 Example 7
N-( l- etyl- 2- pyrrolidylmetyl)- 7- metylsulfamoyl- 1, 4-benzodioksan- 5- karboksamid N-(1-ethyl-2-pyrrolidylmethyl)-7-methylsulfamoyl-1,4-benzodioxane-5-carboxamide
Metyl- 7- metylsulfamoyl- 1, 4- benzodioksan- 5- karboksylat Methyl- 7- methylsulfamoyl- 1, 4- benzodioxane- 5- carboxylate
750 ml metanol ble tilført til en rundkolbe utstyrt med kondensator, og deretter ble, under avkjøling, 273 g konsentrert svovelsyre og 160 g 7-metylsulfamoyl-1,4-benzodioksan-5-karboksylsyre tilsatt. Blandingen ble oppvarmet under tilbakeløp, av-kjølt og helt i vann og natriumkarbonat. Bunnfallet ble separert vasket og tørket. 750 ml of methanol was added to a round bottom flask equipped with a condenser, and then, with cooling, 273 g of concentrated sulfuric acid and 160 g of 7-methylsulfamoyl-1,4-benzodioxane-5-carboxylic acid were added. The mixture was heated under reflux, cooled and poured into water and sodium carbonate. The precipitate was separated, washed and dried.
Det ble oppnådd 143 g metyl-7-metylsulfamoyl-1,4-benzodioksan-5-karboksylat med et smeltepunkt på 159-160°C i et utbytte på 85%. 143 g of methyl-7-methylsulfamoyl-1,4-benzodioxane-5-carboxylate with a melting point of 159-160°C were obtained in a yield of 85%.
N-( l- etyl- 2- pyrrolidylmetyl)- 7- metylsulfamoyl- 1, 4- benzodioksan-5- karboksamid N-(l- ethyl- 2- pyrrolidylmethyl)- 7- methylsulfamoyl- 1, 4- benzodioxane-5- carboxamide
137 g metyl-7-metylsulfamoyl-1,4-benzodioksan-5-karboksylat, 43 g vann og 73 g l-etyl-2-aminometylpyrrolidin ble til-ført til en rundkolbe utstyrt med røreverk .og tilbakeløpskonden-sator. Blandingen ble oppvarmet på et vannbad inntil en prøve helt var oppløselig i fortynnede syrer. Karboksamidet, som ble oppnådd ved avkjøling, ble renset ved overføring til acetat og deretter behandling med 100 ml eddiksyre inn i 950 ml vann. Etter at den resulterende oppløsning var filtrert over kjønrøk, ble basen felt ut ved tilsetning av 20%-ig ammoniakk. Dé resulterende krystaller ble separert, vasket med vann, tørket og renset ved omkrystallisering fra kokende isopropylalkohol. Det ble oppnådd 121 g N-(l-etyl-2-pyrrolidylmetyl)-7-metylsulfamoyl-1,4-benzodioksan-5-karboksamid med et smeltepunkt på 139-140°C 137 g of methyl 7-methylsulfamoyl-1,4-benzodioxane-5-carboxylate, 43 g of water and 73 g of 1-ethyl-2-aminomethylpyrrolidine were added to a round bottom flask equipped with a stirrer and a reflux condenser. The mixture was heated on a water bath until a sample was completely soluble in dilute acids. The carboxamide, which was obtained on cooling, was purified by transfer to acetate and then treatment with 100 ml of acetic acid into 950 ml of water. After the resulting solution was filtered over carbon black, the base was precipitated by the addition of 20% ammonia. The resulting crystals were separated, washed with water, dried and purified by recrystallization from boiling isopropyl alcohol. 121 g of N-(1-ethyl-2-pyrrolidylmethyl)-7-methylsulfamoyl-1,4-benzodioxane-5-carboxamide with a melting point of 139-140°C were obtained
i et utbytte på 66,2%. in a dividend of 66.2%.
Strukturen ble bekreftet ved NMR-analyse. The structure was confirmed by NMR analysis.
Det tilsvarende hydroklorid ble fremstilt ved behandling av karboksamidet med saltsyre (spesifikk tetthet: 1,18) (smeltepunkt: 186-188°C). The corresponding hydrochloride was prepared by treating the carboxamide with hydrochloric acid (specific gravity: 1.18) (melting point: 186-188°C).
Eksempel 8 Example 8
N-( l- etyl- 2- pyrrolidylmetyl)- 2, 3- metylendioksybenzamid På samme ble 34,9 g etyl-2,3-metylendioksybenzoat omsatt med 24,2 g l-etyl-2-aminometylpyrrolidin, og det ble etter behandling og rensing oppnådd 28,3 g N-(l-etyl-2-pyrrolidylmetyl)-2,3-metylendioksybenzamid. N-(l-ethyl-2-pyrrolidylmethyl)-2,3-methylenedioxybenzamide In the same way, 34.9 g of ethyl-2,3-methylenedioxybenzoate were reacted with 24.2 g of l-ethyl-2-aminomethylpyrrolidine, and after treatment there was and purification obtained 28.3 g of N-(1-ethyl-2-pyrrolidylmethyl)-2,3-methylenedioxybenzamide.
De oppnådde NMR-spektra er sammenlignbare med den for-ventede struktur. The obtained NMR spectra are comparable with the expected structure.
Eksempel 9 Example 9
Levoroterende N-( l- etyl- 2- pyrrolidylmetyl)- 7- etylsulfonyl- l, 4- benzodioksan- 5- karboksamid 65 g levoroterende l-etyl-2-aminometylpyrrolidin ble oppløst i 430 ml kloroform i en rundkolbe utstyrt med røreverk og termometer. Den resulterende oppløsning ble avkjølt til 5°C, og deretter ble 148 g. fint pulverisert 7-etylsulfonyl-1,4-benzodioksan-5-karbonylklorid tilsatt mens temperaturen ble holdt ved 5-10°C. Ved slutten av tilføringen av dette stoff ble blandingen omrørt i 1 time og deretter behandlet med 1 liter vann. Etter avdestillering av kloroformen, ble oppløsningen filtrert over kjønrøk, og basen ble felt ut ved et overskudd av 30%-ig soda. De resulterende krystaller ble separert, vasket med vann, tørket og omkrystallisert fra isopropylalkohol. Det ble oppnådd 151,5 g levoroterende N-(l-etyl-2-pyrrolidylmetyl)-7-etylsulfonyl-l,4-benzodioksan-5-karboksamid med et smeltepunkt på 111-112°C i et utbytte på 77,7%. (a)j^ = -54,2° i 5%-ig oppløsning i d.imetylformamid. Levo-rotating N-(l-ethyl-2-pyrrolidylmethyl)-7-ethylsulfonyl-1,4-benzodioxane-5-carboxamide 65 g of levo-rotating l-ethyl-2-aminomethylpyrrolidine were dissolved in 430 ml of chloroform in a round flask equipped with a stirrer and thermometer . The resulting solution was cooled to 5°C, and then 148 g of finely powdered 7-ethylsulfonyl-1,4-benzodioxane-5-carbonyl chloride was added while maintaining the temperature at 5-10°C. At the end of the addition of this substance, the mixture was stirred for 1 hour and then treated with 1 liter of water. After distilling off the chloroform, the solution was filtered over carbon black, and the base was precipitated by an excess of 30% soda ash. The resulting crystals were separated, washed with water, dried and recrystallized from isopropyl alcohol. 151.5 g of levorotatory N-(1-ethyl-2-pyrrolidylmethyl)-7-ethylsulfonyl-1,4-benzodioxane-5-carboxamide with a melting point of 111-112°C were obtained in a yield of 77.7% . (a)j^ = -54.2° in 5% solution in dimethylformamide.
Eksempel 10 Example 10
Dekstroroterende N- ( l- etyl- 2- pyrrolidylmetyl)- 7- etylsulfonyl- l , 4- benzodioksan- 5- karboksamid På samme måte ble 64,5 g dekstroroterende l-etyl-2-amino-metylpyrrolidin omsatt med 146 g 7-etylsulfonyl-1,4-benzodioksan-5-karbonylklorid for. etter behandling og rensing, å gi 133,5 g dekstroroterende N-(l-etyl-2-pyrrolidylmetyl)-7-etylsulfonyl-l,4-benzodioksan-5-karboksamid med et smeltepunkt på 111-112°C i et utbytte på 69,8%. Dextrorotating N-(1-ethyl-2-pyrrolidylmethyl)-7-ethylsulfonyl-1,4-benzodioxane-5-carboxamide In the same way, 64.5 g of dextrorotating l-ethyl-2-amino-methylpyrrolidine were reacted with 146 g of 7- ethylsulfonyl-1,4-benzodioxane-5-carbonyl chloride for. after treatment and purification, to give 133.5 g of dextrorotatory N-(1-ethyl-2-pyrrolidylmethyl)-7-ethylsulfonyl-1,4-benzodioxane-5-carboxamide with a melting point of 111-112°C in a yield of 69.8%.
(ot)^ = 55,5° i 5%-ig oppløsning i dimetylformamid. (ot)^ = 55.5° in a 5% solution in dimethylformamide.
Eksempel li Example li
N-( l- etyl- 2- pyrrolidylmetyl)- 7- etylsulfonyl- l, 4- benzodioksan- 5- karboksamid N-(l- ethyl- 2- pyrrolidylmethyl)- 7- ethylsulfonyl- 1, 4- benzodioxane- 5- carboxamide
På samme måte ble 58 g l-etyl-2-aminometylpyrrolidin omsatt med 131 g 7-etylsulfonyl-1,4-benzodioksan-5-karbonylklorid, og man oppnådde, etter behandling og rensing, 103,5 g N-(l-etyl-2-pyrrolidylmetyl)-7-etylsulfonyl-l,4-benzodioksan-5-karboksamid med et smeltepunkt på 118-119°C i et utbytte på 60,2%. In the same way, 58 g of 1-ethyl-2-aminomethylpyrrolidine were reacted with 131 g of 7-ethylsulfonyl-1,4-benzodioxane-5-carbonyl chloride, and after treatment and purification, 103.5 g of N-(l-ethyl -2-pyrrolidylmethyl)-7-ethylsulfonyl-1,4-benzodioxane-5-carboxamide with a melting point of 118-119°C in a yield of 60.2%.
100 g av den oppnådde base ble oppløst i 220 ml aceton, og deretter ble oppløsningen filtrert på kjønrøk, og en oppløs-ning av 9,5 g saltsyre i aceton ble tilsatt. De resulterende 100 g of the base obtained was dissolved in 220 ml of acetone, and then the solution was filtered on carbon black, and a solution of 9.5 g of hydrochloric acid in acetone was added. The resulting
hydrokloridkrystaller ble separert, vasket med aceton og tørket, og det ble oppnådd 96 g N-(l-etyl-2-pyrrolidylmetyl)-7-etylsulfonyl-1,4-benzodioksan-5-karboksamidhydroklorid med et smeltepunkt på 148-150°C i et utbytte på 88,2%. hydrochloride crystals were separated, washed with acetone and dried, and 96 g of N-(1-ethyl-2-pyrrolidylmethyl)-7-ethylsulfonyl-1,4-benzodioxane-5-carboxamide hydrochloride with a melting point of 148-150°C were obtained in a yield of 88.2%.
Eksempel 12-N-( 1- mety1- 2- pyrrolidylmetyl)- 7- sulfamoyl- 1, 4- benzodioksan- 5- karboksamid Example 12-N-(1-methyl-2-pyrrolidylmethyl)-7-sulfamoyl-1,4-benzodioxane-5-carboxamide
131 g metyl-7-sulfamoyl-1,4-benzodioksan-5-karboksylat, 43 g vann og 66 g l-metyl-2-aminometylpyrrolidin ble tilført til en rundkolbe utstyrt med tilbakeløpskondensator. Blandingen ble oppvarmet på et vannbad inntil en prøve helt var oppløselig i fortynnede syrer. Karboksamidet, som dannet seg ved avkjøling, ble renset ved behandling med en oppløsning av 50 ml eddiksyre i 1250 ml vann. Etter at den resulterende oppløsning var filtrert over kjønrøk, ble basen felt ut ved tilsetning av 20 %-ig ammoniakk. De resulterende krystaller ble separert, vasket med vann, tørket og renset ved omkrystallisering fra kokende metylalkohol. Det ble oppnådd 119,5 g N-(l-metyl-2-pyrrolidylmetyl)-7-sulfamoyl-1,4-benzodioksan-5-karboksamid med et smeltepunkt på 187-188°C i et utbytte på 70,1%. 131 g of methyl 7-sulfamoyl-1,4-benzodioxane-5-carboxylate, 43 g of water and 66 g of 1-methyl-2-aminomethylpyrrolidine were added to a round bottom flask equipped with a reflux condenser. The mixture was heated on a water bath until a sample was completely soluble in dilute acids. The carboxamide, which formed on cooling, was purified by treatment with a solution of 50 ml of acetic acid in 1250 ml of water. After the resulting solution was filtered over carbon black, the base was precipitated by the addition of 20% ammonia. The resulting crystals were separated, washed with water, dried and purified by recrystallization from boiling methyl alcohol. 119.5 g of N-(1-methyl-2-pyrrolidylmethyl)-7-sulfamoyl-1,4-benzodioxane-5-carboxamide with a melting point of 187-188°C were obtained in a yield of 70.1%.
Eksempel 13 Example 13
N-( 1- ally1- 2- pyrrolidylmetyl)- 7- etylsulfonyl- 1, 4- benzodioksan-5-karboksamid N-(1-ally1-2-pyrrolidylmethyl)-7-ethylsulfonyl-1,4-benzodioxane-5-carboxamide
58 g l-allyl-2-aminometylpyrrolidin og 360 ml kloroform ble tilført til en rundkolbe utstyrt med et røreverk og et termometer og deretter, mens temperaturen ble holdt ved 5-10°C, ble 120 g 7-etylsulfonyl-1,4-benzodioksan-5-karbonylklorid tilsatt. Etter omrøring av blandingen og tilsetning av 1 liter vann, ble kloroform destillert av. Den resulterende oppløs-ning ble filtrert gjennom kjønrøk, og deretter ble basen felt ut ved tilsetning av 40 ml 30%-ig sodaoppløsning. De resulterende krystaller ble separert, vasket med vann og deretter tørket. Det ble oppnådd 152 g N-(l-allyl-2-pyrrolidylmetyl)-7-etylsulfonyl-1,4-benzodioksan-5-karboksamid med et smeltepunkt på 78-80°C i et utbytte på 93,4%. 58 g of 1-allyl-2-aminomethylpyrrolidine and 360 ml of chloroform were added to a round bottom flask equipped with a stirrer and a thermometer and then, while maintaining the temperature at 5-10°C, 120 g of 7-ethylsulfonyl-1,4- benzodioxane-5-carbonyl chloride added. After stirring the mixture and adding 1 liter of water, chloroform was distilled off. The resulting solution was filtered through carbon black, and then the base was precipitated by adding 40 ml of 30% soda ash solution. The resulting crystals were separated, washed with water and then dried. 152 g of N-(1-allyl-2-pyrrolidylmethyl)-7-ethylsulfonyl-1,4-benzodioxane-5-carboxamide with a melting point of 78-80°C were obtained in a yield of 93.4%.
146 g av den resulterende base ble oppløst i 219 ml varm absolutt etanol og deretter ble oppløsningen filtrert gjennom kjønrøk og gjort sur ved tilsetning av en oppløsning av 13,5 g saltsyre i 100 ml absolutt etanol. Etter avkjøling ble de dannede krystaller separert, vasket med absolutt alkohol og tørket, og deretter renset ved omkrystallisering fra absolutt alkohol. Det ble oppnådd 119,5 g N-(l-allyl-2-pyrrolidylmetyl)-7-etylsulfonyl-l,4-benzodioksan-5-karboksamidhydroklorid med et smeltepunkt på 138-140°C i et utbytte på 75%. 146 g of the resulting base was dissolved in 219 ml of hot absolute ethanol and then the solution was filtered through carbon black and acidified by adding a solution of 13.5 g of hydrochloric acid in 100 ml of absolute ethanol. After cooling, the formed crystals were separated, washed with absolute alcohol and dried, and then purified by recrystallization from absolute alcohol. 119.5 g of N-(1-allyl-2-pyrrolidylmethyl)-7-ethylsulfonyl-1,4-benzodioxane-5-carboxamide hydrochloride with a melting point of 138-140°C were obtained in a yield of 75%.
Eksempel 14 Example 14
N- ( l- etyl- 2- pyrrolidylmetyl) ^ 2H- 3, 4- dihydro- l, 5- benzodioksepin- 6- karboksamid N-(l- ethyl- 2- pyrrolidylmethyl) ^ 2H- 3, 4- dihydro- l, 5- benzodioxepine- 6- carboxamide
Metyl- 2H- 3, 4- dihydro- l, 5- benzodioksepin- 6- karboksylat Methyl- 2H- 3, 4- dihydro- 1, 5- benzodioxepine- 6- carboxylate
111 g metyl-2,3-dihydroksybenzoat, 660 cm 3 metyletylketon, 167 g 1,3-dibrompropan og 10 g natriumjodid ble tilført til en rundkolbe utstyrt med røreverk og termometer. Blandingen ble oppvarmet til 40°C og deretter ble 182 g kaliumkarbonat tilsatt. Blandingen ble oppvarmet under tilbakeløp og 2 1 vann ble tilsatt. Den oljeaktige fase ble dekantert, ekstrahert med eter, og oppløsningen ble vasket med 10%-ig soda og tørket. Eteren ble fjernet ved destillasjon under vakuum, og det ble oppnådd 86,5 g metyl-2H-3,4-dihydro-l,5-benzodioksepin-6-karboksylat med et kokepunkt på 166-176°C ved 8 mm Hg og i et utbytte på 63%. 111 g of methyl 2,3-dihydroxybenzoate, 660 cm 3 of methyl ethyl ketone, 167 g of 1,3-dibromopropane and 10 g of sodium iodide were added to a round bottom flask equipped with a stirrer and thermometer. The mixture was heated to 40°C and then 182 g of potassium carbonate was added. The mixture was heated under reflux and 2 L of water was added. The oily phase was decanted, extracted with ether, and the solution was washed with 10% soda ash and dried. The ether was removed by distillation under vacuum, and 86.5 g of methyl 2H-3,4-dihydro-1,5-benzodioxepine-6-carboxylate was obtained with a boiling point of 166-176°C at 8 mm Hg and in a yield of 63%.
2H- 3, 4- dihydro- l, 5- benzodioksepin- 6- karbokylsyre 2H- 3, 4- dihydro- 1, 5- benzodioxepine- 6- carboxylic acid
160 g metyl-2H-3,4-dihydro-l,5-benzodioksepin-6-karboksylat og 388 cm 3 soda ble tilført til en rundkolbe utstyrt med kondensator. Blandingen ble oppvarmet under tilbakeløp og deretter helt i 1 liter vann og behandlet med 5 g natriummetabi-sulfitt. Oppløsningen ble filtrert og behandlet med 77 cm<3 >konsentrert saltsyre. Bunnfallet ble separert, vasket med vann og tørket, og det ble oppnådd 120 g 2H-3,4-dihydro-l,5-benzodioksepin-6-karboksylsyre med et smeltepunkt på 65-67°C i et utbytte på 80,5%. 160 g of methyl 2H-3,4-dihydro-1,5-benzodioxepine-6-carboxylate and 388 cm 3 of soda were added to a round bottom flask equipped with a condenser. The mixture was heated under reflux and then poured into 1 liter of water and treated with 5 g of sodium metabisulphite. The solution was filtered and treated with 77 cm<3 >concentrated hydrochloric acid. The precipitate was separated, washed with water and dried, and 120 g of 2H-3,4-dihydro-1,5-benzodioxepine-6-carboxylic acid with a melting point of 65-67°C was obtained in a yield of 80.5% .
2H- 3, 4- dihydro- l, 5- benzodioksepin- 6- karbonylklorid 2H- 3, 4- dihydro- 1, 5- benzodioxepine- 6- carbonyl chloride
246 g tioneylklorid og 134 g 2H-3,4-dihydro-l,5-benzodioksepin-6-karboksylsyre ble tilført til en rundkolbe utstyrt med kondensator. Blandingen ble oppvarmet under tilbakeløp, og deretter ble det overskytende tionylklorid destillert av under vakuum. Det ble oppnådd 14 7 g 2H-3,4-dihydro-l,5-benzodioksepin-6-karbonylklorid med et smeltepunkt på 35-37°C i et utbytte på 100%. 246 g of thioneyl chloride and 134 g of 2H-3,4-dihydro-1,5-benzodioxepine-6-carboxylic acid were added to a round bottom flask equipped with a condenser. The mixture was heated under reflux and then the excess thionyl chloride was distilled off under vacuum. 14 7 g of 2H-3,4-dihydro-1,5-benzodioxepine-6-carbonyl chloride with a melting point of 35-37°C were obtained in a yield of 100%.
N-( l- etyl- 2- pyrrolidylmetyl)- 2H- 3, 4- dihydro- l, 5- benzodioksepin-6- karboksamid 92 g l-etyl-2-aminometylpyrrolidin og 458 ml kloroform ble tilført til en rundkolbe utstyrt med røreverk og termometer, og deretter ble, mens temperaturen ble hold fra 5-10°C, 152 g 2H-3,4-dihydro-l,5-benzodioksepin-6-karbonylklorid tilsatt. Etter 1 times omrøring, mens temperaturen ble tillatt å stige, ble 1450 ml vann tilsatt, og deretter ble kloroform destillert av. Oppløsningen ble filtrert over kjønrøk, og basen ble felt ut ved tilsetning av 75 ml 20%-ig ammoniakk. De dannede krystaller ble separert, vasket med vann og tørket, og det ble oppnådd 191 g N-(l-etyl-2-pyrrolidylmetyl)-2H-3,4-dihydro-l,5-benzodioksepin-6-karboksamidmonohydrat med et smeltepunkt på 51-52°C og i et utbytte på 82,4%.. N-(1-ethyl-2-pyrrolidylmethyl)-2H-3,4-dihydro-1,5-benzodioxepine-6-carboxamide 92 g of 1-ethyl-2-aminomethylpyrrolidine and 458 ml of chloroform were added to a round bottom flask equipped with a stirrer and thermometer, and then, while maintaining the temperature from 5-10°C, 152 g of 2H-3,4-dihydro-1,5-benzodioxepine-6-carbonyl chloride was added. After stirring for 1 hour, while the temperature was allowed to rise, 1450 ml of water was added, and then chloroform was distilled off. The solution was filtered over carbon black, and the base was precipitated by adding 75 ml of 20% ammonia. The formed crystals were separated, washed with water and dried, and 191 g of N-(1-ethyl-2-pyrrolidylmethyl)-2H-3,4-dihydro-1,5-benzodioxepine-6-carboxamide monohydrate with a melting point of at 51-52°C and in a yield of 82.4%..
173,5 g av den fremstilte forbindelse ble oppløst i 173.5 g of the compound produced was dissolved in
750 ml absolutt alkohol. Oppløsningen ble filtrert over kjønrøk, og deretter ble en oppløsning av 62 g 85%-ig fosforsyre i 100 ml absolutt alkohol tilsatt. De dannede krystaller ble separert, vasket med absolutt alkohol og tørket og deretter omkrystallisert fra alkohol. Det ble oppnådd 198 g N-(l-etyl-2-pyrrolidylmetyl)-2H-3,4-dihydro-l,5-benzodioksepin-6-karboksamidfosfat med et smeltepunkt på 189-190°C i et utbytte på 92%. 750 ml absolute alcohol. The solution was filtered over carbon black, and then a solution of 62 g of 85% phosphoric acid in 100 ml of absolute alcohol was added. The crystals formed were separated, washed with absolute alcohol and dried and then recrystallized from alcohol. 198 g of N-(1-ethyl-2-pyrrolidylmethyl)-2H-3,4-dihydro-1,5-benzodioxepine-6-carboxamide phosphate with a melting point of 189-190°C were obtained in a yield of 92%.
Eksempel 15 Example 15
N- ( l- mety, l- 2- pyrrolidylmetyl) - 7- metylsulf amoyl- 1, 4-benzodioksam- 5- karboksamid N-(1-methyl,1-2-pyrrolidylmethyl)-7-methylsulfamoyl-1,4-benzodioxam-5-carboxamide
169 g metyl-7-metylsulfamoyl-1,4-benzodioksan-5-karboksylat, 53 ml vann og 81 g l-metyl-2-aminometylpyrrolidin ble tilført til en rundkolbe utstyrt med en tilbakeløpskondensator. 169 g of methyl 7-methylsulfamoyl-1,4-benzodioxane-5-carboxylate, 53 ml of water and 81 g of 1-methyl-2-aminomethylpyrrolidine were added to a round bottom flask equipped with a reflux condenser.
Blandingen ble oppvarmet på en vannbad inntil en prøve helt var oppløselig i fortynnede syrer. De resulterende kry- The mixture was heated on a water bath until a sample was completely soluble in dilute acids. The resulting cry-
staller ble oppløst i en oppløsning av 50 ml eddiksyre i 1250 staller was dissolved in a solution of 50 ml of acetic acid in 1250
ml vann, deretter ble oppløsningen filtrert over kjønrøk, og basen ble felt ut ved tilsetning av 100 ml 20%-ig ammoniakk. Krystallene ble separert, vasket med vann og tørket. Det ble fremstilt 182 g N-(l-metyl-2-pyrrolidylmetyl)-7-metylsulfamoyl-1,4-benzodioksan-5-karboksamid med et smeltepunkt på 189-190 C ml of water, then the solution was filtered over carbon black, and the base was precipitated by adding 100 ml of 20% ammonia. The crystals were separated, washed with water and dried. 182 g of N-(1-methyl-2-pyrrolidylmethyl)-7-methylsulfamoyl-1,4-benzodioxane-5-carboxamide with a melting point of 189-190 C were produced
i et utbytte på 83,6%. in a yield of 83.6%.
Eksempel 16 Example 16
N-( l- etyl- 2- pyrrolidylmetyl)- 7- etylsulfonyl- l, 4- benzodioksan- 5- karboksamid 13 g 7-etylsulfonyl-1,4-benzodioksan-5-karboksylsyre, 300 ml tetrahydrofuran og 13 g karbonyldiimidazol ble tilført til en rundkolbe utstyrt med røreverk, termometer og kondensator. Blandingen ble omrørt ved omgivelsestemperatur og deretter ble 9,5 g l-etyl-2-aminometylpyrrolidin tilsatt. Omrøringen ble fortsatt ved omgivelsestemperatur, og deretter ble oppløsnings-midlet fordampet under vakuum. De oppnådde krystaller ble vasket med vann og deretter tørket, og det ble fremstilt 14 g N-(l-etyl-2-pyrrolidylmetyl)-7-etylsulfonyl-l,4-benzodioksan-5-karboksamid med et smeltepunkt på 118-119°C i et utbytte på 73,8%. N-(1-ethyl-2-pyrrolidylmethyl)-7-ethylsulfonyl-1,4-benzodioxane-5-carboxamide 13 g of 7-ethylsulfonyl-1,4-benzodioxane-5-carboxylic acid, 300 ml of tetrahydrofuran and 13 g of carbonyldiimidazole were added to a round bottom flask equipped with a stirrer, thermometer and condenser. The mixture was stirred at ambient temperature and then 9.5 g of 1-ethyl-2-aminomethylpyrrolidine was added. Stirring was continued at ambient temperature, and then the solvent was evaporated under vacuum. The crystals obtained were washed with water and then dried, and 14 g of N-(1-ethyl-2-pyrrolidylmethyl)-7-ethylsulfonyl-1,4-benzodioxane-5-carboxamide with a melting point of 118-119° were prepared C in a dividend of 73.8%.
Eksempel 17 Example 17
N-( l- metyl- 2- pyrrolidylmetyl)- 7- dimetylsulfamoyl- 1, 4-benzodioksan- 5- karboksamid N-(1-methyl-2-pyrrolidylmethyl)-7-dimethylsulfamoyl-1,4-benzodioxane-5-carboxamide
En oppløsning av 6 g l-metyl-2-aminometylpyrrolidin i pyridin og deretter dråpevis, under omrøring og med en temperatur, som ble holdt i området 0-5°C, en oppløsning av 3,5 g fos-fortriklorid i 20 ml pyridin, ble tilført til en rundkolbe utstyrt med røreverk, termometer og kondensator. Omrøringen ble fortsatt ved en temperatur fra 0-5°C og deretter ved romtemperatur. 14,5 g 7-dimetylsulfamoyl-1,4-benzodioksan-5-karboksylsyre ble deretter tilsatt. Blandingen ble oppvarmet under, omrøring. Etter at blandingen var avkjølt og oppløsningsmidlet fjernet, ble resten oppløst i kloroform, og oppløsningen ble vasket med vandig natriumkarbonat og tørket på vannfri magnesiumsulfat. Etter konsentrering under redusert trykk, ble det fremstilt 12,5 g N-(l-metyl-2-pyrrolidylmetyl)-7-dimetylsulfamoyl-1,4-benzodioksan-5-karboksamid med et smeltepunkt på 165-166°C i et ut- A solution of 6 g of 1-methyl-2-aminomethylpyrrolidine in pyridine and then dropwise, with stirring and with a temperature maintained in the range of 0-5°C, a solution of 3.5 g of phosphorus trichloride in 20 ml of pyridine , was added to a round bottom flask equipped with a stirrer, thermometer and condenser. Stirring was continued at a temperature of 0-5°C and then at room temperature. 14.5 g of 7-dimethylsulfamoyl-1,4-benzodioxane-5-carboxylic acid was then added. The mixture was heated with stirring. After the mixture was cooled and the solvent removed, the residue was dissolved in chloroform, and the solution was washed with aqueous sodium carbonate and dried over anhydrous magnesium sulfate. After concentration under reduced pressure, 12.5 g of N-(1-methyl-2-pyrrolidylmethyl)-7-dimethylsulfamoyl-1,4-benzodioxane-5-carboxamide with a melting point of 165-166°C were prepared in a -
bytte på 64,5%. change of 64.5%.
Eksempel 18 Example 18
N-( l- cykloheksyl- 3- pyrrolidyl)- 7- metylsulfamoyl- 1, 4-benzodloksan- 5- karboksamid N-(1-cyclohexyl-3-pyrrolidyl)-7-methylsulfamoyl-1,4-benzodloxane-5-carboxamide
84 g l-cykloheksyl-3-aminopyrrolidin, 430 ml kloroform og 146 g 7-metylsulfamoyl-1,4-benzodioksan-5-karbonylklorid ble tilført til en rundkolbe utstyrt med røreverk og termometer. Etter omrøring av blandingen, ble basen ekstrahert med metylenklorid, og deretter ble oppløsningsmidlet fordampet. De dannede krystaller ble oppløst i kokende absolutt alkohol, og den rest-erende oppløsning ble filtrert på kjønrøk. Krystallene, som bel fremstilt ved avkjøling, ble oppløst i en oppløsning av eddiksyre i vann, oppløsningen ble filtrert over kjønrøk, og basen ble gjenutfelt ved tilsetning av 20%-ig ammoniakk. Det ble oppnådd 129,5 g N-(l-cykloheksyl-3-pyrrolidyl)-7-metylsulfamoyl-1,4-benzodioksan-5-karboksamid med et smeltepunkt på 160-161°C 84 g of 1-cyclohexyl-3-aminopyrrolidine, 430 ml of chloroform and 146 g of 7-methylsulfamoyl-1,4-benzodioxane-5-carbonyl chloride were added to a round bottom flask equipped with a stirrer and thermometer. After stirring the mixture, the base was extracted with methylene chloride, and then the solvent was evaporated. The formed crystals were dissolved in boiling absolute alcohol, and the remaining solution was filtered on carbon black. The crystals, which were produced by cooling, were dissolved in a solution of acetic acid in water, the solution was filtered over carbon black, and the base was reprecipitated by adding 20% ammonia. 129.5 g of N-(1-cyclohexyl-3-pyrrolidyl)-7-methylsulfamoyl-1,4-benzodioxane-5-carboxamide with a melting point of 160-161°C were obtained
i et utbytte på 61,2%. in a dividend of 61.2%.
Eksempel IS Example IS
N- ( l- etyl- 2- pyrrolidylmetyl)- 7- dimetylsulf amoyl- 1, 4-benzodioksan- 5- karboksamid 64 g l-etyl-2-aminometylpyrrolidin og 530 ml kloroform ble tilført til en rundkolbe utstyrt med røreverk og termometer, og deretter ble, mens temperaturen ble holdt ved fra 0-5°C, N-(1-ethyl-2-pyrrolidylmethyl)-7-dimethylsulfamoyl-1,4-benzodioxane-5-carboxamide 64 g of l-ethyl-2-aminomethylpyrrolidine and 530 ml of chloroform were added to a round flask equipped with a stirrer and a thermometer, and then, while the temperature was maintained at from 0-5°C,
153 g 7-dimetylsulfamoyl-1,4-benzodioksan-5-karbonylklorid tilsatt. Blandingen ble omrørt i 1 time mens man tillot temperaturen å stige, og deretter ble 1 liter vann tilsatt. Etter avdestillering av kloroform, ble oppløsningen filtrert, og karboksamidet ble felt ut ved tilsetning av 30%-ig sodaoppløsning. De oppnådde krystaller ble filtrert, vasket med vann og tørket. Etter omrystallisering fra absolutt alkohol, ble det oppnådd 144,5 g N-(l-etyl-2-pyrrolidylmetyl)-7-dimetylsulfamoyl-1,4-benzodioksan-5-karboksamid med et smeltepunkt på 146-148°C i et utbytte på 72,8%. 153 g of 7-dimethylsulfamoyl-1,4-benzodioxane-5-carbonyl chloride added. The mixture was stirred for 1 hour while allowing the temperature to rise, and then 1 liter of water was added. After distilling off the chloroform, the solution was filtered, and the carboxamide was precipitated by adding a 30% soda solution. The crystals obtained were filtered, washed with water and dried. After recrystallization from absolute alcohol, 144.5 g of N-(1-ethyl-2-pyrrolidylmethyl)-7-dimethylsulfamoyl-1,4-benzodioxane-5-carboxamide with a melting point of 146-148°C were obtained in a yield of 72.8%.
Eksempel 2 0 Example 2 0
Dekstroroterende N-( l- etyl- 2- pyrrolidylmetyl)- 7- metylsulf amoyl- 1 , 4- benzodioksan- 5- karboksamid 82 g dekstroroterende l-etyl-2-aminometylpyrrolidin, 600 cm<3> kloroform og gradvis, ved en temperatur i området 5-10°C, 200 g 7-metylsulfamoyl-1,4-benzodioksan-5-karbonylklorid, ble tilsatt til en rundkolbe med røreverk og termometer. Dextrorotatory N-(l-ethyl-2-pyrrolidylmethyl)-7-methylsulfamoyl-1,4-benzodioxane-5-carboxamide 82 g dextrorotatory l-ethyl-2-aminomethylpyrrolidine, 600 cm<3> chloroform and gradually, at a temperature in the range 5-10°C, 200 g of 7-methylsulfamoyl-1,4-benzodioxane-5-carbonyl chloride was added to a round bottom flask with a stirrer and thermometer.
Etter tilsetning av 1 liter vann, ble kloroform destillert av, og den gjenværende oppløsning filtrert. Basen ble felt ut ved tilsetning av 60 cm 3 20%-ig ammoniakk. De oppnådde krystaller ble separert, vasket med vann og tørket, og det ble oppnådd 162 g dekstroroterende N-(l-etyl-2-pyrrolidylmetyl)-7-metylsulfamoyl-1,4-benzodioksan-5-karboksamid med et smeltepunkt på 136-137°C i et utbytte på 66%. After adding 1 liter of water, chloroform was distilled off and the remaining solution filtered. The base was precipitated by adding 60 cm 3 of 20% ammonia. The crystals obtained were separated, washed with water and dried, and 162 g of dextrorotatory N-(1-ethyl-2-pyrrolidylmethyl)-7-methylsulfamoyl-1,4-benzodioxane-5-carboxamide with a melting point of 136- 137°C in a yield of 66%.
Eksempel 21 Example 21
Levoroterende N-( l- etyl- 2- pyrrolidylmetyl)- 7- metylsulfamoyl- 1, 4- benzodioksan- 5- karboksamid Levorotatory N-(l- ethyl- 2- pyrrolidylmethyl)- 7- methylsulfamoyl- 1, 4- benzodioxane- 5- carboxamide
På samme måte som ovenfor ble 82 g levoroterende 1-etyl-2-aminometylpyrrolidin omsatt med 195 g 7-metylsulfamoyl-1,4-benzodioksan-5-karbonylklorid, og det ble oppnådd 151 g levoroterende N-(l-etyl-2-pyrrolidylmetyl)-7-metylsulfamoyl-1,4-benzodioksan-5-karboksamid med et smeltepunkt på 136-137°C i et utbytte på 62%. In the same manner as above, 82 g of levorotatory 1-ethyl-2-aminomethylpyrrolidine was reacted with 195 g of 7-methylsulfamoyl-1,4-benzodioxane-5-carbonyl chloride, and 151 g of levorotatory N-(1-ethyl-2- pyrrolidylmethyl)-7-methylsulfamoyl-1,4-benzodioxane-5-carboxamide with a melting point of 136-137°C in a yield of 62%.
Eksempel 22 Example 22
Levoroterende N-( l- allyl- 2- pyrrolidylmetyl)- 7- metylsulfamoyl- 1, 4- bemzodioksan- 5- karboksamid 85 g levoroterende l-allyl-2-aminometylpyrrolidin, 610 cm 3kloroform og gradvis, 178 g 7-metylsulfamoyl-1,4-benzodioksan-5-karbonylklorid, ble ved en temperatur fra 5-10°C tilført til en rundkolbe utstyrt med røreverk og termometer. Levo-rotating N-(l-allyl-2-pyrrolidylmethyl)-7-methylsulfamoyl-1,4-bemzodioxane-5-carboxamide 85 g levo-rotating l-allyl-2-aminomethylpyrrolidine, 610 cm 3chloroform and gradually, 178 g 7-methylsulfamoyl-1 ,4-benzodioxane-5-carbonyl chloride, was added at a temperature of 5-10°C to a round flask equipped with a stirrer and thermometer.
Etter omrøring av blandingen, ble 1,2 1 vann tilsatt, og kloroformen ble destillert av. After stirring the mixture, 1.2 L of water was added and the chloroform was distilled off.
Den gjenværende oppløsning ble filtrert, og deretter ble basen felt ut ved hjelp av 70 cm 3 20%-ig ammoniakk. De dannede krystaller ble separert og vasket med vann. The remaining solution was filtered, and then the base was precipitated using 70 cm 3 of 20% ammonia. The formed crystals were separated and washed with water.
Etter omkrystallisering fra etylacetat, ble det oppnådd 117 g levoroterende N-(l-allyl-2-pyrrolidylmetyl)-7-metylsulfamoyl-1,4-benzodioksan-5-karboksamid med et smeltepunkt på 101-102°C i et utbytte på 49%. After recrystallization from ethyl acetate, 117 g of levorotatory N-(1-allyl-2-pyrrolidylmethyl)-7-methylsulfamoyl-1,4-benzodioxane-5-carboxamide with a melting point of 101-102°C were obtained in a yield of 49 %.
Eksempel 2 3 Example 2 3
Dekstroroterende N-( l- allyl- 2- pyrrolidylmetyl)- 7- metylsulf amoyl- 1 , 4- benzodloksan- 5- karboksamid På samme måte som i eksemplet ovenfor ble 84 g dekstro-rotende l-allyl-2-aminometylpyrrolidin omsatt med 175 g 7-metylsulf amoyl-1 , 4-benzodioksan-5-karbonylklorid, og det ble etter rensing oppnådd 125 g dekstroroterende N-(l-allyl-2-pyrrolidylmetyl)-7-metylsulfamoyl-1,4-benzodioksan-5-karboksamid med et smeltepunkt på 104-105°C i et utbytte på 52,6%. Dextro-rotating N-(1-allyl-2-pyrrolidylmethyl)-7-methylsulfamoyl-1,4-benzodloxane-5-carboxamide In the same way as in the example above, 84 g of dextro-rotating l-allyl-2-aminomethylpyrrolidine were reacted with 175 g of 7-methylsulfamoyl-1,4-benzodioxane-5-carbonyl chloride, and after purification 125 g of dextrorotating N-(1-allyl-2-pyrrolidylmethyl)-7-methylsulfamoyl-1,4-benzodioxane-5-carboxamide were obtained with a melting point of 104-105°C in a yield of 52.6%.
Eksempel 24 Example 24
Dekstroroterende N-( l- metyl- 2- pyrrolidylmetyl)- 7- metylsulf amoyl- 1 , 4- benzodioksan- 5- karboksamid 61 g dekstroroterende l-metyl-2-aminometylpyrrolidin, 465 cm<3> kloroform og i andeler 155 g 7-metylsulfamoyl-1,4-benzodioksan-5-karbonylklorid, ble, mens temperaturen ble holdt ved 5-10°C, tilført til en rundkolbe utstyrt med røreverk og termometer. Etter omrøring av blandingen og tilsetning av 1850 cm<3 >vann, ble kloroform destillert av, og den gjenværende oppløs-ning ble filtrert. Basen ble felt ut ved tilsetning av 6 5 cm<3 >20%-ig ammoniakk. De dannede krystaller blé filtrert av, vasket og tørket. Det ble oppnådd 154 g dekstroroterende N-(l-metyl-2-pyrrolidylmetyl)-7-metylsulfamoyl-1,4-benzodioksan-5-karboksamid med et smeltepunkt på 187-188°C i et utbytte på 78,5%. Dextrorotating N-(l-methyl-2-pyrrolidylmethyl)-7-methylsulfamoyl-1,4-benzodioxane-5-carboxamide 61 g dextrorotating l-methyl-2-aminomethylpyrrolidine, 465 cm<3> chloroform and in portions 155 g 7 -methylsulfamoyl-1,4-benzodioxane-5-carbonyl chloride, while the temperature was maintained at 5-10°C, was added to a round flask equipped with a stirrer and thermometer. After stirring the mixture and adding 1850 cm<3> of water, chloroform was distilled off and the remaining solution was filtered. The base was precipitated by the addition of 6 5 cm<3 >20% ammonia. The formed crystals were filtered off, washed and dried. 154 g of dextrorotating N-(1-methyl-2-pyrrolidylmethyl)-7-methylsulfamoyl-1,4-benzodioxane-5-carboxamide with a melting point of 187-188°C were obtained in a yield of 78.5%.
Eksempel 25 Example 25
Levoroterende N-( l- metyl- 2- pyrrolidylmetyl)- 7- metylsulfamoyl- 1, 4- benzodioksan- 5- karboksamid Levorotatory N-(1- methyl- 2- pyrrolidylmethyl)- 7- methylsulfamoyl- 1, 4- benzodioxane- 5- carboxamide
På samme måte som i eksemplet ovenfor ble 71 g levoroterende l-metyl-2-aminometylpyrrolidin omsatt med 180,5 g 7-metylsulf amoyl-1 , 4-benzodioksan-5-karbonylklorid , og det ble oppnådd 175 g levoroterende N-(l-metyl-2-pyrrolidylmetyl)-7-metylsulfamoyl-1,4-benzodioksan-5-karboksamid med et smeltepunkt på 187-187,5°C i et utbytte på 77%. In the same way as in the above example, 71 g of levorotatory l-methyl-2-aminomethylpyrrolidine was reacted with 180.5 g of 7-methylsulfamoyl-1,4-benzodioxane-5-carbonyl chloride, and 175 g of levorotatory N-(l -methyl-2-pyrrolidylmethyl)-7-methylsulfamoyl-1,4-benzodioxane-5-carboxamide with a melting point of 187-187.5°C in a yield of 77%.
Eksempel 2 6 Example 2 6
N- ( l- etyl- 2- pyrrolidylmetyl)- 8- metylsulfamoyl- 2H- 3 , 4-dihydro- 1, 5- benzodioksepin- 6- karboksamid 8- klorsulfonyl- 2H- 3, 4- dihydro- l, 5- benzodioksepin- 6- karboksylsyre 1092 cm<3> klorsulfonsyre ble tilført til en rundkolbe utstyrt med røreverk, kondensator og termometer. Deretter ble i andeler 106 g 2H-3,4-dihydro-l,5-benzodioksepin-6-karboksylsyre tilsatt, mens temperaturen ble holdt mellom 5 og 10°C. Blandingen ble omrørt ved omgivelsestemperatur og deretter helt N- (l- ethyl- 2- pyrrolidylmethyl)- 8- methylsulfamoyl- 2H- 3, 4-dihydro- 1, 5- benzodioxepine- 6- carboxamide 8- chlorosulfonyl- 2H- 3, 4- dihydro- 1, 5- benzodioxepine - 6- carboxylic acid 1092 cm<3> chlorosulfonic acid was added to a round flask equipped with a stirrer, condenser and thermometer. Then 106 g of 2H-3,4-dihydro-1,5-benzodioxepine-6-carboxylic acid were added in portions, while the temperature was kept between 5 and 10°C. The mixture was stirred at ambient temperature and then poured
på is. Krystallene ble separert, vasket med vann og tørket. on ice. The crystals were separated, washed with water and dried.
Det ble oppnådd 146 g 8-klorsulfonyl-2H-3,4-dihydro-l,5-benzodioksepin-6-karboksylsyre med et smeltepunkt på 114-115°C i et utbytte på 91%. 8- metylsulfamoyl- 2H- 3, 4- dihydro- l, 5- benzodioksepin- 6- karboksylsyre 146 g of 8-chlorosulfonyl-2H-3,4-dihydro-1,5-benzodioxepine-6-carboxylic acid with a melting point of 114-115°C were obtained in a yield of 91%. 8- methylsulfamoyl- 2H- 3, 4- dihydro- 1, 5- benzodioxepine- 6- carboxylic acid
233 g av en vandig metalaminoppløsning ble tilført til 233 g of an aqueous metalamine solution was added
en rundkolbe utstyrt med røreverk og termometer, hvoretter i andeler 146 g 8-klorsulfonyl-2H-3,4-dihydro-l,5-benzodioksepin-6-karboksylsyre ble tilført, mens temperaturen ble holdt mellom 5 og 10°C. Blandingen ble omrørt, og bunnfallet ble deretter oppløst i vann. Oppløsningen ble filtrert og behandlet med 150 cm 3 konsentrert saltsyre. Krystallene ble separert, vasket og tørket, og det ble oppnådd 112 g 8-metylsulfamoyl-2H-3,4-dihydro-1,5-benzodioksepin-6-karboksylsyre med et smeltepunkt på 145-146°C i et utbytte på 78%. a round flask equipped with a stirrer and thermometer, after which 146 g of 8-chlorosulfonyl-2H-3,4-dihydro-1,5-benzodioxepine-6-carboxylic acid were added in portions, while the temperature was maintained between 5 and 10°C. The mixture was stirred, and the precipitate was then dissolved in water. The solution was filtered and treated with 150 cm 3 of concentrated hydrochloric acid. The crystals were separated, washed and dried, and 112 g of 8-methylsulfamoyl-2H-3,4-dihydro-1,5-benzodioxepine-6-carboxylic acid with a melting point of 145-146°C were obtained in a yield of 78% .
8- metylsulfamoyl- 2H- 3, 4- dihydro- l, 5- benzodioksepin- 6- karbonylklorid 8- methylsulfamoyl- 2H- 3, 4- dihydro- 1, 5- benzodioxepine- 6- carbonyl chloride
220g tionylklorid og 177 g 8-metylsulfamoyl-2H-3,4-dihydro-l , 5-benzodioksepin-6-karboksylsyre ble tilført til en rundkolbe utstyrt med kondensator. Blandingen ble oppvarmet, og deretter ble overskytende tioneylklorid destillert av under vakuum, og det ble oppnådd 188g 8-metylsulfamoyl-2H-3,4-dihydro-1,5-benzodioksepin-6-karbonylklorid med et smeltepunkt på 93- 220 g of thionyl chloride and 177 g of 8-methylsulfamoyl-2H-3,4-dihydro-1,5-benzodioxepine-6-carboxylic acid were added to a round bottom flask equipped with a condenser. The mixture was heated, and then excess thioneyl chloride was distilled off under vacuum, and 188 g of 8-methylsulfamoyl-2H-3,4-dihydro-1,5-benzodioxepine-6-carbonyl chloride with a melting point of 93-
94°C i et utbytte på 100%. 94°C in a yield of 100%.
N-( l- etyl- 2- pyrrolidylmetyl)- 8- metylsulfamoyl- 2H- 3, 4- dihydro-1, 5- benzodioksepin- 6- karboksamid 79 g l-etyl-2-aminometylpyrrolidin, 750 cm metyletylketon og gradvis, 188 g 8-metylsulfamoyl-2H-3,4-dihydro-l,5-benzodioksepin-6-karbonylklorid ble, mens temperaturen ble holdt ved 5-10°C, tilført til en rundkolbe utstyrt med røreverk og termometer. N-(l- ethyl- 2- pyrrolidylmethyl)- 8- methylsulfamoyl- 2H- 3, 4- dihydro-1, 5- benzodioxepin- 6- carboxamide 79 g l-ethyl-2-aminomethylpyrrolidine, 750 cm methyl ethyl ketone and gradually, 188 g of 8-methylsulfamoyl-2H-3,4-dihydro-1,5-benzodioxepine-6-carbonyl chloride was, while maintaining the temperature at 5-10°C, added to a round-bottomed flask equipped with a stirrer and thermometer.
Hydrokloridbunnfallet ble separert, vasket med metyletylketon og tørket. The hydrochloride precipitate was separated, washed with methyl ethyl ketone and dried.
Etter omkrystallisering fra metylalkohol ble hydroklori-det oppløst i 850 cm<3> vann. Oppløsningen ble filtrert hvoretter basen ble felt ut ved tilsetning av 60 cm<3> 20%-ig ammoniakk. De dannede krystaller ble separert, vasket med vann og tørket. Det ble oppnådd 180 g N-(1-etyl-2-pyrrolidylmetyl)-8-mety1sulfamoyl-2H-3,4-dihydro-1,5-benzodioksepin-6-karboksamid med et smeltepunkt på 144-145°C i et utbytte på 63,8%. After recrystallization from methyl alcohol, the hydrochloride was dissolved in 850 cm<3> of water. The solution was filtered, after which the base was precipitated by adding 60 cm<3> of 20% ammonia. The formed crystals were separated, washed with water and dried. 180 g of N-(1-ethyl-2-pyrrolidylmethyl)-8-methylsulfamoyl-2H-3,4-dihydro-1,5-benzodioxepine-6-carboxamide with a melting point of 144-145°C were obtained in a yield of 63.8%.
Eksempel 2 7 Example 2 7
N-( I- etyl- 2- pyrrolidylmetyl)- 2, 3- metylendioksybenzamid-hydroklorid N-(I- ethyl- 2- pyrrolidylmethyl)- 2, 3- methylenedioxybenzamide hydrochloride
134 g l-etyl-2-aminometylpyrrolidin, 950 cm<3> kloroform 134 g of 1-ethyl-2-aminomethylpyrrolidine, 950 cm<3> chloroform
og gradvis, 183 g 2,3-metylendioksybenzoylklorid, ble, mens temperaturen ble holdt mellom 5 og 10°C, tilført til en rundkolbe utstyrt med røreverk og termometer. and gradually, 183 g of 2,3-methylenedioxybenzoyl chloride, while maintaining the temperature between 5 and 10°C, was added to a round bottom flask equipped with a stirrer and thermometer.
Etter tilsetning av 1 liter vann, ble kloroform destillert av, og deretter ble den gjenværende oppløsning filtrert. After adding 1 liter of water, chloroform was distilled off, and then the remaining solution was filtered.
Etter tilsetning av 120 cm<3> 20%-ig ammoniakk og ekstra-hering med eter, ble den eteriske oppløsning tørket over kaliumkarbonat, og deretter ble eteren destillert av. After addition of 120 cm<3> of 20% ammonia and extraction with ether, the ethereal solution was dried over potassium carbonate, and then the ether was distilled off.
Den fremstilte base ble oppløst i 300 cm 3 aceton, og deretter ble det tilsatt en oppløsning av 34 g saltsyre i 33 0 cm<3> aceton. The prepared base was dissolved in 300 cm 3 of acetone, and then a solution of 34 g of hydrochloric acid in 330 cm<3> of acetone was added.
Hydrokloridutfellingen ble tørket, vasket med aceton og tørket igjen. The hydrochloride precipitate was dried, washed with acetone and dried again.
Etter omkrystallisering fra isopropylalkohol, ble det oppnådd 154 g N-(l-ety1-2-pyrrolidylmetyl)-2,3-metylendioksybenzamid-hydroklorid med et smeltepunkt fra 127,5-128,5°C i et utbytte på 49,7%. After recrystallization from isopropyl alcohol, 154 g of N-(1-ethyl-1-2-pyrrolidylmethyl)-2,3-methylenedioxybenzamide hydrochloride with a melting point of 127.5-128.5°C were obtained in a yield of 49.7% .
Eksempel 28 Example 28
N-( l^ ety1- 2- pyrrolidylmetyl)- 8- metoksy- l, 4- benzodioksan-5- karboksamidoksalat N-(1^ethyl-2-pyrrolidylmethyl)-8-methoxy-1,4-benzodioxane-5-carboxamidoxolate
8- metoksy- l, 4- benzodioksan- 5- karboksylsyre 8- methoxyl, 4- benzodioxane- 5- carboxylic acid
171,5 g 2,3-dihydroksy-4-metoksybenzosyre, 515 cm alkohol, 280 cm<3> sodalut og 175 g etylbromid ble tilført til en rundkolbe utstyrt med røreverk, termometer og innløpsrør for nitrogen. Blandingen ble oppvarmet under tilbakeløp, deretter avkjølt og helt i 2,8 1 vann. Oppløsningen ble filtrert og behandlet med 85 cm konsentrert saltsyre. Bunnfallet ble filtrert av, vasket og tørket. Etter omkrystallisering i dimetylformamid, ble det oppnådd 110 g 8-metoksy-l,4-benzodioksan-5-karboksylsyre med et smeltepunkt på 224-226°C i et utbytte på 57%. 171.5 g of 2,3-dihydroxy-4-methoxybenzoic acid, 515 cc of alcohol, 280 cc of sodium hydroxide solution and 175 g of ethyl bromide were added to a round bottom flask equipped with a stirrer, thermometer and inlet tube for nitrogen. The mixture was heated under reflux, then cooled and poured into 2.8 L of water. The solution was filtered and treated with 85 cm of concentrated hydrochloric acid. The precipitate was filtered off, washed and dried. After recrystallization in dimethylformamide, 110 g of 8-methoxy-1,4-benzodioxane-5-carboxylic acid with a melting point of 224-226°C were obtained in a yield of 57%.
8- metoksy- l, 4- benzodioksan- 5- karbonylklorid 8- methoxyl, 4- benzodioxane- 5- carbonyl chloride
391 g tionylklorid og 138 g 8-metoksy-l,4-benzodioksan-5-karboksylsyre ble tilført til en rundkolbe utstyrt med kondensator. Blandingen ble oppvarmet til 50-55°C, og deretter ble overskytende tioneylklorid destillert av under vakuum. Det ble oppnådd 151 g 8-metoksy-l,4-benzodioksan-5-karbonylklorid i et utbytte på 100%. 391 g of thionyl chloride and 138 g of 8-methoxy-1,4-benzodioxane-5-carboxylic acid were added to a round bottom flask equipped with a condenser. The mixture was heated to 50-55°C, and then excess thioneyl chloride was distilled off under vacuum. 151 g of 8-methoxy-1,4-benzodioxane-5-carbonyl chloride were obtained in a yield of 100%.
N-( l- etyl- 2- pyrrolidylmetyl)- 8- metoksyl, 4- benzodioksan- 5- kar-boksamidoksalat 87 g l-etyl-2-aminometylpyrrolidin og 775 cm 3 metyletylketon ble tilført til en rundkolbe utstyrt med røreverk og termometer hvoretter i andeler 155 g 8-metoksy-l,4-benzodioksan-5-karbonylklorid ble tilsatt mens temperaturen ble holdt fra '5-10°C. Etter omrøring ble blandingen oppløst i 1500 cm 3 vann, og deretter ble metyletylketon destillert av. Den gjenværende oppløsning ble filtrert og deretter behandlet med natriumhydroksyd. Oljen ble dekantert, deretter ekstrahert med metylenklorid. Oppløs-ningen ble tørket over kaliumkarbonat, og deretter ble metylenklorid destillert under vakuum. Det ble oppnådd 224,5 g N-(l-etyl-2-pyrrolidylmetyl)-8-metoksy-l,4-benzodioksan-5-karboksamid. N-(l-ethyl-2-pyrrolidylmethyl)-8-methoxyl, 4-benzodioxan-5-carboxamidoxalate 87 g of l-ethyl-2-aminomethylpyrrolidine and 775 cm 3 of methyl ethyl ketone were added to a round flask equipped with a stirrer and thermometer after which in portions 155 g of 8-methoxy-1,4-benzodioxane-5-carbonyl chloride was added while maintaining the temperature from 5-10°C. After stirring, the mixture was dissolved in 1500 cm 3 of water, and then methyl ethyl ketone was distilled off. The remaining solution was filtered and then treated with sodium hydroxide. The oil was decanted, then extracted with methylene chloride. The solution was dried over potassium carbonate, and methylene chloride was then distilled under vacuum. 224.5 g of N-(1-ethyl-2-pyrrolidylmethyl)-8-methoxy-1,4-benzodioxane-5-carboxamide were obtained.
197,5 g av den fremstilte base ble oppløst i 760 cm 3 absolutt alkohol, og deretter ble det tilsatt 67 g oksalsyre i opp-løsning i 195 cm<3> absolutt alkohol. De dannede krystaller ble filtrert av, vasket med absolutt alkohol og deretter tørket. 197.5 g of the prepared base was dissolved in 760 cm 3 of absolute alcohol, and then 67 g of oxalic acid in solution in 195 cm<3> of absolute alcohol was added. The formed crystals were filtered off, washed with absolute alcohol and then dried.
Det ble fremstilt 208,5 g N-(l-etyl-2-pyrrolidylmetyl)-8-metoksy-1,4-benzodioksan-5-karboksamidoksalat med et smeltepunkt på 129-130°C i et utbytte på 82%. 208.5 g of N-(1-ethyl-2-pyrrolidylmethyl)-8-methoxy-1,4-benzodioxane-5-carboxamidoxate with a melting point of 129-130°C were produced in a yield of 82%.
Eksempel 2S Example 2S
N- ( l- etyl- 2-^ pyrrolidylmetyl) - 8- metoksy- 7- sulf amoyl- 1, 4-benzodioksan- 5- karboksamid N-(1-ethyl-2-^pyrrolidylmethyl)-8-methoxy-7-sulfamoyl-1,4-benzodioxane-5-carboxamide
8- metoksy- 7- klorsulfonyl- 1, 4- benzodioksan- 5- karboksylsyre 8- methoxy- 7- chlorosulfonyl- 1, 4- benzodioxane- 5- carboxylic acid
1045 cm 3 klorsulfonsyre ble tilført til en rundkolbe utstyrt med røreverk, termometer og kondensator, hvoretter 110 g 1045 cm 3 of chlorosulfonic acid was added to a round bottom flask equipped with a stirrer, thermometer and condenser, after which 110 g
8-metoksy-l,4-benzodioksan-5-karboksylsyre ble tilsatt i porsjoner mens temperaturen ble holdt ved fra 5-10°C. Blandingen ble omrørt ved omgivelsestemperatur og deretter helt på is. Bunnfallet ble filtrert av, vasket og tørket, og det ble oppnådd 159 g 8-metCoksy-7-klorsulfonyl-1,4-benzodioksan-5-karboksylsyre i et utbytte på 98%. 8-Methoxy-1,4-benzodioxane-5-carboxylic acid was added in portions while maintaining the temperature at from 5-10°C. The mixture was stirred at ambient temperature and then poured onto ice. The precipitate was filtered off, washed and dried, and 159 g of 8-metCoxy-7-chlorosulfonyl-1,4-benzodioxane-5-carboxylic acid were obtained in a yield of 98%.
8- metoksy- 7- sulfamoyl- 1, 4- benzodioksan- 5- karboksylsyre 8- methoxy- 7- sulfamoyl- 1, 4- benzodioxane- 5- carboxylic acid
300 g 34%-ig ammoniakk ble tilført til en rundkolbe utstyrt med røreverk og termometer. Deretter ble 159 g 8-metoksy-7-klorsulfonyl-1,4-benzodioksan-5-karboksylsyre tilsatt i andeler mens temperaturen ble holdt ved fra 0-5°C. Blandingen ble om-rørt, og deretter ble bunnfallet oppløst i vann. Oppløsningen ble filtrert og vasket med 280 cm 3konsentrert saltsyre. Bunnfallet ble filtrert av, vasket og tørket, og det ble oppnådd 118 g 8-metoksy-7-sulfamoyl-1,4-benzodioksan-5-karboksylsyre med et smeltepunkt på 247-248°C i et utbytte på 82%. 300 g of 34% ammonia was added to a round flask equipped with a stirrer and thermometer. Then 159 g of 8-methoxy-7-chlorosulfonyl-1,4-benzodioxane-5-carboxylic acid was added in portions while the temperature was maintained at from 0-5°C. The mixture was stirred, and then the precipitate was dissolved in water. The solution was filtered and washed with 280 cm 3 of concentrated hydrochloric acid. The precipitate was filtered off, washed and dried, and 118 g of 8-methoxy-7-sulfamoyl-1,4-benzodioxane-5-carboxylic acid with a melting point of 247-248°C were obtained in a yield of 82%.
Metyl- 8- métoksy- 7- sulfamoyl- 1, 4- benzodioksan- 5- karboksylat Methyl- 8- methoxy- 7- sulfamoyl- 1, 4- benzodioxane- 5- carboxylate
396 g metanol ble tilført til en rundkolbe utstyrt med kondensator, deretter ble 51 g svovelsyre og 114,5 g 8-metoksy-7-sulfamoyl-1,4-benzodioksan-5-karboksylsyre tilsatt under av-kjøling. Blandingen ble oppvarmet under tilbakeløp og deretter helt i 485 cm 3 vann og 40 g natriumkarbonat. Bunnfallet ble filtrert av, vasket og tørket, og det ble oppnådd 110,5 g metyl-8-metoksy-7-sulfamoyl-1,4-benzodioksan-5-karboksylsyre med et smeltepunkt på 202-203°C i et utbytte på 92%. N-( l- etyl- 2- pyrrolidylmetyl)- 8- metoksy- 7- sulfamoyl- 1, 4- benzodioksan- 5- karboksamid 396 g of methanol were added to a round bottom flask equipped with a condenser, then 51 g of sulfuric acid and 114.5 g of 8-methoxy-7-sulfamoyl-1,4-benzodioxane-5-carboxylic acid were added while cooling. The mixture was heated under reflux and then poured into 485 cm 3 of water and 40 g of sodium carbonate. The precipitate was filtered off, washed and dried, and 110.5 g of methyl-8-methoxy-7-sulfamoyl-1,4-benzodioxane-5-carboxylic acid with a melting point of 202-203°C were obtained in a yield of 92 %. N-(l- ethyl- 2- pyrrolidylmethyl)- 8- methoxy- 7- sulfamoyl- 1, 4- benzodioxane- 5- carboxamide
150 g metyl-8-metoksy-7-sulfamoyl-1,4-benzodioksan-5-karboksylat og 750 cm<3> etylenglykol ble tilført til en rundkolbe. Etter oppløsning ble 127 g l-etyl-2-aminometylpyrrolidin tilsatt, og blandingen ble oppvarmet til 50°C. Den resulterende oppløs-ning ble oppløst i 2 1 vann og surgjort ved hjelp av 120 cm<3 >eddiksyre. Det således dannede bunnfall ble filtrert av, vasket med vann og tørket. Bunnfallet ble deretter gjenoppløst i 915 cm 3 varmt vann. Oppløsningen ble filtrert, og deretter ble basen felt ut med ammoniakk. Bunnfallet ble filtrert av, vasket med vann og deretter tørket. Det ble oppnådd 144 g (N-(l-etyl-2-pyrrolidylmetyl)-8-metoksy-7-sulfamoyl-1,4-benzodioksan-5-karboksamid med et smeltepunkt på 110-115°C i et utbytte på 73%. 150 g of methyl 8-methoxy-7-sulfamoyl-1,4-benzodioxane-5-carboxylate and 750 cm<3> of ethylene glycol were added to a round bottom flask. After dissolution, 127 g of 1-ethyl-2-aminomethylpyrrolidine was added, and the mixture was heated to 50°C. The resulting solution was dissolved in 2 L of water and acidified with 120 cm<3> of acetic acid. The precipitate thus formed was filtered off, washed with water and dried. The precipitate was then redissolved in 915 cm 3 of hot water. The solution was filtered, and then the base was precipitated with ammonia. The precipitate was filtered off, washed with water and then dried. 144 g of (N-(1-ethyl-2-pyrrolidylmethyl)-8-methoxy-7-sulfamoyl-1,4-benzodioxane-5-carboxamide with a melting point of 110-115°C were obtained in a yield of 73% .
Eksempel 30 Example 30
N-( 1- benzyl- 2- pyrrolidylmetyl)- 7- dietylsulfamoyl- 1, 4-benzodioksan- 5- karboksamidfosfat N-(1- benzyl- 2- pyrrolidylmethyl)- 7- diethylsulfamoyl- 1, 4- benzodioxane- 5- carboxamide phosphate
7- dietylsulfamoyl- 1, 4- benzodioksan- 5- karboksylsyre 7- diethylsulfamoyl- 1, 4- benzodioxane- 5- carboxylic acid
200 ml vann, 100 ml dietylamin og 200 ml trietylamin 200 ml water, 100 ml diethylamine and 200 ml triethylamine
ble tilført til en rundkolbe utstyrt med røreverk og termometer. Deretter ble 140 g 7-klorsulfonyl-1,4-benzodioksan-5-karboksylsyre tilsatt i andeler, mens temperaturen ble holdt ved 20-30°C. Blandingen ble omrørt ved omgivelsestemperatur, og deretter ble 500 ml vann tilsatt. Oppløsningen ble filtrert og behandlet med 300 ml saltsyre. Bunnfallet ble filtrert av, vasket og tørket. Det ble oppnådd 117 g 7-dietylsulfamoyl-1,4-benzodioksan-5-karboksylsyre med et smeltepunkt på 149°C i et utbytte på 74%. was added to a round bottom flask equipped with a stirrer and thermometer. Then 140 g of 7-chlorosulfonyl-1,4-benzodioxane-5-carboxylic acid were added in portions, while the temperature was kept at 20-30°C. The mixture was stirred at ambient temperature, and then 500 ml of water was added. The solution was filtered and treated with 300 ml of hydrochloric acid. The precipitate was filtered off, washed and dried. 117 g of 7-diethylsulfamoyl-1,4-benzodioxane-5-carboxylic acid with a melting point of 149°C were obtained in a yield of 74%.
N-( 1- benzyl- 2- pyrrolidyl- metyl)- 7- dietylsulfamoyl- 1, 4-benzodioksan- 5- karboksamid- fosfat. 40 ml vann, 37,8 g 7-dietylsulfamoyl-1,4-benzodioksan-5-karboksylsyre, 12,5 g trietylamin og 120 ml metyletylketon ble tilført til en rundkolbe utstyrt med røreverk og termometer hvoretter 17,2 g isobutylklorformat ble tilsatt ved en temperatur fra 15-20°C. N-(1-benzyl-2-pyrrolidyl-methyl)-7-diethylsulfamoyl-1,4-benzodioxane-5-carboxamide phosphate. 40 ml of water, 37.8 g of 7-diethylsulfamoyl-1,4-benzodioxane-5-carboxylic acid, 12.5 g of triethylamine and 120 ml of methyl ethyl ketone were added to a round bottom flask equipped with a stirrer and thermometer, after which 17.2 g of isobutyl chloroformate was added at a temperature of 15-20°C.
Etter omrøring av blandingen ble 25 g l-benzyl-2-amino-metylpyrrolidin tilsatt, mens temperaturen ble holdt ved 15-20°C. After stirring the mixture, 25 g of 1-benzyl-2-amino-methylpyrrolidine was added, while the temperature was maintained at 15-20°C.
Blandingen ble omrørt ved omgivelsestemperatur, hvoretter oppløsningsmidlene ble fjernet. Resten ble oppløst i 200 ml metylenklorid og 300 ml vann. Etter omrøring ble oppløsnings-midlet dekantert og deretter tørket over magnesiumsulfat. Opp-løsningen ble filtrert, og deretter ble oppløsningsmidlet fjernet. Den resulterende forbindelse ble oppløst i etanol ved koketemper-atur, og det ble tilsatt 18 g 85%-ig fosforsyre. Krystallene, som dannet seg ved avkjøling, ble filtrert av, vasket med iskald etanol og deretter tørket. Det ble oppnådd 56 g N-(1-benzyl-2-pyrrolidylmetyl)-7-dietylsulfamoyl-1,4-benzodioksan-5-karboksamid-fosfat med et smeltepunkt på 180°C i et utbytte på 79,6%. The mixture was stirred at ambient temperature, after which the solvents were removed. The residue was dissolved in 200 ml of methylene chloride and 300 ml of water. After stirring, the solvent was decanted and then dried over magnesium sulfate. The solution was filtered, and then the solvent was removed. The resulting compound was dissolved in ethanol at boiling temperature, and 18 g of 85% phosphoric acid were added. The crystals, which formed on cooling, were filtered off, washed with ice-cold ethanol and then dried. 56 g of N-(1-benzyl-2-pyrrolidylmethyl)-7-diethylsulfamoyl-1,4-benzodioxane-5-carboxamide phosphate with a melting point of 180°C were obtained in a yield of 79.6%.
Eksempel 31 Example 31
N-( l- etyl- 2- pyrrolidylmetyl)- 8- etylsulfonyl- 2H- 3, 4- dihydro-1, 5- benzodioksepln- 6- karboksamidhydroklorid 8- merkapto- 2H- 3, 4- dihydro- l, 5- benzodioksepin- 6- karboksylsyre N-(l- ethyl- 2- pyrrolidylmethyl)- 8- ethylsulfonyl- 2H- 3, 4- dihydro- 1, 5- benzodioxepln- 6- carboxamide hydrochloride 8- mercapto- 2H- 3, 4- dihydro- 1, 5- benzodioxepine - 6- carboxylic acid
En oppløsning av 106 g 8-klorsulfonyl-2H-3,4-dihydro-l,5-benzodioksepin-6-karboksylsyre i 273 ml eddiksyre og 159,5 g tinn ble tilført til en rundkolbe utstyrt med røreverk og termometer. Blandingen ble omrørt under oppvarming til 40-45°C, og deretter ble 705 ml konsentrert saltsyre tilsatt. Etter oppvarming til 55-60°C, ble oppløsningen avkjølt. Bunnfallet ble filtrert av, vasket og tørket. Det ble oppnådd 65 g 8-merkapto-2H-3,4-dihydro-l,5-benzodioksepin-6-karboksylsyre med et smeltepunkt på 99,5-100°C i et utbytte på 80%. A solution of 106 g of 8-chlorosulfonyl-2H-3,4-dihydro-1,5-benzodioxepine-6-carboxylic acid in 273 ml of acetic acid and 159.5 g of tin was added to a round flask equipped with a stirrer and thermometer. The mixture was stirred while heating to 40-45°C, and then 705 ml of concentrated hydrochloric acid was added. After heating to 55-60°C, the solution was cooled. The precipitate was filtered off, washed and dried. 65 g of 8-mercapto-2H-3,4-dihydro-1,5-benzodioxepine-6-carboxylic acid with a melting point of 99.5-100°C were obtained in a yield of 80%.
8- etyltio- 2H- 3, 4- dihydro- l, 5- benzodioksepin- 6- karboksylsyre 8- ethylthio- 2H- 3, 4- dihydro- 1, 5- benzodioxepine- 6- carboxylic acid
86 g 8-merkapto-2H-3,4-dihydro-l,5-benzodioksepin-6-karboksylsyre, 152 ml vann, 76 ml soda og 58,5 g etylsulfat ble til-ført til en rundkolbe utstyrt med kondensator. Blandingen ble oppvarmet under tilbakeløp og deretter avkjølt. Det ble tilsatt 150 ml vann, og deretter ble oppløsningen filtrert og behandlet med 60 ml saltsyre. Bunnfallet ble filtrert, vasket og tørket. Det ble således oppnådd 88 g 8-etyltio-2H-3,4-dihydro-l,5-benzodioksepin-6-karboksylsyre med et smeltpunkt på 66-67°C i et utbytte på 91% . 8- etylsulfonyl- 2H- 3, 4- dihydro- l, 5- benzodioksepin- 6- karboksylsyre 88 g 8-etyltio-2H-3,4-dihydro-l,5-benzodioksepin-6-karboksylsyre i 528 ml eddiksyre ble tilført til en rundkolbe utstyrt med kondensator, hvoretter 210 ml hydrogenperoksyd ble tilsatt i andeler. Oppløsningen ble oppvarmet, og eddiksyren fjernet under vakuum. Resten ble oppløst i 180 ml vann og avkjølt. Bunnfallet ble filtrert av, vasket og tørket, og det ble oppnådd 90 g 8-etylsulfonyl-2H-3,4-dihydro-l,5-benzodioksepin-6-karboksylsyre med et smeltepunkt på 142-143°C i et utbytte på 91%. 86 g of 8-mercapto-2H-3,4-dihydro-1,5-benzodioxepine-6-carboxylic acid, 152 ml of water, 76 ml of soda ash and 58.5 g of ethyl sulphate were added to a round flask equipped with a condenser. The mixture was heated under reflux and then cooled. 150 ml of water was added, and then the solution was filtered and treated with 60 ml of hydrochloric acid. The precipitate was filtered, washed and dried. 88 g of 8-ethylthio-2H-3,4-dihydro-1,5-benzodioxepine-6-carboxylic acid with a melting point of 66-67°C were thus obtained in a yield of 91%. 8-ethylsulfonyl-2H-3,4-dihydro-1,5-benzodioxepine-6-carboxylic acid 88 g of 8-ethylthio-2H-3,4-dihydro-1,5-benzodioxepine-6-carboxylic acid in 528 ml of acetic acid were added to a round bottom flask equipped with a condenser, after which 210 ml of hydrogen peroxide was added in portions. The solution was heated and the acetic acid removed under vacuum. The residue was dissolved in 180 ml of water and cooled. The precipitate was filtered off, washed and dried, and 90 g of 8-ethylsulfonyl-2H-3,4-dihydro-1,5-benzodioxepine-6-carboxylic acid with a melting point of 142-143°C were obtained in a yield of 91 %.
8- etylsulfonyl- 2H- 3, 4- dihydro- l, 5- benzodioksepin- 6- karbonylklorid 8- ethylsulfonyl- 2H- 3, 4- dihydro- 1, 5- benzodioxepine- 6- carbonyl chloride
75 g tionylklorid og 90 g 8-etylsulfonyl-2H-3,4-dihydro-1,5-benzodioksepin-6-karboksylsyre ble tilført til en rundkolbe utstyrt med kondensator. Blandingen ble oppvarmet til 4 5-50°C og tionylklorid i overskudd ble fjernet under vakuum. Resten ble behandlet med petroleter, deretter filtrert, vasket og tørket. Det ble oppnådd 94 g 8-etylsulfonyl-2H-3,4-dihydro-l,5-benzodioksepin-6-karbonylklorid med et smeltepunkt på 108-110°C 75 g of thionyl chloride and 90 g of 8-ethylsulfonyl-2H-3,4-dihydro-1,5-benzodioxepine-6-carboxylic acid were added to a round bottom flask equipped with a condenser. The mixture was heated to 45-50°C and excess thionyl chloride was removed under vacuum. The residue was treated with petroleum ether, then filtered, washed and dried. 94 g of 8-ethylsulfonyl-2H-3,4-dihydro-1,5-benzodioxepine-6-carbonyl chloride with a melting point of 108-110°C were obtained
i et utbytte på 98%. in a yield of 98%.
N-( l- etyl- 2- pyrrolidylmetyl)- 8- etylsulfonyl- 2H- 3, 4- dihydro- l, 5-benzodioksepin- 6- karboksamidhydroklorid N-(l- ethyl- 2- pyrrolidylmethyl)- 8- ethylsulfonyl- 2H- 3, 4- dihydro- 1, 5- benzodioxepin- 6- carboxamide hydrochloride
39,5 g l-etyl-2-aminometylpyrrolidin i 282 ml kloroform ble tilført til en rundkolbe utstyrt med røreverk og termometer, hvoretter 94 g 8-etylsulfonyl-2H-3,4-dihydro-l,5-benzodioksepin-6-karbonylklorid ble tilsatt i andeler mens temperaturen ble holdt ved 5-10°C. Blandingen ble oppvarmet og deretter helt i vann. Den vandige fase ble avkjølt, filtrert og behandlet med 3 0 ml soda. Bunnfallet ble ekstrahert med metylenklorid, og den organiske fase ble tørket over kaliumkarbonat. Oppløsnings-midlet ble destilert av, resten oppløst i isopropylalkohol og behandlet med en oppløsning av saltsyre i isopropylalkohol. Bunnfallet ble filtrert av, vasket med alkohol og tørket. Det ble oppnådd 98 g N-(l-etyl-2-pyrrolidylmetyl)-8-etylsulfonyl-2H-3,4-dihydro-l,5-benzodioksepin-6-karboksamidhydroklorid med smeltepunkt 141-142°C i et utbytte på 73%. 39.5 g of 1-ethyl-2-aminomethylpyrrolidine in 282 ml of chloroform was added to a round-bottomed flask equipped with a stirrer and thermometer, after which 94 g of 8-ethylsulfonyl-2H-3,4-dihydro-1,5-benzodioxapine-6-carbonyl chloride was added in portions while the temperature was maintained at 5-10°C. The mixture was heated and then poured into water. The aqueous phase was cooled, filtered and treated with 30 ml of soda ash. The precipitate was extracted with methylene chloride, and the organic phase was dried over potassium carbonate. The solvent was distilled off, the residue dissolved in isopropyl alcohol and treated with a solution of hydrochloric acid in isopropyl alcohol. The precipitate was filtered off, washed with alcohol and dried. 98 g of N-(1-ethyl-2-pyrrolidylmethyl)-8-ethylsulfonyl-2H-3,4-dihydro-1,5-benzodioxepine-6-carboxamide hydrochloride with melting point 141-142°C were obtained in a yield of 73 %.
Eksempel 32 Example 32
" N-( 1- etyl- 2- pyrrolidylmetyl)- 6, 7- dibrom- 8- nitro- 1, 4- : benzodioksan- 5- karboksamid" . "N-(1-ethyl-2-pyrrolidylmethyl)-6,7-dibromo-8-nitro-1,4-:benzodioxane-5-carboxamide".
6, 7- dibrom- l, 4- benzodioksan- 5- karboksylsyre 6, 7- dibromo- 1, 4- benzodioxane- 5- carboxylic acid
1440 ml eddiksyre og 360 g 1,4-benzodioksan-5-karboksylsyre ble tilført til en rundkolbe utstyrt med røreverk, innfør-ingstrakt og kondensator. Blandingen ble oppvarmet til 55°C, hvoretter det ble tilsatt en oppløsning av 700 g brom i 360 ml eddiksyre i porsjoner. Blandingen ble oppvarmet til 120°C og deretter avkjølt til 15°C. Bunnfallet ble filtrert av, vasket med eddiksyre og tørket, og det ble oppnådd 332 g 6,7-dibrom-1,4-benzodioksan-5-karboksylsyre med et smeltepunkt på 212°C. Strukturen ble bekreftet ved NMR-analyser. 1440 ml of acetic acid and 360 g of 1,4-benzodioxane-5-carboxylic acid were added to a round bottom flask equipped with a stirrer, introduction funnel and condenser. The mixture was heated to 55°C, after which a solution of 700 g of bromine in 360 ml of acetic acid was added in portions. The mixture was heated to 120°C and then cooled to 15°C. The precipitate was filtered off, washed with acetic acid and dried, and 332 g of 6,7-dibromo-1,4-benzodioxane-5-carboxylic acid with a melting point of 212°C were obtained. The structure was confirmed by NMR analyses.
6, 7- dibrom- 8- nitro- l, 4- benzodioksan- 5- karboksylsyre 6, 7- dibromo- 8- nitro- 1, 4- benzodioxane- 5- carboxylic acid
166 g 6,7-dibrom-l,4-benzodioksan-5-karboksylsyre og 500 166 g of 6,7-dibromo-1,4-benzodioxane-5-carboxylic acid and 500
ml eddiksyre ble tilført til en rundkolbe. Blandingen ble opp- ml of acetic acid was added to a round bottom flask. The mixture was up-
varmet til 37°C, hvoretter det ble tilsatt en oppløsning av 60 ml salpetersyre (d=l,49) i 60 ml eddiksyre samt svovelsyre som katalysator. Etter oppvarming til 50°C ble blandingen helt i kaldt vann under omrøring. Bunnfallet ble filtrert av, vasket med vann og tørket. Det ble oppnådd 107 g 6,7-dibrom-8-nitro-1,4-benzodioksan-5-karboksylsyre med et smeltepunkt på 237°C. heated to 37°C, after which a solution of 60 ml nitric acid (d=1.49) in 60 ml acetic acid and sulfuric acid was added as a catalyst. After heating to 50°C, the mixture was poured into cold water with stirring. The precipitate was filtered off, washed with water and dried. 107 g of 6,7-dibromo-8-nitro-1,4-benzodioxane-5-carboxylic acid with a melting point of 237°C were obtained.
Syren ble renset ved behandling med en oppløsning av The acid was purified by treatment with a solution of
50 g natriumbikarbonat i 500 ml vann og utfelling ved hjelp av saltsyre. Bunnfallet ble filtrert av, vasket og tørket, og det ble oppnådd krystaller med et smeltepunkt på 23 8°C i et utbytte på 61%. Strukturen ble bekreftet ved NMR-analyser. 6, 7- dibrom- 8- nitro- l, 4- benzodioksan- 5- karbonylklorid 96 g 6,7-dibrom-8-nitro-l,4-benzodioksan-5-karboksylsyre og 200 ml tionylklorid ble tilført til en rundkolbe utstyrt med røreverk og termometer. Blandingen ble oppvarmet under tilbake-løp, hvoretter tionylklorid i overskudd ble fjernet under vakuum. Resten ble oppløst i 100 ml isopropyleter, deretter ble oppløs-ningsmidlet fjernet, og produktet ble lufttørket. Det ble oppnådd 91 g 6,7-dibrom-8-nitrq-l,4-benzodioksan-5-karbonylklorid med et smeltepunkt på 215°C i et utbytte på 91%. 50 g of sodium bicarbonate in 500 ml of water and precipitation using hydrochloric acid. The precipitate was filtered off, washed and dried, and crystals with a melting point of 238°C were obtained in a yield of 61%. The structure was confirmed by NMR analyses. 6,7-dibromo-8-nitro-1,4-benzodioxane-5-carbonyl chloride 96 g of 6,7-dibromo-8-nitro-1,4-benzodioxane-5-carboxylic acid and 200 ml of thionyl chloride were added to a round bottom flask equipped with with stirrer and thermometer. The mixture was heated under reflux, after which excess thionyl chloride was removed under vacuum. The residue was dissolved in 100 ml of isopropyl ether, then the solvent was removed, and the product was air-dried. 91 g of 6,7-dibromo-8-nitro-1,4-benzodioxane-5-carbonyl chloride with a melting point of 215°C were obtained in a yield of 91%.
N-( 1- ety1- 2- pyrrolidylmetyl)- 6, 7- dibrom- 8- nitro- l, 4-benzodioksan- 5- kårboksamid N-(1-ethyl1-2-pyrrolidylmethyl)-6,7-dibromo-8-nitro-1,4-benzodioxan-5-carboxamide
I en kolbe utstyrt med røreverk og termometer innføres In a flask equipped with a stirrer and thermometer is introduced
500 ml metyletylketon og 18 g l-etyl-2-aminometylpyrrolidin. 500 ml of methyl ethyl ketone and 18 g of 1-ethyl-2-aminomethylpyrrolidine.
Man avkjøler til 10°C og innfører deretter i andeler uten å overskride 20°C, 50 g 6,7-dibrom-8-nitro-l,4-benzodioksan-5-karbonylklorid. Den oppnådde oppløsning omrøres i 1\ time ved omgivelsestemperatur, hvoretter de dannede krystaller separeres, vaskes med metyletylketon og tørkes. Det oppnådde produkt opp-løses i 400 ml vann ved omgivelsestemperatur. Man tilsetter 7 g aktivkull, filtrerer og feller ut basen ved tilsetning av It is cooled to 10°C and then introduced in portions without exceeding 20°C, 50 g of 6,7-dibromo-8-nitro-1,4-benzodioxane-5-carbonyl chloride. The obtained solution is stirred for 1 hour at ambient temperature, after which the crystals formed are separated, washed with methyl ethyl ketone and dried. The product obtained is dissolved in 400 ml of water at ambient temperature. 7 g of activated charcoal is added, filtered and the base is precipitated by adding
50 ml 20%-ig ammoniakk. De dannede krystaller separeres, 50 ml of 20% ammonia. The formed crystals are separated,
vaskes med vann og tørkes og man oppnår 40 g N-(l-ety1-2-pyrro-lidinylmetyl)-6,7-dibrom-8-nitro-l,4-benzodioksan-5-karboksamid med smeltepunkt 213°C i et utbytte av 65%. washed with water and dried and 40 g of N-(1-ethyl-2-pyrrolidinylmethyl)-6,7-dibromo-8-nitro-1,4-benzodioxane-5-carboxamide with melting point 213°C are obtained in a yield of 65%.
Eksempel 33 Example 33
N-( l- etyl- 2- pyrrolidylmetyl)- 8- amino- l, 4- benzodioksan-5- karboksamiddihydroklorid N-(1-ethyl-2-pyrrolidylmethyl)-8-amino-1,4-benzodioxane-5-carboxamide dihydrochloride
8- amino- l, 4- benzodioksan- 5- karboksylsyre 8- amino- 1, 4- benzodioxane- 5- carboxylic acid
400 ml vann, 98,5 g 6,7-dibrom-8-nitro-l,4-benzodioksan-5-karboksylsyre, 100 ml soda og 10 g Pd/C ble tilført til en autoklav hvoretter hydrogen, under et trykk på 40 kg/cm 2 ble tilført under oppvarming til 50°C. Blandingen ble filtrert og deretter behandlet med 95 ml saltsyre. Bunnfallet ble filtrert av, vasket og tørket, og det ble oppnådd 42 g 8-amino-1,4-benzodioksan-5-karboksylsyre med et smeltepunkt på 186°C 400 ml of water, 98.5 g of 6,7-dibromo-8-nitro-1,4-benzodioxane-5-carboxylic acid, 100 ml of soda and 10 g of Pd/C were added to an autoclave followed by hydrogen, under a pressure of 40 kg/cm 2 was added while heating to 50°C. The mixture was filtered and then treated with 95 ml of hydrochloric acid. The precipitate was filtered off, washed and dried, and 42 g of 8-amino-1,4-benzodioxane-5-carboxylic acid with a melting point of 186°C was obtained
i et utbytte på 83,7%. in a yield of 83.7%.
N-( l- etyl- 2- pyrrolidylmetyl)- 8- amino- l, 4- benzodioksan- 5- karboks-amiddihydroklorid N-(1-ethyl-2-pyrrolidylmethyl)-8-amino-1,4-benzodioxane-5-carboxamide dihydrochloride
Ifølge den fremgangsmåte, som er beskrevet i eks. 2, ble According to the method described in ex. 2, became
42 g 8-amino-l,4-benzodioksan-5-karboksylsyre oppvarmet med metanol og den resulterende forbindelse behandlet med 33 g 1-etyl-2-aminometylpyrrolidin og deretter med en oppløsning av 13 g saltsyre i absolutt alkohol. Det ble oppnådd 49 g N-(l-etyl-2-pyrrolidylmetyl)-8-amino-l,4-benzodioksan-5-karboksamid-dihydroklorid med et smeltepunkt på 173°C i et utbytte på 60%. 42 g of 8-amino-1,4-benzodioxane-5-carboxylic acid heated with methanol and the resulting compound treated with 33 g of 1-ethyl-2-aminomethylpyrrolidine and then with a solution of 13 g of hydrochloric acid in absolute alcohol. 49 g of N-(1-ethyl-2-pyrrolidylmethyl)-8-amino-1,4-benzodioxane-5-carboxamide dihydrochloride with a melting point of 173°C were obtained in a yield of 60%.
Eksempel 34 Example 34
N-( l- etyl- 2- pyrrolidylmetyl)- 8- acetamino- l, 4- benzodioksan-5- karboksamid N-(1-ethyl-2-pyrrolidylmethyl)-8-acetamino-1,4-benzodioxane-5-carboxamide
8- acetamino- l, 4- benzodioksan- 5- karboksylsyre 8-acetamino-1,4-benzodioxane-5-carboxylic acid
43 g 8-amino-l,4-benzodioksan-5-karboksylsyre og 72 ml eddiksyre ble tilført til en rundkolbe hvoretter 24,5 ml eddiksyreanhydrid ble tilsatt i andeler. Blandingen ble oppvarmet til 60-70°C og deretter avkjølt. Bunnfallet ble filtrert av, vasket med eddiksyre og vann og deretter tørket. Det ble oppnådd 44 g 8-acetamino-l,4-benzodioksan-5-karboksylsyre med et smeltepunkt på 233°C i et utbytte på 84%. 43 g of 8-amino-1,4-benzodioxane-5-carboxylic acid and 72 ml of acetic acid were added to a round bottom flask after which 24.5 ml of acetic anhydride were added in portions. The mixture was heated to 60-70°C and then cooled. The precipitate was filtered off, washed with acetic acid and water and then dried. 44 g of 8-acetamino-1,4-benzodioxane-5-carboxylic acid with a melting point of 233°C were obtained in a yield of 84%.
N-( l- etyl- 2- pyrrolidylmetyl)- 8- acetamino- l, 4- benzodioksan- 5-karboksamid , N-(1-ethyl-2-pyrrolidylmethyl)-8-acetamino-1,4-benzodioxane-5-carboxamide,
Ifølge den fremgangsmåte som er beskrevet i eks. 30, ble 8-acetamino-l,4-benzodioksan-5-karboksylsyre oppvarmet med isobutylklorformat og l-etyl-2-aminometylpyrrolidin. Det ble oppnådd N-(1-ety1-2-pyrrolidylmetyl)-8-acetamino-l,4-benzodioksan-5-karboksamid. Strukturen ble bekreftet ved NMR-analyse. According to the procedure described in ex. 30, 8-acetamino-1,4-benzodioxane-5-carboxylic acid was heated with isobutyl chloroformate and 1-ethyl-2-aminomethylpyrrolidine. N-(1-ethyl-2-pyrrolidylmethyl)-8-acetamino-1,4-benzodioxane-5-carboxamide was obtained. The structure was confirmed by NMR analysis.
Eksempel 35 Example 35
N-( l- allyl- 2- pyrrolidylmetyl)- 7, 8- azimido- l, 4- benzodioksan- 5 - karboksamid N-(1-allyl-2-pyrrolidylmethyl)-7,8-azimido-1,4-benzodioxane-5-carboxamide
7, 8- azimido- l, 4- benzodioksan- 5- karboksylsyre 7, 8-azimido-1,4-benzodioxane-5-carboxylic acid
42 g 8-acetamino-l,4-benzodioksan-5-karboksylsyre, 75 ml eddiksyre og 75 ml eddiksyreanhydrid ble tilført til en rundkolbe hvoretter en oppløsning av 17,5 ml salpetersyre (d=l,49) 42 g of 8-acetamino-1,4-benzodioxane-5-carboxylic acid, 75 ml of acetic acid and 75 ml of acetic anhydride were added to a round flask after which a solution of 17.5 ml of nitric acid (d=1.49)
i 17 ml eddiksyre ble tilsatt, mens man lot temperaturen stige. Etter oppløsning og krystallisering ble 50 ml eddiksyre tilsatt. Blandingen ble omrørt ved 40-45°C og deretter avkjølt til 20°C. Bunnfallet ble filtrert av, vasket med eddiksyre og vann og tørket, og det ble oppnådd 13,5 g av en 50%-ig blanding av 7-nitro-8-acetamino-l,4-benzodioksan-5-karboksylsyre og 6-nitro-8-acetamino-l,4-benzodioksan-5-karboksylsyre. 13 g av denne 50%-ige blanding av 7-nitro-8-acetamino-1,4-benzodioksan-5-karboksylsyre og 6-nitro-8-acetamino-l,4-benzodioksan-5-karboksylsyre, 90 ml vann, 4,5 ml natriumhydroksyd, noe Raney-nikkel og hydrogen under et trykk på 50 kg/cm<o >ble tilført til en autoklav. Ved enden av hydrogenabsorpsjonen ble nikkel filtrert av, og oppløsningen ble behandlet med 12 ml saltsyre og deretter med en oppløsning av 3,5 g natriunitrit i 10 ml vann ved en temperatur fra 20-25°C. Det oppnådde bunnfall ble filtrert av, vasket og deretter behandlet med en vandig natriumhydroksydoppløsning. Blandingen ble gjort sur, og deretter ble bunnfallet filtrert av, vasket og tørket, og det ble oppnådd 30 g 7,8-azimido-l,4-benzodioksan-5-karboksylsyre med et smeltepunkt på 2 60°C, under dekomponering, i et utbytte på 59%. in 17 ml of acetic acid was added, while the temperature was allowed to rise. After dissolution and crystallization, 50 ml of acetic acid was added. The mixture was stirred at 40-45°C and then cooled to 20°C. The precipitate was filtered off, washed with acetic acid and water and dried, and 13.5 g of a 50% mixture of 7-nitro-8-acetamino-1,4-benzodioxane-5-carboxylic acid and 6-nitro -8-acetamino-1,4-benzodioxane-5-carboxylic acid. 13 g of this 50% mixture of 7-nitro-8-acetamino-1,4-benzodioxane-5-carboxylic acid and 6-nitro-8-acetamino-1,4-benzodioxane-5-carboxylic acid, 90 ml of water, 4.5 ml of sodium hydroxide, some Raney nickel and hydrogen under a pressure of 50 kg/cm<o>were fed into an autoclave. At the end of the hydrogen absorption, nickel was filtered off and the solution was treated with 12 ml of hydrochloric acid and then with a solution of 3.5 g of sodium nitrite in 10 ml of water at a temperature of 20-25°C. The resulting precipitate was filtered off, washed and then treated with an aqueous sodium hydroxide solution. The mixture was acidified, and then the precipitate was filtered off, washed and dried, and 30 g of 7,8-azimido-1,4-benzodioxane-5-carboxylic acid with a melting point of 2 60°C was obtained, with decomposition, in a yield of 59%.
N-( 1- ally1- 2- pyrrolidylmetyl)- 7, 8- azimido- l, 4- benzodioksan- 5-karboksamid N-(1-ally1-2-pyrrolidylmethyl)-7,8-azimido-1,4-benzodioxane-5-carboxamide
7,8-azimido-1,4-benzodioksan-5-karboksylsyren ble behandlet med N-hydroksyftalimid sammen dicykloheksylkarbodiimid. Det oppnådde ftalimidkarboksylat ble behandlet med l-allyl-2-amino-metylpyrrolidin. Det ble oppnådd N-(1-ally1-2-pyrrolidylmetyl)-7,8-azimido-l,4-benzodioksan-5-karboksamid hvis struktur ble bekreftet ved NMR-analyse. The 7,8-azimido-1,4-benzodioxane-5-carboxylic acid was treated with N-hydroxyphthalimide together with dicyclohexylcarbodiimide. The phthalimide carboxylate obtained was treated with 1-allyl-2-amino-methylpyrrolidine. N-(1-allyl-2-pyrrolidylmethyl)-7,8-azimido-1,4-benzodioxane-5-carboxamide was obtained, the structure of which was confirmed by NMR analysis.
Eksempel 3 6 Example 3 6
N-( l- allyl- 2- pyrrolidylmetyl)- 6, 7- azimido- 1, 4- benzodioksan- 5- karboksamidhydroklorld N-(1-allyl-2-pyrrolidylmethyl)-6,7-azimido-1,4-benzodioxane-5-carboxamide hydrochloride
1, 4- benzodioksan- 6, 7- dlnitro- 5- karboksylsyre 1, 4- benzodioxane- 6, 7- dlnitro- 5- carboxylic acid
165 ml salpetersyre (d=l,49) ble tilført til 500 ml rundkolbe utstyrt med røreverk og termometer. 90 g 1,4-benzodioksan-5-karboksylsyre ble tilsatt ved 10°C. Blandingen ble holdt i 2 timer ved romtemperatur hvoretter 1 liter kaldt vann ble tilsatt. Bunnfallet ble filtrert av, vasket med vann og tørket ved 50°C og deretter renset ved omkrystallisering i eddiksyre. Det ble oppnådd 87 g 1,4-benzodioksan-6,7-dinitro-5-karboksylsyre med et smeltepunkt på 211°C. 165 ml of nitric acid (d=1.49) was added to a 500 ml round flask equipped with a stirrer and thermometer. 90 g of 1,4-benzodioxane-5-carboxylic acid was added at 10°C. The mixture was kept for 2 hours at room temperature, after which 1 liter of cold water was added. The precipitate was filtered off, washed with water and dried at 50°C and then purified by recrystallization in acetic acid. 87 g of 1,4-benzodioxane-6,7-dinitro-5-carboxylic acid with a melting point of 211°C were obtained.
1, 4- benzodioksan- 6, 7- diamino- 5- karboksylsyre 1, 4- benzodioxane- 6, 7- diamino- 5- carboxylic acid
135 g 1,4-benzodioksan-6,7-dinitro-5-karboksylsyre, 135 g of 1,4-benzodioxane-6,7-dinitro-5-carboxylic acid,
500 ml vann og 50 ml sodalut ble tilført til en 1 liters autoklav og hydrogenert under et trykk på 80 kg/cm 2 i nærvær av Raney-nikkel. Blandingen ble oppvarmet til 100°C i 2 timer 500 ml of water and 50 ml of caustic soda were added to a 1 liter autoclave and hydrogenated under a pressure of 80 kg/cm 2 in the presence of Raney nickel. The mixture was heated to 100°C for 2 hours
og deretter avkjølt og filtrert. Nikkelet ble vasket på filteret med 200 ml, og filtratene ble slått sammen. En prøve ble surgjort med saltsyre for å danne 1,4-benzodioksan-6,7-diamino-5-karboksylsyredihydroklorid som ble filtrert, vasket og tørket. Smeltepunktet var 153°C. and then cooled and filtered. The nickel was washed on the filter with 200 ml, and the filtrates were combined. A sample was acidified with hydrochloric acid to form 1,4-benzodioxane-6,7-diamino-5-carboxylic acid dihydrochloride which was filtered, washed and dried. The melting point was 153°C.
1, 4- benzodioksan- 6, 7- azimido- 5- karboksylsyre 1, 4- benzodioxane- 6, 7- azimido- 5- carboxylic acid
Det ovenfor oppnådde filtrat ble tilført til en 2 liters rundkolbe utstyrt med røreverk og termometer. En oppløsning av 35 g natriumnitrit i 70 ml vann ble tilsatt dråpevis ved en temperatur fra 20-35°C. Det krystalliserte produkt ble filtrert av, vasket med vann og tørket ved 50°C, og det ble oppnådd 96 g 1,4-benzodioksan-6,7-azimido-5-karboksylsyre i et utbytte på 87%. Strukturen ble bekreftet ved NMR-analyse. The filtrate obtained above was added to a 2 liter round bottom flask equipped with a stirrer and thermometer. A solution of 35 g of sodium nitrite in 70 ml of water was added dropwise at a temperature of 20-35°C. The crystallized product was filtered off, washed with water and dried at 50°C, and 96 g of 1,4-benzodioxane-6,7-azimido-5-carboxylic acid were obtained in a yield of 87%. The structure was confirmed by NMR analysis.
1, 4- benzodioksan- 6, 7- azimido- 5N- ftalimidkarboksylat 1, 4- benzodioxane- 6, 7- azimido- 5N- phthalimide carboxylate
74 g 1,4-benzodioksan-6,7-azimido-5-karboksylsyre, 1 liter dimetylformamid, 57 g N-hydroksyftalimid, 74,5 g dicykloheksylkarbodiimid ble oppvarmet ved en temperatur på 90°C i 30 min. Etter avkjøling til 20°c, ble krystallene filtrert av, vasket med 150 ml dimetylformamid. Filtratet ble fordampet under vakuum, og resten ble oppvarmet med 400 ml metanol. Fast-stoffet ble filtrert av, vasket og tørket. Det ble oppnådd 80 g 1,4-benzodioksan-6,7-azimido-5N-ftalimidkarboksylat med et smeltepunkt på over 250°C i et utbytte på 65,6%. 74 g of 1,4-benzodioxane-6,7-azimido-5-carboxylic acid, 1 liter of dimethylformamide, 57 g of N-hydroxyphthalimide, 74.5 g of dicyclohexylcarbodiimide were heated at a temperature of 90°C for 30 min. After cooling to 20°C, the crystals were filtered off, washed with 150 ml of dimethylformamide. The filtrate was evaporated under vacuum and the residue was heated with 400 ml of methanol. The solid was filtered off, washed and dried. 80 g of 1,4-benzodioxane-6,7-azimido-5N-phthalimide carboxylate with a melting point of over 250°C were obtained in a yield of 65.6%.
N-( l- allyl- 2- pyrrolidylmetyl)- 6, 7- azimido- l, 4- benzodioksan- 5-karboksamidhydroklorid 92 g 1,4-benzodioksan-6,7-azimido-5N-ftalimidkarboksylat, 500 ml dimetylformamid ble tilført til en 1 liters rundkolbe utstyrt med røreverk og termometer. 45 g l-allyl-2-amino-metylpyrrolidin ble tilført under omrøring mens man hold romtemperatur i 2 timer. Etter fordamping av oppløsningsmidlet, ble resten behandlet med 500 ml varm aceton. Etter filtrering ble 50 ml av en etanolisk oppløsning av saltsyre tilsatt til filtratet. Produktet ble filtrert, vasket og omkrystallisert, og det ble oppnådd 50 g N,(l-allyl-2-pyrrolidylmetyl)-6,7-azimido-l,4-benzodioksan-5-karboksamidhydroklorid med et smeltepunkt på 255°C. N-(1-allyl-2-pyrrolidylmethyl)-6,7-azimido-1,4-benzodioxane-5-carboxamide hydrochloride 92 g of 1,4-benzodioxane-6,7-azimido-5N-phthalimide carboxylate, 500 ml of dimethylformamide were added to a 1 liter round flask equipped with a stirrer and thermometer. 45 g of 1-allyl-2-amino-methylpyrrolidine were added with stirring while maintaining room temperature for 2 hours. After evaporation of the solvent, the residue was treated with 500 ml of hot acetone. After filtration, 50 ml of an ethanolic solution of hydrochloric acid was added to the filtrate. The product was filtered, washed and recrystallized, and 50 g of N,(1-allyl-2-pyrrolidylmethyl)-6,7-azimido-1,4-benzodioxane-5-carboxamide hydrochloride with a melting point of 255°C were obtained.
Strukturen ble bekreftet ved IR- og NMR-analyser. The structure was confirmed by IR and NMR analyses.
Eksempel 3 7 Example 3 7
N-( 1- etyl- 2- pyrrolidylmetyl)- 1, 4- benzodioksan- 5- karboks-amidhydroklorid N-(1- ethyl- 2- pyrrolidylmethyl)- 1, 4- benzodioxane- 5- carboxamide hydrochloride
På samme måte, som beskrevet i eks. 28, ble, ved omsetning av 1,4-benzodioksan-5-karbonylklorid med l-etyl-2-amino-metylpyrrolidin, N-(l-ety1-2-pyrrolidyImetyl)-1,4-benzodioksan-5-karboksamidhydroklorid oppnådd med et smeltepunkt på 149-150°C. In the same way, as described in ex. 28, by reaction of 1,4-benzodioxane-5-carbonyl chloride with 1-ethyl-2-amino-methylpyrrolidine, N-(1-ethyl-2-pyrrolidylmethyl)-1,4-benzodioxane-5-carboxamide hydrochloride was obtained with a melting point of 149-150°C.
Forbindelsene i synteseeksemplene, som er beskrevet The compounds in the synthesis examples, which are described
ovenfor, er samlet i tabell I. above, are collected in table I.
Forbindelsene fremstilt ifølge oppfinnelsen benyttes i forskjellige former, slik som kapsler, tabletter, piller, granuler, injiserbare oppløsninger, preparater, som i og for seg er kjente. Man kan benytte stoffer som ikke reagerer med forbindelsene, f.eks. laktose, magnesiumstearat, stivelse, talkum, celluloser, levilit, alkalimetall-laurylsulfater, sakkarose og andre bærere, som benyttes i medisinske preparater. The compounds produced according to the invention are used in various forms, such as capsules, tablets, pills, granules, injectable solutions, preparations, which are known in and of themselves. You can use substances that do not react with the compounds, e.g. lactose, magnesium stearate, starch, talc, celluloses, levilite, alkali metal lauryl sulphates, sucrose and other carriers, which are used in medicinal preparations.
Forbindelsene fremstilt ifølqe oppfinnelsen, kan inngis i doser The compounds produced according to the invention can be administered in doses
på 50-900 mg/dag. Det er fordelaktig å bruke 50-300 mg/dag, of 50-900 mg/day. It is advantageous to use 50-300 mg/day,
og fortrinnsvis ca. 100-150 mg/dag. and preferably approx. 100-150 mg/day.
Forbindelsene fremstilt ifølge oppfinnelsen har interessante anksiolyttiske, psykostimulerende, disinhiber-ende og tymoanaleptiske virkninger som gir egenskaper som er egnet ved terapeutisk anvendelse på det psykofunksjonelle området, og spesielt når det gjelder gastroenterologi, kardio-logi, urologi, rheumatologi og gynekologi. The compounds produced according to the invention have interesting anxiolytic, psychostimulant, disinhibitory and thymoanaleptic effects which give properties which are suitable for therapeutic use in the psychofunctional area, and especially when it comes to gastroenterology, cardiology, urology, rheumatology and gynaecology.
Det lave toksiske nivå er forenelig ved bruk i human-terapi uten fare for sekundærvirkninger. The low toxic level is compatible with use in human therapy without the risk of secondary effects.
Den akutte giftighet for forbindelsene fremstilt ifølge oppfinnelsen ble bestemt på sveitsiske mus ved parenteral (intra-venøs, intraperitoneal og subkutan) inngivelse og ved oral inngivelse. De bestemte LD,-q er vist i tabell II. The acute toxicity of the compounds prepared according to the invention was determined on Swiss mice by parenteral (intravenous, intraperitoneal and subcutaneous) administration and by oral administration. The determined LD,-q are shown in Table II.
På grunn av de spesielt høye antiemetiske virkninger er forbindelsene som fremstilles i eksemplene 1 til 4, 6, 7, 11 til 13, 15, 18, 19 og 26 spesielt foretrukket. Due to the particularly high antiemetic effects, the compounds prepared in Examples 1 to 4, 6, 7, 11 to 13, 15, 18, 19 and 26 are particularly preferred.
Nummereringen av forbindelsene i de følgende tabeller tilsvarer eksempelnummerne. The numbering of the compounds in the following tables corresponds to the example numbers.
Forbindelsene fremstilt ifølge oppfinnelsen er videre frie for kataleptisk virkning. De ble inngitt subkutant i rotter. Kriteriert med henblikk på den kataleptiske tilstand var immo-bilitet for dyret i 30 sek. der forbena var spredd ut og anordnet omhyggelig på trekuber, som var 4 cm høye, slik at man anbragte dyret i en uvanlig og ukomfortabel stilling. The compounds produced according to the invention are furthermore free of cataleptic action. They were administered subcutaneously to rats. Criterion with regard to the cataleptic state was immobility for the animal for 30 sec. where the forelegs were spread out and arranged carefully on wooden cubes, which were 4 cm high, so that the animal was placed in an unusual and uncomfortable position.
Den kataleptiske aktivitet ble målt ved den maksimale virkning. Resultatene er gitt i tabell III: The cataleptic activity was measured by the maximum effect. The results are given in Table III:
Fra disse resultater ser man at forbindelsene fremstilt ifølge oppfinnelsen er frie for kataleptisk virkning i rotter. Denne egenskap tillater klinisk bruk av forbindelsene fremstil ifølge oppfinnelsen med en høy toleransegrad med henblikk på de ekstra-pyramidale sustem. Forbindelsene fremstilt ifølge oppfinnelsen er også funnet å være spesielt aktive i hunder med henblikk på sentral-emetiske midler, slik som apomorfin. Den eksperimentelle prosedyre, som ble fulgt, var ifølge Chen og Ensor. Forbindelsene fremstilt ifølge oppfinnelsen ble inngitt subkutant 30 min. From these results it can be seen that the compounds produced according to the invention are free of cataleptic action in rats. This property allows the clinical use of the compounds prepared according to the invention with a high degree of tolerance with regard to the extra-pyramidal system. The compounds prepared according to the invention have also been found to be particularly active in dogs with regard to central emetic agents, such as apomorphine. The experimental procedure followed was according to Chen and Ensor. The compounds produced according to the invention were administered subcutaneously for 30 min.
før apomorfin (100 ug/kg/SC); dyret ble observert 5j time etter injeksjon av alkaloidet. before apomorphine (100 ug/kg/SC); the animal was observed 5j hours after injection of the alkaloid.
Resultatene er gitt i tabell IV. The results are given in Table IV.
Den interesse, som ble vekket ved utførelse av labo-ratorieforsøkene, ble funnet å være rettferdiggjort med human-kliniske prøver på forbindelsene fremstilt ifølqe oppfinnelsen. The interest, which was aroused by carrying out the laboratory tests, was found to be justified by human clinical tests on the compounds produced according to the invention.
Blant annet ble det gjennomført følgende eksempler: Among other things, the following examples were carried out:
- En 38 år gammel pasient led av Hodgkins-sykdom, og ble underkastet gjentatte kjemoterapi som ute-pasient 1 gang i uken. Hver sesjon ble ledsaget av kvalmeanfall og kraftig oppkast, noe som varte 24 timer, på tross av den vanlige behandling. - A 38-year-old patient suffered from Hodgkin's disease, and was subjected to repeated chemotherapy as an outpatient once a week. Each session was accompanied by nausea and severe vomiting, which lasted 24 hours, despite the usual treatment.
Behandling 24 timer før begynnelsen av perfusjonen og Treatment 24 hours before the start of the perfusion and
4 timer etterpå med 50 mg N-(l-etyl-2-pyrrolidylmetyl)-7-metylsulf amoyl-1 , 4-benzodioksan-5-karboksamid undertrykket totalt kvalmen og brekningsanfallene. Produktet ble helt og holdent tolerert, og det ble ikke bemerket noen sekundærvirkninger. - En 28 år gammel pasient led av en neurose med ner-vøse anfall som kuliminerte i tre forsøk på selvmord. Analytisk behandling i 18 måneder, gjorde det mulig å oppnå sosial rein-tegrering, men hadde liten virkning på nerveaspektet. 4 hours afterwards with 50 mg of N-(1-ethyl-2-pyrrolidylmethyl)-7-methylsulfamoyl-1,4-benzodioxane-5-carboxamide completely suppressed the nausea and vomiting attacks. The product was completely tolerated and no secondary effects were noted. - A 28-year-old patient suffered from a neurosis with nervous attacks that culminated in three suicide attempts. Analytical treatment for 18 months made it possible to achieve social integration, but had little effect on the nervous aspect.
Inngivelsen av 50 mg N-(l-metyl-2-pyrrolidylmetyl)-7-metylsulfamoyl-l,4-benzodioksan-5-karboksamid tre ganger pr. dag, forårsaket i løpet av få dager en total forsvinnen av alle nervøse problemer uten problematisk sedativ virkning. Produktet ble helt og holdent tolerert, og det ble ikke bemerket noen bivirkninger . - En 78 år gammel pasient hadde i 8 måneder være lid-ende av alvorlig reaksjonell depresjon. Det at det forelå en prostatisk adenom kontraindikerte bruk av tricykliske forbindelser . The administration of 50 mg of N-(1-methyl-2-pyrrolidylmethyl)-7-methylsulfamoyl-1,4-benzodioxane-5-carboxamide three times per day, caused in a few days a total disappearance of all nervous problems without problematic sedative effect. The product was completely tolerated, and no side effects were noted. - A 78-year-old patient had been suffering from severe reactionary depression for 8 months. The presence of a prostatic adenoma contraindicated the use of tricyclic compounds.
Han ble behandlet tre ganger pr. dag med 50 mg N-(l-metyl-2-pyrrolidylmetyl)-7-metylsulfamoyl-1,4-benzodioksan-5-karboksamid, og etter tre uker, da tilstanden vesentlig var forbedret, var han i stand til å forlate hospitalet. Behand-lingen, som ble fortsatt hjemme i tre måneder, gjorde det mulig å opprettholde en utmerket psykisk balanse, med gjenopp-tak av de normale aktiviteter for en pensjonert person på He was treated three times per day with 50 mg of N-(1-methyl-2-pyrrolidylmethyl)-7-methylsulfamoyl-1,4-benzodioxane-5-carboxamide, and after three weeks, when his condition had significantly improved, he was able to leave the hospital. The treatment, which was continued at home for three months, made it possible to maintain an excellent mental balance, with the resumption of the normal activities of a retired person on
denne alder. this age.
Produktet ble tolerert fullt ut, og det ble ikke bemerket bivirkninger. - En 42 år gammel pasient ble underkastet hystereo-tomi på grunn av fibroma på 5 måneder siden. Noen dager etter operasjonen, opptrådte hetetokter (10-20 pr. dag) med svette-atakker, noe som vekket pasienten om natten, og som forårsaket forstyrrelser i arbeidet. The product was fully tolerated and no side effects were noted. - A 42-year-old patient underwent hystereotomy for fibroma 5 months ago. A few days after the operation, hot flashes appeared (10-20 per day) with sweat attacks, which woke the patient at night and caused disturbances in work.
Hun ble behandlet med N-(l-ety1-2-pyrrolidylmetyl)-7-metylsulfamoyl-1,4-benzodioksan-5-karboksamid i form av en enkelt dose på 100 mg pr. dag, og symptomene forsvant innen 4 dager. Etter 5 måneder opptrådte kun et hetetokt hver annen eller tredje dag. She was treated with N-(1-ethyl1-2-pyrrolidylmethyl)-7-methylsulfamoyl-1,4-benzodioxane-5-carboxamide in the form of a single dose of 100 mg per day, and the symptoms disappeared within 4 days. After 5 months, only one hot flush occurred every two or three days.
Produktet ble perfekt tolerert og ingen bivirkninger ble bemerket. - En 47 år gammel pasient led, etter menopausen, av gjentatte cystitis-angrep med en frekvens og en alvorlighet som gjorde sosial omgang umulig. Pasienten konsulterte allmennpraktiserende leger og spesialister. Alle prøver var negative og all behandling var uten virkning i dette klassiske cystitistilfelle. Pasienten ble deretter behandlet noen dager med N-(l-metyl-2-pyrrolidylmetyl)-7-metylsulfamoyl-1,4-benzodioksan-5-karboksamid i en dose på 150 mg/dag, og symptomene forsvant totalt og den normale psykiske tilstand ble gjenopp-rettet . The product was perfectly tolerated and no side effects were noted. - A 47-year-old patient suffered, after the menopause, from repeated cystitis attacks with a frequency and severity that made social intercourse impossible. The patient consulted general practitioners and specialists. All tests were negative and all treatment was ineffective in this classic case of cystitis. The patient was then treated for a few days with N-(1-methyl-2-pyrrolidylmethyl)-7-methylsulfamoyl-1,4-benzodioxane-5-carboxamide at a dose of 150 mg/day, and the symptoms completely disappeared and the normal mental state was re-corrected.
Claims (14)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR7623835A FR2360305A1 (en) | 1976-08-04 | 1976-08-04 | NEW 2,3-ALKYLENE BIS (OXY) BENZAMIDE SUBSTITUTES, THEIR DERIVATIVES AND THEIR PREPARATION METHODS |
Publications (3)
Publication Number | Publication Date |
---|---|
NO772739L NO772739L (en) | 1978-02-07 |
NO152133B true NO152133B (en) | 1985-04-29 |
NO152133C NO152133C (en) | 1985-08-07 |
Family
ID=9176558
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO772739A NO152133C (en) | 1976-08-04 | 1977-08-03 | ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE 2,3-ALKYLENE-BIS-OXYBENZAMIDES |
Country Status (37)
Country | Link |
---|---|
JP (1) | JPS57167914A (en) |
AR (1) | AR219709A1 (en) |
AT (1) | AT358034B (en) |
AU (1) | AU516033B2 (en) |
BE (1) | BE857350A (en) |
BG (1) | BG36496A3 (en) |
CA (1) | CA1114371A (en) |
CH (1) | CH629198A5 (en) |
CS (1) | CS216246B2 (en) |
DD (1) | DD133237A5 (en) |
DE (1) | DE2760414C2 (en) |
DK (1) | DK152366C (en) |
EG (1) | EG12716A (en) |
ES (1) | ES461175A1 (en) |
FI (1) | FI63938C (en) |
GR (1) | GR61351B (en) |
HK (2) | HK40382A (en) |
HU (1) | HU179064B (en) |
IE (2) | IE45646B1 (en) |
IL (2) | IL52644A0 (en) |
IN (1) | IN145473B (en) |
LU (1) | LU77897A1 (en) |
MC (1) | MC1154A1 (en) |
MW (1) | MW2077A1 (en) |
NL (1) | NL172063C (en) |
NO (1) | NO152133C (en) |
NZ (1) | NZ184816A (en) |
OA (1) | OA05728A (en) |
PH (3) | PH22114A (en) |
PL (1) | PL111071B1 (en) |
PT (1) | PT66865B (en) |
RO (1) | RO72963A (en) |
SE (2) | SE440776B (en) |
SU (1) | SU716523A3 (en) |
YU (1) | YU40005B (en) |
ZA (1) | ZA774701B (en) |
ZM (1) | ZM6077A1 (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9027098D0 (en) * | 1990-12-13 | 1991-02-06 | Beecham Group Plc | Pharmaceuticals |
US10083697B2 (en) | 2015-05-27 | 2018-09-25 | Google Llc | Local persisting of data for selectively offline capable voice action in a voice-enabled electronic device |
JP6452575B2 (en) * | 2015-08-19 | 2019-01-16 | 株式会社トクヤマ | Manufacturing method of mirtazapine |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR1473829A (en) * | 1964-06-09 | 1967-03-24 | Ile De France | Nu- (tertiary-aminoalkyl) -methylene dioxybenzamides and their preparation |
-
1977
- 1977-07-11 MC MC771250A patent/MC1154A1/en unknown
- 1977-07-29 ES ES461175A patent/ES461175A1/en not_active Expired
- 1977-07-29 IN IN1165/CAL/77A patent/IN145473B/en unknown
- 1977-07-29 GR GR54066A patent/GR61351B/en unknown
- 1977-07-29 DE DE19772760414 patent/DE2760414C2/de not_active Expired - Fee Related
- 1977-07-29 PT PT6686577A patent/PT66865B/en unknown
- 1977-07-29 BG BG037047A patent/BG36496A3/en unknown
- 1977-08-01 BE BE1008313A patent/BE857350A/en not_active IP Right Cessation
- 1977-08-01 YU YU188277A patent/YU40005B/en unknown
- 1977-08-01 AU AU27507/77A patent/AU516033B2/en not_active Expired
- 1977-08-01 OA OA56243A patent/OA05728A/en unknown
- 1977-08-02 LU LU77897A patent/LU77897A1/xx unknown
- 1977-08-02 RO RO9124577A patent/RO72963A/en unknown
- 1977-08-02 AT AT569677A patent/AT358034B/en not_active IP Right Cessation
- 1977-08-02 IE IE1600/77A patent/IE45646B1/en not_active IP Right Cessation
- 1977-08-02 IE IE2409/80A patent/IE45647B1/en not_active IP Right Cessation
- 1977-08-02 EG EG45577A patent/EG12716A/en active
- 1977-08-03 MW MW2077A patent/MW2077A1/en unknown
- 1977-08-03 NO NO772739A patent/NO152133C/en unknown
- 1977-08-03 SE SE7708849A patent/SE440776B/en not_active IP Right Cessation
- 1977-08-03 NL NL7708616A patent/NL172063C/en not_active IP Right Cessation
- 1977-08-03 CA CA283,994A patent/CA1114371A/en not_active Expired
- 1977-08-03 HU HUSO001195 patent/HU179064B/en not_active IP Right Cessation
- 1977-08-03 DK DK346977A patent/DK152366C/en not_active IP Right Cessation
- 1977-08-03 IL IL52644A patent/IL52644A0/en not_active IP Right Cessation
- 1977-08-03 NZ NZ18481677A patent/NZ184816A/en unknown
- 1977-08-03 DD DD20042077A patent/DD133237A5/en not_active IP Right Cessation
- 1977-08-03 ZA ZA00774701A patent/ZA774701B/en unknown
- 1977-08-03 CH CH956277A patent/CH629198A5/en not_active IP Right Cessation
- 1977-08-04 CS CS775179A patent/CS216246B2/en unknown
- 1977-08-04 PH PH20078A patent/PH22114A/en unknown
- 1977-08-04 SU SU772507701A patent/SU716523A3/en active
- 1977-08-04 PL PL1977200066A patent/PL111071B1/en not_active IP Right Cessation
- 1977-08-04 FI FI772362A patent/FI63938C/en not_active IP Right Cessation
- 1977-08-04 ZM ZM6077A patent/ZM6077A1/en unknown
- 1977-08-08 AR AR26867377A patent/AR219709A1/en active
-
1981
- 1981-03-25 PH PH25426-AA patent/PH18629A/en unknown
- 1981-08-07 PH PH26025A patent/PH17710A/en unknown
-
1982
- 1982-03-19 JP JP4547682A patent/JPS57167914A/en active Granted
- 1982-06-25 IL IL66138A patent/IL66138A0/en not_active IP Right Cessation
- 1982-09-16 HK HK40382A patent/HK40382A/en unknown
- 1982-09-16 HK HK40482A patent/HK40482A/en unknown
- 1982-11-17 SE SE8206546A patent/SE453390B/en not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US4306072A (en) | Substituted 2,3-alkylene bis (oxy)-4,5 (or 5,6) azimido benzamides and derivatives thereof | |
IE51507B1 (en) | Tricyclic imidazole derivatives | |
NO166164B (en) | EQUIPMENT FOR AA ESTABLISH ELECTRICAL CONNECTION WITH A SINGLE SKIN ELECTRODE. | |
US4960773A (en) | Xanthine derivatives | |
EA008249B1 (en) | Novel prodrug of 1-methyl-2(4-amidinophenylaminomethyl)-benzimidazol-5-yl-carboxylic acid-(n-2-pyridil-n-2-hydroxycarbonylethyl)-amide, production and use thereof as medicaments | |
JPS59181273A (en) | Novel 4'-flavone carboxylic acids, pharmaceutically acceptable derivatives of them, manufacture and use as therapy | |
NO152133B (en) | ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE 2,3-ALKYLENE-BIS-OXYBENZAMIDES | |
SE431869B (en) | PROCEDURE FOR PREPARING N- (1-CYCLOHEXYL-3-PYRROLIDINYL) -BENZAMIDES WITH ANTI-MEMICAL EFFECT | |
Baines et al. | The synthesis and pharmacology of some substituted 1, 3-benzodioxoles and 1, 4-benzodioxans | |
SU900808A3 (en) | Process for preparing aminopropanol derivatives of 6-hydroxy-2,3,4,5-tetrahydro-1h-1-benzaszepine-2-one or their salts | |
JPS6399057A (en) | Glycine derivative | |
US3829446A (en) | Oxobenzofuran intermediates | |
US20030069417A1 (en) | Novel synthesis and crystallization of piperazine ring-containing compounds | |
US4268512A (en) | Substituted 2,3-alkylene bis (oxy) benzamides and derivatives and method of preparation | |
GB1571447A (en) | Substituted 2,3-alkyleneduoxybenzamides | |
US3676463A (en) | Oxobenzofuran carboxamides | |
US3452052A (en) | Certain 1-(2**1-benzofuranyl)-1-hydroxy-2-alkylamino or aralkylamino ethanes | |
KR900006745B1 (en) | Process for the preparation of 5-amino-1,2-dithiol-3-one compounds | |
US3294635A (en) | 3, 4-dihydro-benzoxazinones-(1, 3, 2) as an analgesic agent | |
US4255580A (en) | Substituted 2,3-alkylene bis (oxy) benzamides and derivatives | |
US3494925A (en) | 1 - p - chlorophenyl - 3 - imino - 2 - methyl- 2,3,5,6,7,8 - hexahydroimidazo(1,5 - a)pyridine and intermediates therefor | |
KR800001149B1 (en) | New substituted 2,3-alkylene bis-(oxy)-benzamides and their preparation | |
US3268546A (en) | Certain 2-benzoxazolinone compounds having methoxy and halo substituents | |
US3538113A (en) | N-substituted phthalimidines | |
US3532716A (en) | 2'-amino-(spiro-(1,4-benzodioxane-2,1'-cyclopropane)) |